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The majority of cellular ATP is produced by the mitochondrial F1Fo-ATP syn-
thase, also called complex V, which consists of nuclear- and mitochondrial-encoded
subunits. In order to form a functional enzyme, its proteins must be expressed at
appropriate levels, delivered to the correct destination within mitochondria and then
properly assembled. Proteins called assembly factors assist in the assembly process
and tightly regulate it on various levels.
The F1Fo-ATP synthase is thought to assemble in a modular way, involving
the formation of distinct assembly intermediates that associate with each other
in a defined order. Importantly, formation of the proton-conducting membrane
channel is the last step of complex V biogenesis. The channel-forming Atp6 and
Atp9 subunits are retained within two different assembly intermediates and their
association generates a mature F1Fo-ATP synthase. How this last step of complex
V biogenesis is regulated in order to prevent premature proton-channel formation
and thus membrane potential dissipation is currently poorly understood.
Recently, the Inner Membrane Assembly Complex (INAC) was identified that
participates in the assembly of yeast F1Fo-ATP synthase. Its two members, Ina22
and Ina17, were shown to physically associate with nuclear-encoded F1Fo-ATP syn-
thase subunits and to facilitate assembly of the peripheral stalk of complex V. In
this study, we revise the current knowledge of F1Fo-ATP synthase biogenesis and de-
scribe a novel regulatory role of INAC. We found that INAC interacts not only with
nuclear-encoded, but also with mitochondrial-encoded structural subunits, as well
as other assembly factors of the F1Fo-ATP synthase, within two distinct assembly
intermediates. One of these intermediates contains Atp6 and the other one contains
the Atp9 ring, that together form a proton-conducting channel. We found that, in
contrast to what was known before, all nuclear-encoded subunits associate with the
Atp6-containing assembly intermediate prior to their interaction with the Atp9 ring.
Therefore, a novel F1Fo-ATP synthase assembly intermediate was characterized in
this study.
Our extensive analyses revealed that the INA complex is involved in the most
critical step of complex V biogenesis, namely formation of the proton-conducting
membrane channel. Therefore, INAC ensures the tight coupling of proton movement
to ATP production. Moreover, our data provides novel insights into the composi-




1.1 Early evolution of eukaryotes
Oxygen is one of the life-defining elements on Earth. Changes in the concen-
tration of this element can be tracked throughout Earth’s history and correspond
to the thrive and decline of various life forms on our planet. Moreover, increased
concentrations of atmospheric oxygen enabled the development of efficient energy
production systems, such as oxidative phosphorylation, and a rapid expansion of
eukaryotic forms of life and multicellular organisms.
Geologically, Earth was formed around 4.5 billion years ago and remained un-
inhabited for almost one billion years (Dalrymple, 2001). The atmosphere of our
planet at that time contained very little free oxygen, if at all. It was saturated with
gases like CO2, N2, H2S, CO and was highly reducing (Kasting, 1993; Dismukes
et al., 2001; Kump, 2008). It was shown already at the beginning of the last cen-
tury that, when given an energy source, organic molecules can be spontaneously
formed from a gas mixture that resembles the early atmosphere on Earth (Miller,
1953). Whether this complex chemistry has indeed created early life on our planet
is still a matter of debate. However, it is known that the first bacterial forms of
life appeared around 3.7 billion years ago and produced their energy by anoxygenic
photosynthesis, using hydrogen and sulphur as electron donors (Olson, 2006).
It is generally accepted that cyanobacteria were the first organisms to produce
oxygen and, therefore, their appearance on Earth around 2.5 billion years ago pre-
dated aerobic respiration (Planavsky et al., 2014). The Great Oxygenation Event,
caused by a rapid increase in atmospheric oxygen concentration by photosynthetic
cyanobacteria, induced the first known massive extinction on Earth that wiped out
the majority of all existing obligate anaerobic species.
The increase in atmospheric oxygen concentration triggered the development of
a principally novel aerobic metabolism and, consequently, the eukaryotic expansion.
In the presence of oxygen, sugars became a significantly more efficient energy source,
giving up to 18 times more ATP compared to anaerobic metabolism (Dismukes et al.,
2001). Such an increase in energy supply made it possible for complex biochemical




1.2 Main features of eukaryotic cells
Eukaryotic cells differ significantly from prokaryotes. First of all, eukaryotes
enclose their genetic information within a separate compartment, the nucleus, and
therefore strictly separate nuclear transcription from cytoplasmic translation. Sec-
ond, they are almost ten times bigger in size and contain intracellular membrane-
enclosed compartments called organelles (Palade, 1964). Each organelle in the cell
is surrounded by at least one membrane, built up from two layers of bi-polar phos-
pholipids. Membranes create a hydrophobic barrier in the hydrophilic cytoplasm
that do not allow molecules to freely diffuse within the cell. This, in turn, allows
each organelle to create and to maintain a unique biochemical environment, includ-
ing pH, ion concentration and a specialized proteome. Therefore, eukaryotic cells
evolved and sustained an enormous complexity. In fact, biochemically incompatible
anabolic and catabolic reactions can be differentially regulated due to their spatial
separation.
Despite all the advantages, eukaryotes faced new problems associated with
increased energy demands for maintaining complex processes and regulatory net-
works. Interestingly, the most energy-requiring processes in the cell are associated
with the quality control of transcription, mRNA splicing and maturation, protein
synthesis, protein targeting and homeostasis (Liberek et al., 2008; Amma et al.,
2008). Therefore, eukaryotic cells rely much more on aerobic energy production via
oxidative phosphorylation than prokaryotes. Simply because aerobic oxidation of
substrates is much more efficient than anaerobic, the development of the oxidation-
phosphorylation (OXPHOS) system allowed eukaryotes to thrive and multicellular
organisms to evolve. Interestingly, all eukaryotes contain their OXPHOS machinery
within a unique organelle, the mitochondrion.
1.3 Mitochondria
1.3.1 Origins of mitochondria
Mitochondria appeared as a result of a single endosymbiotic event between two
prokaryotic organisms approximately 1.5 billion years ago. According to the most
accepted hypothesis, the host cell, an obligate anaerobe, engulfed an endosymbiotic
cell by active phagocytosis. The endosymbiont was an aerobe that used metabo-
lites, produced by the host cell, and detoxified oxygen. Complete sequencing of
numerous mitochondrial and prokaryotic genomes showed that mitochondria most
likely originate from an α-proteobacterial ancestor (Lang et al., 1999; Andersson
et al., 2003). Interestingly, the genome of the bacterium Rickettsia prowazekii is
the most “mitochondria-like” and resembles tremendously the most “bacteria-like”
mitochondrial genome of Reclinomonas americana (Andersson et al., 1998). An
3
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extensive sequencing of various mitochondrial genomes showed that they are exclu-
sively dedicated to mitochondrial translation, electron transport chain function and
the production of ATP (Gray et al., 1999; Lang et al., 1999). Moreover, sequencing
has revealed that most mitochondrial genomes underwent a “reductive evolution”,
resulting in smaller genomes encoding less proteins in higher eukaryotes, compared to
the large ancestral-like mitochondrial genomes of protists (Andersson and Kurland,
1998). The reduction of the genome capacity happened mostly due to the transfer
of mitochondrial-encoded genes to the nucleus, which is still an ongoing process in
many flowering plants (Martin and Herrmann, 1998). But, in some cases, the func-
tion of mitochondrial gene products was taken over by unrelated nuclear-encoded
proteins. One such example is the substitution of a bacteria derived multisubunit
RNA-polymerase to a single-subunit bacteriophage T3/T7-like polymerase in mito-
chondria of almost all eukaryotes (Gray and Lang, 1998). In some cases, however,
mitochondrial genes were simply lost and never functionally replaced. This hap-
pened, for example, with the S. cerevisiae respiratory chain complex I, which is no
longer present in this species (Kurland and Andersson, 2000).
1.3.2 Mitochondria-like organelles
“Mitochondria”, in a broader sense, is a family of related organelles present in
various species of the eukaryotic phylum. They can be divided into four major groups
based on whether they produce ATP and on their mechanism for ATP production.
Mitochondria. Mitochondria, such as those present in mammalian cells, use
molecular oxygen (O2) as a final electron acceptor to produce up to 36 mol of ATP
per mol of glucose. Water and carbon dioxide are their by-products. Mitochondria
contain their own DNA, translation machinery and an electron-transport chain.
These organelles are typical for higher eukaryotes, plants and many protists.
Anaerobic mitochondria. Many invertebrate species adapted to life in anaer-
obic conditions. Their mitochondria do not use O2 as a final electron acceptor and
they therefore excrete end products like carbon dioxide, acetate, propionate and
succinate. Although these organelles retained their electron-transport chain, they
are less efficient than aerobic mitochondria and produce only 5 mol of ATP per mol
of glucose (Mentel and Martin, 2008).
Hydrogenosomes. Hydrogenosomes were discovered in 1973 in the unicellular
eukaryotes, Trychomonads, and since then in many more unrelated species (Müller
and Fox, 1984; Müller, 1993). These organelles produce ATP by a simple fermenta-
tion of pyruvate and produce molecular hydrogen as a final endproduct. Aside for
few exceptions, hydrogenosomes do not have their own genome or electron-transport
chain (Boxma et al., 2005). Two different hypotheses exist on their origin. According
to the first, hydrogenosomes evolved from aerobic mitochondria after the acquisi-
tion of anaerobic enzymes (Embley et al., 1997). The second hypothesis claims that
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mitochondria and hydrogenosomes evolved simultaneously from a common ancestor
and specialized later to aerobic and anaerobic conditions, respectively (Martin et al.,
2001).
Mitosomes. This last group of mitochondria-like organelles is not involved
in ATP synthesis, as all necessary enzymes were transferred to the cytoplasm. Mi-
tosomes have neither a genome, nor the respiratory chain and protein translation
machinery (Mai et al., 1999; Tovar et al., 1999; von der Giezen and Tovar, 2005).
The only function which they fulfill is the production of FeS clusters as enzymatic
co-factors, a process that, with one known, exception can not be done anywhere else
in the eukaryotic cell (Müller, 1993; Karnkowska et al., 2016).
1.3.3 Mitochondrial structure and dynamics
As a result of their endosymbiotic origin, mitochondria are surrounded by two
membranes. The outer mitochondrial membrane (OMM) originates from the plasma
membrane of the host cell, whereas the inner mitochondrial membrane (IMM) once
belonged to the engulfed α-proteobacterium (Fig. 1.1). Therefore, two soluble com-
partments are separated in the mitochondria - the matrix and the inter membrane
space (IMS).
The OMM does not create a barrier for small molecules due to the presence of
porins. Therefore, ion concentrations in the cytoplasm and the IMS do not differ
significantly (Benz, 1994). On the other hand, the IMM is highly impermeable
to small molecules allowing mitochondria to establish an electrochemical gradient
across the IMM, which drives protein import into the organelle (discussed in 1.3.5)
and ATP production. The IMM has a much larger surface area compared to the
Figure 1.1 A schematic representation of the mitochondrion. The mitochondrion is an
organelle with two membranes and two soluble compartments. OMM, outer mitochon-
drial membrane, IMM, inner mitochondrial membrane, IMS, inter membrane space.
OMM and forms invaginations towards the matrix, called cristae. The IMM can
be divided into structurally and functionally distinct domains. The inner boundary
membrane is located close to the OMM and houses protein import machinery, as here
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the translocases of the inner and the outer membranes come into contact. Cristae
junctions are sites where the inner boundary membrane bends to form cristae. A
highly specialized protein machinery has evolved to maintain cristae junctions -
the MICOS complex (Mitochondrial Contact site and Cristae Organization System)
(van der Laan et al., 2012). Moreover, cristae are additionally stabilized by dimers of
F1Fo-ATP synthase which, together with MICOS, maintain the unique ultastructure
of the IMM (Arnold et al., 1998; Paumard et al., 2002).
Mitochondria are very dynamic organelles that form an interconnected network
in the cell. The size of this network is controlled by the opposing processes of
fusion and fission. In human, fission is performed by Dynamin-related protein 1
(DRP1) and results in fragmentation of the mitochondrial network that facilitates
autophagic removal of damaged mitochondria (Taguchi et al., 2007). Fusion, on the
other hand, is performed by Mitofusin 1 and 2 (MFN1, MFN2), two GTP-binding
proteins of the OMM (Chen et al., 2003) and Optic Atrophy 1 (OPA1) (Ishihara
et al., 2006). Balance between fusion and fission events is necessary for proper
mitochondrial function and quality control. The mitochondrial network responds
greatly to external signals, such as nutrient availability, stress, diseases, and varies
significantly between organs and tissues (Wai and Langer, 2016). Therefore, the
regulation of mitochondrial dynamics is key to efficient mitochondrial adaptation
and is one of the main topics of current mitochondrial research.
1.3.4 Mitochondrial functions
Mitochondria fulfill various functions in the cell, including energy production,
fatty acid and lipid biosynthesis, biosynthesis of heme and iron-sulphur (FeS) clus-
ters (Lill and Mühlenhoff, 2008, Tovar et al., 2003), Ca2+-signaling (Clapham, 2007),
programmed cell death (Green and Reed, 1998) and ROS (reactive oxygen species)
signaling (Shadel and Horvath, 2015). They have been implicated in aging and
cancer and their disfunction is associated with many severe disorders. Recent dis-
coveries have shown that mitochondria maintain physical contacts with other cellular
organelles, like the ER (Mishra and Chan, 2017). Moreover, they are important for
intracellular communication and maintenance of cytoplasmic protein homeostasis
(Ruan et al., 2017). Surprisingly, mitochondria have recently been suggested to be
involved in the biogenesis of peroxisomes (Sugiura et al., 2017).
Though it is generally assumed that the main function of mitochondria is ATP
synthesis, there are organisms for which this process is dispensable. Yeast S. cere-
visiae can switch between aerobic and anaerobic metabolism, implying that energy
production by mitochondria is not essential. However, yeast can not survive without
mitochondria, meaning that the organelle is essential per se. The understanding of
this phenomena came when mitosomes were discovered. Mitosomes do not have an
electron transport chain and do not produce ATP. However, they house essential
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steps in the production of enzymatic cofactors, such as FeS clusters. Until recently
it was generally accepted that there is no other organelle in the cell that can take
over this function. However, a discovery of oxymonad Monocercomonoides sp., a
eukaryotic organism without mitochondria, has changed this dogma. In this organ-
ism, the enzymes of the FeS cluster biosynthesis pathway were translocated to the
cytoplasm and the mitochondria were consequently lost (Karnkowska et al., 2016).
1.3.5 Import of nuclear-encoded proteins into mitochondria
Yeast mitochondria contain approximately 1000 different proteins within four
distinct compartments – OMM, IMS, IMM and the matrix (Sickmann, 2003; Schmidt
et al., 2010). 99% of the mitochondrial proteome is encoded in the nuclear genome
and only a handful of proteins (8 in S. cerevisiae) are produced “in house” (Ott
and Herrmann, 2010). Thus, mitochondria depend greatly on cytosolic translation
and the correct targeting and import of nuclear-encoded proteins (Chacinska et al.,
2009). In most cases, mitochondrial proteins are targeted to the organelle by a
presequence, an amphipatic α-helix that varies greatly in length and amino acid
composition (Schatz and Dobberstein, 1996; Vögtle et al., 2009; Schulz et al., 2015),
or by internal hydrophobic recognition sites, common for multispanning membrane
and soluble IMS proteins (Chacinska et al., 2009). Independent of how the proteins
are targeted, they are imported into the organelle in an unfolded state and therefore
guided by cytoplasmic chaperones to prevent their aggregation (Young et al., 2003).
Although it is generally accepted that proteins are imported into the mitochondria
post-translationally, recent data suggests that co-translational protein import might
also be possible (Wiliams et al., 2014). Five major import pathways exist that
deliver proteins to mitochondria.
Translocase of the Outer Membrane, TOM. The TOM complex is the
main entry gate to the mitochondria that delivers substrate proteins to at least four
different downstream import machineries (Ryan et al., 2000). Tom20 and Tom22
are protein-receptors that recognize N-terminal presequences, whereas Tom70 rec-
ognizes the internal hydrophobic signals of metabolite carriers. However, Tom70
was recently shown to interact with the presequence of Mdl1 and therefore to act
as a presequence-receptor (Melin et al., 2015). Receptor proteins pass on their sub-
strates to Tom40, a β-barrel channel in the OMM. The inner side of Tom40 has both
negatively charged and hydrophobic residues, which interact with positively charged
presequences and hydrophobic signals of imported substrates, respectively (Shiota
et al., 2015).
Translocase of the Inner Membrane, TIM23. The central core of the
TIM23 complex, Tim23, forms a channel in the IMM (Truscott et al., 2001) that
mediates both protein insertion into the IMM and translocation to the matrix.
Whereas membrane protein insertion requires only the membrane potential (van der
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Laan et al., 2007), additional energy from ATP hydrolysis is needed for matrix
translocation. mtHsp70 assists ATP-driven protein translocation through the Tim23
channel (Lang et al., 1999) and functions together with the Presequence translocase
- Associated import Motor (PAM), which consists of the Pam18, Pam16, Pam17,
Mge1 and Tim44 proteins.
TIM22. The TIM22 complex inserts proteins with internal targeting sig-
nals, such as members of the mitochondrial metabolite-carrier family, into the IMM
(Rehling et al., 2004). The substrates first pass through the Tom40 channel and are
guided to TIM22 by small chaperones of the IMS that prevent substrate aggregation
(Koehler et al., 1998). The chaperones dock their substrates onto TIM22 (Wagner
et al., 2008), a pore-forming dimer, which then opens in a membrane potential-
dependent manner to accommodate α-helices and mediate membrane protein inser-
tion (Rehling et al., 2003). Recently, in yeast, subunit 3 (Sdh3) of the complex II
of the respiratory chain was shown to cooperate with TIM22 in the biogenesis and
assembly of membrane proteins, implying that subunits of the respiratory chain can
have dual functions (Gebert et al., 2011).
Mitochondrial IMS Assembly (MIA) pathway Proteins destined for the
IMS contain multiple disulfide bridges and a characteristic motif, called the IMS
sorting signal (MISS) (Sideris et al., 2009). These proteins are properly folded in
the IMS with the help of MIA machinery, consisting of Mia40 together with the
sulfhydril oxidase Erv1 (Mesecke et al., 2005).
Sorting and Assembly machinery of the outer Membrane, SAM. The
outer mitochondrial membrane contains a unique type of protein that originates from
a prokaryotic ancestor – integral β-barrels. These proteins are initially imported
via the TOM complex to the mitochondrial IMS, where they associate with small
chaperones to prevent their aggregation. The final step of membrane insertion is
mediated by the SAM complex, consisting of a channel-forming Sam50, together
with Sam35 and Sam37 (Wiedemann et al., 2003).
The Mitochondrial import complex, MIM. Mim1 was found to assist the
insertion of OMM proteins anchored to the membrane by a single N-terminal α-helix,
like Tom20 and Tom70, and multispanning membrane proteins, like Ugo1 (Becker
et al., 2008; Papic et al., 2011). Interestingly, the biogenesis of the C-tail anchored
proteins of the OMM is not understood and the protein machinery for their insertion
has not yet been identified. However, it is known that the lipid composition of the
membrane is essential for their insertion (Kemper et al., 2008).
Non-canonical pathways for protein import. Evidence has emerged that
some proteins do not use any of the 5 known canonical import machineries for their
import, but rather a combination of several. One example is the outer membrane
protein, Om45, that contains an N-terminal membrane anchor and a large IMS-
exposed domain. Om45 is first imported into the mitochondrion in a membrane-
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potential-dependent manner via the TOM and TIM23 complexes. However, at some
point Om45 escapes these translocases and is inserted into the OMM by MIM (Song
et al., 2014; Wenz et al., 2014).
1.4 Expression of the mitochondrial genome
1.4.1 The mitochondrial genome
In the course of evolution, eukaryotic organisms have retained a mitochondrial
genome (mtDNA). The reason for this is still a matter of debate. Replication and
transcription of mtDNA, as well as the translation of the produced mRNAs requires
the import of hundreds of proteins from the cytoplasm and consumes enormous
cellular resources. Two major theories dominate in the field that explain why not
all mitochondrial genes were transferred to the nucleus. The hydrophobicity theory
suggests that mitochondrial proteins, if translated in the cytoplasm, would not be
efficiently imported into the mitochondria because of their high hydrophobicity (von
Heijne, 1986). The co-location for redox regulation hypothesis claims that retaining
a genome inside of the organelle allows it to regulate gene expression according to
its redox state (Allen, 1993).
The mitochondrial genomes among eukaryotes are extremely diverse and encode
for different protein-components of the OXPHOS machinery. The yeast S.cerevisiae
is an important model organism for which manipulation of the mtDNA is possible
and, therefore, its gene-expression system is relatively well-characterized. In the
following section, maintenance of the S. cerevisiae genome, as well as the biogenesis
of mitochondrial-encoded proteins, will be discussed in more detail.
mtDNA is packed together with associated proteins into mitochondrial nu-
cleoids that vary in size from 0.2 to 0.9 μm. Depending on whether cells were
cultured aerobically or anaerobically, there can be as many as 60 to 8 nucleoids
present in one cell, respectively, with each nucleoid containing from 1 to 20 copies
of mtDNA (Miyakawa et al., 1987; Shiiba et al., 1997). mtDNA is packed by posi-
tively charged non-histone proteins of High Mobility Group family (HMG) (Caron
et al., 1979; Diffley and Stillman, 1991). Abf2 is the best studied HMG protein in
yeast. It was estimated that 1 molecule of Abf2 is present per 15-30 bp of mtDNA
(Brewer et al., 2003). The absence of Abf2 leads to yeast mitochondrial genome
instability, but not to the complete loss of mitochondrial nucleoids (Newman et al.,
1996), meaning that there are more proteins involved in nucleoid packaging.
Yeast mtDNA encodes for 2 rRNAs (15S rRNA and 21S rRNA), 24 tRNAs, 7
mRNAs, and the 9S RNA component of RNase P (Foury et al., 1998) (Fig. 1.2).
8 proteins are encoded by mtDNA in total, 7 of them are components of the respira-
tory chain and one is a structural component of a small ribosomal subunit (Var1).
Depending on the laboratory strain, yeast mtDNA contains up to 13 introns (9 of
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Figure 1.2 Organisation of the S. cerevisiae mitochondrial genome. The yeast mitochon-
drial genome encodes for 2 rRNAs, 24 tRNAs, 7 mRNAs and 9S RNA component of
RNase P. Genes encoding for Cox1, Cytb and 21S rRNA contain introns. rRNA,
ribosmal RNA; tRNA, transfer RNA. Adapted from Jacobs, 2001.
group I and 4 of group II) within the COX1, COB and 21S rRNA genes (Pel and
Grivell, 1993). Intronic ORFs encode endonucleases, maturases and reverse tran-
scriptases required for splicing and transcript maturation. Due to long noncoding
regions, the yeast mitochondrial genome is 75 kB in length and is almost five times
bigger than the human mitochondrial genome.
1.4.2 Mitochondrial transcription and maturation of transcripts
Transcription in mitochondria is performed by a nuclear-encoded mitochon-
drial RNA polymerase (mtRNAP), consisting of the catalytic subunit Rpo41p and
the transcription factor Mtf1p (Greenleaf et al., 1986; Jang and Jaehning, 1991).
Rpo41p is related to bacteriophage polymerases and therefore originated from nei-
ther the endosymbiont nor the host cell (Shutt and Gray, 2006). mtRNAP binds to
simple nonanucleotide promoter sequences to initiate the transcription of 13 different
polycistronic primary transcripts (Osinga et al., 1982; Christianson and Rabinowitz,
1983). The mechanism of transcriptional termination in yeast mitochondria remains
unknown.
In S. cerevisiae, transcription in mitochondria is controlled by ATP levels as
all transcripts start with an adenine nucleotide (Amiott and Jaehning, 1983). How-
ever, the regulation of mitochondrial gene expression happens mainly at the post-
transcriptional level, during transcript processing and translation, and involves
10
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Table 1.1 Factors involved in the expression of the S. cerevisiae genome
Gene Protein function References
AEP1 Stability and expression of ATP9 mRNA Payne et al., 1993; Ziaja et al.,
1993
AEP2 Stability and translation of ATP9 mRNA Finnegan et al., 1995
AEP3 Stability and expression of ATP6/8 mRNA Ellis et al., 2004
ATP22 Translation of Atp6 Zeng et al., 2007a
ATP25 Stability of ATP9 mRNA and Atp9 ring assembly Zeng et al., 2008
CBP1 5’ end processing of COB mRNA, together with Pet127 Dieckmann et al., 1982; Dieck-
mann et al., 1984
CBP2 Splicing of the bi5 and bi2 group I introns of COB mRNA
precursor
Gampel et al., 1989
CBP3 Expression and assembly of Cytb Gruschke et al., 2011;
CBP6 Expression and assembly of Cytb Gruschke et al., 2011; Dieck-
mann and Tzagoloff, 1985
CBS1 Translation of the COB mRNA Rödel, 1986
CBS2 Translation of the COB mRNA Rödel, 1986
CBT1 5’ end processing of the COB mRNA Rieger et al., 1997
COA3 Translation of COX1 mRNA and assembly of complex
IV
Mick et al., 2010
COX14 Translation of the COX1 mRNA and assembly of Com-
plex IV
Barrientos et al., 2004
MAM33 Translational activator for COX1 mRNA Seytter et al., 1998; Roloff and
Henry, 2015
MRS1 Splicing of the bi3 intron of COB mRNA and the ai5β
intron of COX1 mRNA
Bousquet et al., 1990
MSS18 Splicing of the ai5β intron of COX1 mRNA
MSS51 Translation of COX1 mRNA Barrientos et al., 2004; Perez-
Martinez et al., 2003
MSS116 Splicing of group I and II introns from COX1 and COB
mRNAs
Huang et al., 2004
NCA2 Processing and expression of the ATP6/8 mRNA Camougrand et al., 1995
NCA3 Processing and expression of the ATP6/8 mRNA Pelissier et al., 1995
PET111 Translation of the COX2 mRNA Green-Willms et al., 2001
PET122 Translation of the COX3 mRNA Naithani et al., 2003
PET309 Stability of intron-containing transcripts and translation
of the COX1 mRNA
Manthey and McEwen, 1995
PET494 Translation of the COX3 mRNA Müller and Fox, 1984; Naithani
et al., 2003
PET54 Translation of the COX3 mRNA and splicing of the ai5β
intron of COX1 mRNA
Costanzo et al., 1989; Valen-
cik et al., 1989; Naithani et al.,
2003; Mayorga et al., 2016
QRI5 Processing of intron-containing transcripts and transla-
tion of the COX1 mRNA
Barros et al., 2006
RMD9 Mitochondrial protein with role in delivering mRNAs to
ribosomes
Williams et al., 2007
Continued on the next page
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Table 1.1 – Continued from previous page
Gene Protein function References
RSM28 Mitochondrial ribosomal protein of the small subunit;
possibly promotes translation initiation
Williams et al., 2005; Williams
et al., 2007
SMT1 Negative regulator of ATP6/8 mRNA translation Rak et al., 2016
SOV1 Var1 expression Sanchirico, 1998
Modified from Lipinski et al., 2010
almost exclusively nuclear-encoded proteins (summarized in Table 1.1). In brief, in-
trons are spliced-out with the help of intron-encoded maturases and nuclear-encoded
splicing factors, such as Mss18, Cbp2 and Mrs1. Afterwards, the mature 3’ ends of
the transcripts are formed by processing at a conserved dodecamer sequence (Osinga
et al., 1984).
This cleavage, in some cases, physically separates mRNAs from the initial poly-
cistronic transcripts. In other cases, open reading frames remain associated, as in
the case of the bicistronic ATP6/ATP8 mRNA. The exact mechanism and ma-
chinery required for 3’ end processing is not yet fully characterized. Interestingly,
yeast mitochondria lack the poly(A) polymerase and therefore do not polyadeny-
late mRNA precursors (Gagliardi et al., 2004). However, all yeast mitochondrial
mRNAs contain long 5’ untranslated regions (5’ UTRs), which provide binding sites
for nuclear-encoded, gene-specific, translational activators and proteins that regu-
late mRNA stability (Bonnefoy et al., 2001; Naithani et al., 2003; Green-Willms
et al., 2001; Costanzo et al., 1989). tRNAs are excised from the polycistronic pre-
cursors and are further processed at their 3’ and 5’ ends (Chen and Martin, 1988;
Stribinskis et al., 1996).
In yeast, the expression of the mitochondrial genome is balanced between tran-
scription and RNA degradation. The degradation of mtRNAs is performed by the
mitochondrial degradosome complex, consisting of RNA helicase Suv3 and exori-
bonuclease Dss1 (Dziembowski et al., 2003). Knockout of either protein leads to a
similar phenotype – an accumulation of excised intronic sequences, non-processed
transcripts and therefore a loss of mitochondrial translation.
1.4.3 Mitochondrial translation
It was initially believed that, due to its origin, the mitochondrial translation
system should not differ significantly from that of bacteria. However, recent discov-
eries clearly showed that there is very little conservation between the two in regard
to codon usage, mRNAs, tRNAs and ribosomal structure. In this section, the S.
cerevisiae translation system will be discussed in more detail.
Mitochondrial tRNAs and mRNAs. Here, several major features of the
mitochondrial translation systems will be mentioned:
12
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(I) The yeast mitochondrial genome encodes a full set of tRNAs, however, one
nuclear-encoded lysine tRNA is imported into the mitochondrial matrix from the
cytoplasm. Most likely, this tRNA has a regulatory function as it is not essential for
mitochondrial protein translation (Schneider, 2011). Overall, mitochondria contain
only 24 tRNAs (in comparison to more than 40 in bacteria) that correspond to 20
different amino acids, meaning that each tRNA needs to recognize additional codons
(Wesolowski and Fukuhara, 1979).
(II) The genetic code, used by mitochondria, varies significantly from the canon-
ical one (for example, leucine codons CUA, CUC, CUG and CUU are used for
threonine).
(III) Mitochondrial mRNAs contain long 5’ and 3’ untranslated regions, im-
portant for translational regulation. Moreover, they lack a classical Shine-Dalgarno
region for translation initiation and it is not really understood how the start codon
is recognized (Dunstan et al., 1997; Christian and Spremulli, 2010). As has already
been mentioned, yeast mitochondrial mRNAs are not polyadenylated at their 3’
ends.
Mitochondrial ribosomes. Recently, high-resolution cryo-EM structures of
a large ribosomal subunit, as well as of a complete mitochondrial ribosome, were
published (Amunts et al., 2014; Desai et al., 2017). The large subunit of a mito-
chondrial ribosome (54S) contains a 21S rRNA and 39 proteins, 13 of which are
unique to mitochondria. The small subunit (37S) consists of a 15S rRNA and 34
proteins, including 14 without homologs in the evolutionarily-related bacterial ribo-
some. Therefore, mitochondrial ribosomes have an overall increased protein content
compared to bacterial ribosomes, as well as a higher protein:RNA ratio (2:1 in mito-
chondria compared to 1:2 in prokaryotes). The most significant difference is the loss
of the 5S rRNA in mitochondrial ribosomes. Normally, 5S rRNA forms a central
protuberance on the large subunit (Dontsova and Dinman, 2005), but in yeast, the
central protuberance is formed around the 21S rRNA expansion segment. Despite
all the structural differences, the catalytic centers contain conserved nucleotides,
implying that the overall protein synthesis mechanism is conserved.
The translation cycle in mitochondria. Translation in mitochondria pro-
ceeds through conserved stages, called initiation, elongation and termination. Initi-
ation is usually the rate-limiting and the most regulated step. Yeast mitochondrial
initiation factor 2 (IF2) is encoded by the nuclear IFM1 gene. IF2 is the most
evolutionary-conserved factor present in both cytoplasmic and mitochondrial trans-
lation systems in various species. IF2 binds initiator tRNAMet and positions it on a
start-codon in a GTP-dependent manner. In yeast, mtDNA encodes for two differ-
ent tRNAMet, one for the initiation and another one for the elongation cycle. Despite
the usage of a specialized initiator tRNA, its formylation in yeast mitochondria is
not required (Garofalo et al., 2003). The yeast mitochondrial translation system dif-
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fers significantly from the cytosolic, as initiation of translation requires additional
translational activators (TA). Each mRNA requires a specific nuclear-encoded TA
(Table 1.1) that interacts with the 5’ UTR of the corresponding mRNA and, usually,
with the mitochondrial ribosome. Despite a significant amount of data about the
role of TAs, the molecular details of their function remain unknown.
Two factors are involved in the yeast mitochondrial elongation cycle, Mef1 and
Mef2, homologous to the prokaryotic elongation factors EF-G and EF-Tu, respec-
tively (Vambutas et al., 1991). A bacterial homolog of EF-Ts is not present in S.
cerevisiae, however, it was found in Schizosaccharomyces pombe and human mito-
chondria (Towpik, 2005). EF-Tu delivers the aminoacyl-tRNAs to the mitochondrial
ribosome in complex with GTP, whereas EF-G catalyzes the coordinated movement
of tRNA and mRNA during the elongation cycle.
Normally, termination occurs when a translating ribosome encounters one of
the three stop codons - UGA, UAA, UAG. However, mitochondria have reduced
the number of termination codons to only two, with UGA coding for tryptophan
(Fox, 1979). The termination step is mediated by two factors, mitochondrial release
factor mRF1 and ribosomal recycling factor RRF. mRF1 decodes the stop signal on
mRNA and is a homolog of prokaryotic RF1 and RF2 (Pel et al., 1992).
1.4.4 Co-translational membrane protein insertion
The mitochondrial genome encodes seven membrane proteins of OXPHOS sys-
tem. Most of them are polytopic membrane proteins that span the IMM up to 12
times (Cox1), with only Atp8 having a single transmembrane domain (Fig. 1.3).
During insertion, proteins follow the positive-inside rule, similar to bacterial mem-
brane proteins. This means that protein loops and termini in the matrix carry a net
positive charge, whereas the soluble IMS domains are charged negatively (Ott and
Herrmann, 2010).
Figure 1.3 Mitochondrial-encoded membrane proteins of S. cerevisiae. The yeast mito-
chondrial genome encodes for 7 protein components of the OXPHOS system. IMS,
inter membrane space. Adapted from Ott and Herrmann, 2010.
The mitochondrial membrane protein insertion system is homologous to the
bacterial machinery. The bacterial YidC complex usually assembles small substrates
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that lack highly charged domains, whereas the membrane insertion of larger pro-
teins requires the SecYEG translocon (Nagamori et al., 2004; Driessen and Nouwen,
2008). The mitochondrial insertion system was simplified over the course of evo-
lution and only the YidC homolog, Oxa1, is present in S. cerevisiae (Hell et al.,
2001). Oxa1 is a member of the YidC/Alb3/Oxa1 family that represents proteins of
bacterial membranes, chloroplast and inner mitochondrial membranes, respectively.
Oxa1 contains a catalytic core composed of 5 transmembrane segments, similar to
YidC (Kumazaki et al., 2014a; Kumazaki et al., 2014b). The protein was shown to
dimerize (Kohler et al., 2009). An Oxa1 dimer, containing 10 transmembrane spans,
resembles the bacterial SecY translocon and most likely is the actively translocating
form of the channel, as dimerization allows the formation of a membrane-conducting
channel, as well as the release of proteins into the membrane.
In yeast, Oxa1 directly binds to translating ribosomes via its C-terminus and
therefore engages with nascent chains (Jia et al., 2003). Apart from mediating
protein membrane insertion, Oxa1 is believed to facilitate the folding and assembly
of membrane proteins. This suggestion came from an observation that in E. coli,
subunit c of the F1Fo-ATP synthase (homolog of the mitochondrial Atp9 protein)
is assembled into the mature enzyme with the help of Oxa1 homolog YidC (van der
Laan et al., 2004) and was later proven to be the case in yeast (Jia et al., 2007).
Surprisingly, only membrane insertion of the Cox2 protein strictly depends on Oxa1,
whereas all other mitochondrial-encoded products are integrated into the membrane
even when Oxa1 is absent (Hell et al., 2001; Bauer et al., 1994). Therefore, multiple
genetic screens were performed in order to identify additional components of the
mitochondrial insertion machinery.
Cox18 is one more member of the YidC/Alb3/Oxa1 family, found in yeast
mitochondria. It contains the conserved insertase domain but, unlike Oxa1, does
not have the C-terminus required for the interaction with ribosomes (Souza et al.,
2000; Saracco and Fox, 2002; van Bloois et al., 2007). Cox18 was proposed to play
an important role in the assembly of the C-terminus of Cox2 and, therefore, to be
involved in cytochrome c oxidase biogenesis.
To decrease the probability of nascent chain aggregation, translation in mito-
chondria is coupled to membrane protein insertion. As a result, actively translating
mitochondrial ribosomes are associated with the IMM. In yeast, a nuclear-encoded
Mba1 protein mediates ribosomal attachment to the membrane insertion machin-
ery (Preuss et al., 2001; Ott et al., 2006). Cryo-electron tomography studies have
shown that Mba1 is aligned with the tunnel exit to provide an uninterrupted route
for the nascent chain from the ribosome to the membrane (Pfeffer et al., 2015).
Although Mba1 is not an essential protein, a simultaneous deletion of MBA1 and




The second mitochondrial ribosomal tether is Mdm38, a 65 kDa protein that
was identified in a systematic genome-wide screen for genes important for mito-
chondrial distribution and morphology (MDM) (Dimmer et al., 2002). Mdm38 was
found to associate with mitochondrial ribosomes (Frazier et al., 2006). Deletion of
MDM38 leads to a severe respiration defect and altered mitochondrial morphology.
The observation that Mdm38 associates with newly-translated mitochondrially en-
coded proteins, together with impaired Atp6 and Cytb insertion into the inner mito-
chondrial membrane upon MDM38 deletion, makes it a likely candidate to facilitate
ribosomal attachment to the IMM (Frazier et al., 2006). Moreover, it was shown
that simultaneous deletion of MBA1 and MDM38 results in yeast synthetic lethality
on non-fermentable carbon sources, suggesting overlapping functions of Mba1 and
Mdm38 for biogenesis of the respiratory chain (Bauerschmitt et al., 2010).
1.5 Mitochondrial Oxidative Phosphorylation System
1.5.1 Structure and function of OXPHOS system
The mitochondrion is the main source of energy in the eukaryotic cell. It
converts energy from reducing equivalents (NADH, FADH2) into the form of high-
energy ATP bonds. Five different enzyme complexes located in the IMM drive this
process (Fig. 1.4). Complexes I, III and IV transfer electrons to acceptor molecules
and pump protons from the matrix into the IMS, generating a proton gradient.
The last enzyme complex, complex V (or F1Fo-ATP synthase), uses this proton
gradient to generate ATP from ADP and Pi. All enzymes involved are composed
of multiple subunits of different genetic origin. Assembly of these complexes is
a multistep process that requires numerous assembly factors and a sophisticated
regulation mechanism.
There are two ways for electrons to enter the electron transport chain. The
first is to be transferred from NADH, through complex I (NADH:ubiquinone oxi-
doreductase), to ubiquinone. The second is a transfer from succinate to complex
II (succinate:ubiquinone oxidoreductase) and then to ubiquinone. Electrons travel
from ubiquinone, through complex III (ubiquinol:ferricytochrome c oxidoreductase),
to cytochrome c and, finally, through complex IV (cytochrome c oxidase) to oxygen.
Only electron transfer through complex II is not coupled with proton pumping to
the IMS.
Complex I (NADH:ubiquinone oxidoreductase or NADH dehydrogenase) is the
first proton-pumping complex of the respiratory chain. It transfers 2 electrons from
NADH and pumps 4 protons from the matrix to the IMS. One molecule of flavin
mononucleotide and several iron-sulfur clusters participate in the redox reactions
catalyzed by NADH dehydrogenase (Weiss et al., 1991). S. cerevisiae does not
have complex I. Instead, it uses an alternative enzyme, FAD rotenone-insensitive
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Figure 1.4 Mitochondrial OXPHOS system. The oxidation-phosphorylation system consists
of four complexes of the respiratory chain (I-IV) and complex V, or F1Fo-ATP syn-
thase. Electrons are passed from NADH and FADH2 to molecular oxygen in a series
of reactions to produce ATP. Q, ubiquinone.
dehydrogenase that has a single nuclear-encoded subunit and does not possess a
proton-pumping function (de Vries and Grievell, 1988; Lenaz and Genova, 2010).
Neurospora crassa was initially used as a eukaryotic model to study complex I struc-
ture. It was shown that the complex consists of two parts orientated perpendicular
to each other in an overall L-shaped structure (Guenebaut et al., 1997). Moreover,
the recently published crystal structure of Yarrowia lipolitica complex I provided
valuable insights into the structure and mechanism of complex I function (Zicker-
mann et al., 2015).
Succinate:ubiquinone oxidoreductase, or succinate dehydrogenase (SDH, com-
plex II), is highly conserved among all aerobic organisms and is a membrane-bound
enzyme of the Krebs cycle that catalyzes the oxidation of succinate to fumarate and
transfers electrons to ubiquinone. In contrast to other enzymes of the respiratory
chain, complex II does not contain structural subunits encoded in the mitochondrial
genome. SDH consists of 4 polypeptides, a FAD moiety and four iron-sulfur clusters
in the redox center. SDH transfers 2 electrons to ubiquinone and is considered to
be the smallest enzyme of the respiratory chain (Hatefi, 1985, Lenaz and Genova,
2010).
Ubiquinone is a small hydrophobic mobile electron carrier, reduced by com-
plexes I and II, and oxidized by complex III of the respiratory chain during electron
transfer (Genova and Lenaz, 2011). Ubiquinone can exist in three redox states: fully
oxidized (ubiquinone), semiquinone (ubisemiquinone) and fully reduced (ubiquinol).
Complex III, or ubiquinol-cytochrome c oxidoreductase (bc1 complex), accepts elec-
trons from ubiquinol (Hatefi, 1985). In S. cerevisiae, this complex consists of 10
different subunits: three respiratory subunits (cytochrome b, cytochrome c and
Rieske iron-sulfur protein); 2 core proteins (Cor1 and Qcr1) and 5 additional low-
molecular weight proteins. Only cytochrome b is encoded by the mitochondrial cob
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gene (Tzagoloff, 1995). Complex III passes electrons to another mobile electron
carrier, called cytochrome c.
Cytochrome c belongs to the cytochrome protein family but, in contrast to
other members of this family, it is hydrophilic and loosely associated with the inner
mitochondrial membrane. The main function of cytochrome c is to shuttle elec-
trons between complex III and complex IV of the respiratory chain (Volkov and van
Nuland, 2012).
The heme-copper oxygen reductase – cytochrome c oxidase (COX), or complex
IV, is the last enzyme in the respiratory chain. It transfers electrons to molecular
oxygen, thereby generating water, oxidizing cytochrome c and pumping protons
across the IMM (Capaldi, 1990). Yeast complex IV contains 11 different subunits.
The three largest subunits (Cox1, Cox2 and Cox3) are mitochondrial-encoded. The
other 8 are synthesized in the cytoplasm and imported by the TOM/TIM23 import
machineries (Mick et al., 2011). Genetic studies suggest that mitochondrial-encoded
proteins form the catalytic core of the enzyme, while nuclear-encoded proteins either
participate in complex assembly or modulate its catalysis and stability. Studies in S.
cerevisiae have revealed that more than 41 specific genes are additionally required
for the assembly and maturation of cytochrome c oxidase (Poynton et al., 1995;
Carr and Winge, 2003; Mick et al., 2011).
Respiratory chain complexes from S. cerevisiae, and other higher eukaryotes,
form higher-order structures called supercomplexes or respirasomes, whose structure
and assembly mechanisms were recently revealed (Mileykovskaya et al., 2012; Letts
et al., 2016; Cogliati et al., 2016; Wu et al., 2016). Respirasomes are advantageous to
the cell by increasing the efficiency of electron transfer and reducing the production
of reactive oxygen species (ROS) (Lenaz et al., 2010; Schägger, 2001). Supercom-
plexes can be easily visualized using Blue Native PAGE protein separation after
mitochondrial solubilization using a mild detergent (Schägger and Jagow, 1991).
1.5.2 Biogenesis of complex III
Complexes of the respiratory chain assemble from subunits of two different ge-
netic origins. Therefore, the coordinated expression of nuclear and mitochondrial
genomes is required for successful OXPHOS system biogenesis. Yeast cells have de-
veloped a sophisticated mechanism for the assembly of complex III and IV, which
includes a feedback-loop communication between mitochondrial translation and as-
sembly.
Ubiquinol-cytochrome c oxidoreductase is the first complex of the respiratory
chain in yeast that couples electron transfer to proton translocation across the in-
ner mitochondrial membrane. It consists of ten proteins, nine being encoded in the
nucleus and one, cytochrome b, being mitochondrial-encoded. In this section, bio-
genesis of the yeast cytochrome c reductase will be discussed; particular attention
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will be paid to the role of Cbp3/Cbp6 and Cbp4 proteins in its biogenesis.
The cytochrome b mRNA precursor is synthesized with 3 introns (bl2, bl3 and
bl4) that belong to groups I and II. The latter means that the introns themselves
possess catalytic activity required for their self-excision in vitro. In vivo, however,
additional proteins are needed to stabilize RNA structure and to promote efficient
splicing. Such proteins are Mss116, a protein with an RNA chaperone function
that belongs to the DEAD-box protein family, Cbp2 and Mrs1 (Huang et al., 2004;
Gampel et al., 1989; Bousquet et al., 1990). The mature COB mRNA is stabilized
by the Cbp1 protein. It was shown that in the absence of Cbp1, COB mRNA levels
are drastically decreased and, therefore, cytochrome b is not translated (Dieckmann
et al., 1982). An additional function for Cbp1 was proposed, namely the processing
of the 5’ UTR of COB mRNA during its maturation (Dieckmann et al., 1984).
Expression of cytochrome b requires several factors. Cbs1 and Cbs2 were shown
to interact with the 5’ UTR of COB mRNA to activate its translation (Rödel, 1986).
Interestingly, when the COB 5’ UTR was exchanged to the 5’ UTR of ATP9 mRNA,
Cbs1 and Cbs2 were no longer required for efficient cytochrome b translation. In line
with this, when the 5’ UTR of COX3 mRNA, encoding cytochrome c oxidase subunit
3, was exchanged to the 5’ UTR of COB transcript, Cox3 expression became strictly
Cbs1-dependent (Rödel and Fox, 1987). Both observations imply that untranslated
regions of mitochondrial mRNAs contain specific recognition elements, required for
binding of gene-specific translational activators (Rödel et al., 1985; Rödel, 1986).
Additionally, Cbs1 and Cbs2 interact with mitochondrial ribosomes, but not with
the newly translated cytochrome b, most probably to bringe the ribosome and the
mRNA together (Kehrein et al., 2015).
Two more factors are required for efficient cytochrome b biogenesis. Cbp3 and
Cbp6 are involved in a feedback loop mechanism required for the coordination of
cytochrome b synthesis and assembly (Dieckmann and Tzagoloff, 1985; Wu et al.,
2016; Gruschke et al., 2011; Gruschke et al., 2012). Deletion of CBP3 and CBP6
results in impaired yeast respiration due to the lack of mature complex III. Inter-
estingly, upon CBP3/CBP6 deletion, cytochrome b is still translated, although at
a reduced rate, but its stability is significantly decreased, most probably due to the
impaired assembly with the nuclear-encoded subunits. Translation and stability of
other mitochondrial-encoded OXPHOS machinery subunits is not affected in cbp
mutants (Gruschke et al., 2011).
Cbp3 and Cbp6 form a stable dimer that localizes to the mitochondrial matrix.
The dimer associates peripherally with the inner mitochondrial membrane and with
a mitochondrial ribosome near the peptide exit tunnel. Therefore, the Cbp3/Cbp6
dimer associates with newly translated cytochrome b to prevent it from degradation
and to assist it during further assembly steps. Before any structural subunits join the
assembly pipeline, cytochrome b binds Cbp3, Cbp6 and a membrane-bound assembly
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factor Cbp4 (Fig. 1.5). This first assembly intermediate, called intermediate I,
accumulates in wild type cells to levels easily detectable by Western blotting and
most likely represents a pool of cytochrome b that is ready to assemble into complex
III.
One of the crucial steps in cytochrome b biogenesis is hemylation. Cytochrome
b contains two hemes; bH, located closer to the matrix side, and bL, incorporated
into the IMS side of the IMM membrane (Yun et al., 1991). The two hemes are co-
ordinated by histidine residues in a four-helix bundle (Yun et al., 1991; Hunte et al.,
2000). Their incorporation into cytochrome b is an essential step and an important
check-point in the biogenesis process. Recently, the hemylation of cytochrome b
during its assembly was described (Hildenbeutel et al., 2014). It was shown that
bL is the first site to be hemylated. Heme incorporation happens when cytochrome
b is associated with Cbp3 and Cbp6 before the formation of intermediate I. An
efficient first hemylation event allows Cbp4 to join the assembly and intermediate
I to be formed. The authors proposed that insertion of bL heme induces conforma-
tional changes in cytochrome b that promote Cbp4 association. Cbp4 binding, in
turn, induces changes in cytochrome b structure, necessary for the second hemy-
lation event. The hemylation of the bH site happens when cytochrome b is a part
of intermediate I. Importantly, successful second hemylation triggers association of
cytochrome b with the first structural subunits, Qcr7 and Qcr8, and releases the
Cbp3/Cbp6 dimer. Cbp3/Cbp6 release is an important trigger that allows com-
plex III assembly to proceed further. Moreover, it is essential for the reactivation
of cytochrome b translation as the Cbp3/Cbp6 dimer relocates to the ribosome to
activate cytochrome b synthesis. In case hemylation fails, Cbp3 and Cbp6 remain
trapped in intermediate I, ensuring that no more cytochrome b is synthesized. Such
a feedback loop is also activated if delivery of nuclear-encoded complex III subunits,
namely Qcr7, Qcr8, Cor1 and Cor2, fails. This mechanism couples the translation
of cytochrome b with its assembly to ensure their coordination.
After Qcr7 and Qcr8 are assembled and the Cbp3/Cbp6 dimer is released,
intermediate II is formed (Fig. 1.5). Importantly, Cbp4 remains associated with
it until Cor1 and Cor2 are added to give rise to intermediate III. In intermediate
III, no more assembly factors are present as cytochrome b is already efficiently
stabilized by structural subunits. Next, the second catalytically active subunit, Cyt
c1, is added together with Qcr6, to produce intermediate IV. Intermediate IV, as
well as intermediate I, accumulate to detectable amounts in wild type cells and was












Figure 1.5 A schematic representation of cytochrome b assembly. Biogenesis of cytochrome b includes several sequential steps. First, the protein
is synthesized by membrane-bound ribosomes. At this stage, Cbs1/Cbs2 interaction with the 5’ UTR of COB mRNA, as well as Cbp3/Cbp6
association with the ribosome, is required. Next, the fully synthesized cytochrome b remains bound to Cbp3/Cbp6 and interacts with Cbp4
to form the assembly intermediate I. During these first steps, cytochrome b acquires its heme moieties. Afterwards, Qcr7 and Qcr8 join the
assembly line that induces Cbp3/Cbp6 release from assembly intermediate I. Subunits Cor1, Cor2, cytochrome c1, and Qcr6 are added to form
intermediates III and IV. Rip1, Qcr9 and Qcr10 are added in the last step in order to form the mature enzyme. Modified from Gruschke et al.,
2012. IMS, inter membrane space; IMM, inner mitochondrial membrane.
21
INTRODUCTION
The last catalytic subunit of complex III, Rip1, is added together with two non-
essential subunits, Qcr9 and Qcr10, to form the mature enzyme. Interestingly, Rip1
biogenesis requires specialized factors. First, Mzm1 interacts with Rip1 to stabilize
its FeS clusters and, most likely, to facilitate its association with Bcs1 (Atkinson
et al., 2011). Bcs1 is a AAA-protease that binds Rip1 and transports it across the
IMM, which represents a unique pathway of mitochondrial protein translocation
(Wagener et al., 2011).
The fully assembled complex III homodimerizes in the inner mitochondrial
membrane (Xia et al., 1997; Hunte et al., 2000) and is never present in wild type
cells in a monomeric form. It is not clear when exactly the dimerization occurs and
whether there are additional factors involved in this process. Complex III dimers
associate with either one or two copies of mature cytochrome c oxidase (complex IV)
to form supercomplexes of the respiratory chain (Cruciat et al., 1999; Heinemeyer
et al., 2007; Vukotic et al., 2012). This presumably facilitates catalytic reactions
performed by the complexes and additionally stabilizes them in the IMM (Vonck
and Schäfer, 2009).
1.5.3 Structure and function of the yeast F1Fo-ATP synthase
F1Fo-ATP synthases (in short, ATP synthases or complex V) is a group of
enzymes that couples ATP synthesis/hydrolysis to the electrochemical membrane
potential, which is built up by either protons or sodium ions across biological mem-
branes. These complexes are present in bacteria, mitochondria and plant chloro-
plasts and share a common structure. The mitochondrial ATP synthase subunit
composition and the mechanism of ATP synthesis are very much conserved among
various eukaryotic species. Organisms differ only in their accessory subunits that
either modify the enzyme’s structure or have a regulatory function. Yeast ATP
synthase consists of approximately 20 proteins, 7 of them are nonessential as they
only regulate the oligomeric state of the enzyme or modulate its function (Table
1.2) (Arnold et al., 1998; Wittig and Schägger, 2008). Among the 13 essential pro-
teins, 10 are encoded on the nuclear genome and 3 (Atp6, Atp8 and Atp9) are
mitochondrial-encoded.
The mitochondrial ATP synthase can be subdivided into two major parts - a
soluble F1, which has catalytic activity, and a hydrophobic membrane-bound Fo
part, which translocates protons across the IMM and transmits the energy from this
translocation to F1. The F1 module consists of a catalytic head and a central stalk
(Fig. 1.6). The catalytic head is a hexamer composed of a protein dimer occurring
in three copies. Each dimer contains Atp1 (F1α) and Atp2 (F1β) and possesses a
nucleotide binding pocket (Stock et al., 1999). The Fo part consists of a hydrophobic
ring made from 10 molecules of Atp9 (subunit c) together with one copy of Atp6
(subunit a). Additionally, the yeast Fo part of F1Fo-ATP synthase contains Atp17
22
INTRODUCTION
and Atp8, both essential for proper assembly and function (Devenish et al., 2000).
The Fo part couples proton movement down the electrochemical gradient to the
rotation of the Atp9 ring (Weber and Senior, 2003). The central stalk, built from
Atp3 (F1γ), Atp15 (F1ε) and Atp16 (F1δ), transmits these rotational movements to
the catalytically active region by elastic power transmission (Noji et al., 1997). The
peripheral (or lateral) stalk interacts with both F1 and Fo and keeps the catalytically
active domain static, relative to the rotary element of the enzyme. Atp4 (subunit
b), Atp5 (OSCP), Atp7 (subunit d) and Atp14 (subunit h) form the peripheral stalk
(Walker and Dikson 2006).
Table 1.2 Subunits of the S. cerevisiae ATP synthase
Subunit Synonym Gene Genome Module Essentiality
α Atp1 ATP1 N F1, catalytic head Essential
β Atp2 ATP2 N F1, catalytic head Essential
γ Atp3 ATP3 N F1, central stalk Essential
δ Atp16 ATP16 N F1, central stalk Essential
ε Atp15 ATP15 N F1, central stalk Essential
b Atp4 ATP4 N Fo, lateral stalk Essential
d Atp7 ATP7 N Fo, lateral stalk Essential
h Atp14 ATP14 N Fo, lateral stalk Essential
OSCP Atp5 ATP5 N Fo, lateral stalk Essential
f Atp17 ATP17 N Fo, lateral stalk Essential
a Atp6 ATP6 M Fo, rotor Essential
8 Atp8 ATP8 M Fo, rotor Essential
c Atp9 ATP9 M Fo, rotor Essential
j/i Atp18 ATP18 N Dimer-specific Dispensable
e Atp21 ATP21/TIM11 N Dimer-specific Dispensable
g Atp20 ATP20 N Dimer-specific Dispensable
k Atp19 ATP19 N Dimer-specific Dispensable
Inh1 Inh1 INH1 N Regulatory Dispensable
Stf1 Stf1 STF1 N Regulatory Dispensable
Stf2 Stf2 STF2 N Regulatory Dispensable
N, nuclear genome; M, mitochondrial genome. Modified from Wittig and Schägger,
2008 and Rühle and Leister, 2015.
The complete F1Fo-ATP synthase is known to form dimers and oligomers
(Arnold et al., 1998). Such oligomerization is needed for maintaining the cristae
structure and local increase in membrane potential. Recently yeast dimer specific
subunits were found: Atp18 (subunit i/j), Atp19 (subunit k), Atp20 (subunit g)




Figure 1.6 Structure of the S. cerevisiae F1Fo-ATP synthase complex. The catalytical
“head” and central stalk form the F1 subunit. 10 c subunits form an oligomeric ring,
through which protons traverse the membrane. Subunit a remains membrane-bound
and forms contacts with the lateral stalk to prevent rotation of the catalytic domain.
The OSCP subunit links the peripheral stalk to the F1. PDB accession number 4b2q,
Davies et al., 2012.
1.5.4 Mechanism of ATP synthesis by F1Fo-ATP synthase
Energy produced by proton translocation across the membrane is used by the
F1Fo-ATP synthase to catalyze ATP production from ADP and inorganic phosphate
(Weber and Senior, 2003). It is important to understand that proton translocation is
performed by the membrane rotor, whereas ATP synthesis happens on the catalytic
head. The central stalk directly links these two modules to each other and transmits
the energy between them by elastic power transmission. The peripheral (lateral)
stalk keeps the catalytic head static, which is absolutely necessary for the coupling
of proton translocation and ATP production.
Atp6 interacts directly with Atp9 subunits in the rotor. The C-terminal domain
of each Atp9 subunit contains negatively charged carboxy groups of either Gln or
Asn residues exposed on the outside of the ring. Protons enter a channel formed by
Atp6 and Atp9 from the IMS side and neutralize the negative charge of the above-
mentioned residues. Once the residue is neutralized, it changes its conformation in
order to move more to the hydrophobic lipid environment that induces rotation of
the Atp9 ring. This translocation brings another negatively charged residue to the
channel to keep the rotation going. While moving around the rotational axis, the
neutralized residue reaches another site on the Atp6/Atp9 interface which has a local
environment that promotes its reionization and subsequent proton release from the
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IMS side of the channel (Nakamoto et al., 2008; Symersky et al., 2012). Movement
of the rotor, in turn, induces conformational changes in the Atp3 subunit which
passes this structural transformation to the Atp1/Atp2 dimers. The asymmetry of
Atp3 promotes each of the three Atp2 subunits within a hexamer to adopt different
conformations that differentiate their nucleotide-binding and catalytic properties.
Therefore, conformational changes in Atp3 driven by Atp9 ring rotation drive the
catalytic cycle of ATP synthesis (Senior et al., 2002).
1.5.5 Biogenesis of mitochondrial-encoded F1Fo-ATP synthase subunits
Biogenesis of Atp9. Translation of ATP9 mRNA, as well as its stability,
depends on Aep1 (acts as a translation activator), Aep2 (regulates either mRNA
stability or its translation) and Atp25 (has a dual role in translation of Atp9, as
well as in ATP synthase assembly) (Ackerman et al., 1991; Finnegan et al., 1991;
Finnegan et al., 1995; Payne et al., 1993; Ellis et al., 1999; Zeng et al., 2008). The
dual role of Atp25 can be explained by its unusual biogenesis. After synthesis, Atp25
is cleaved in two fragments that both get imported into mitochondria and have dis-
tinct functions. The C-terminal fragment of 25 kDa stabilizes ATP9 mRNA and
promotes its translation. The N-terminal part of Atp25 promotes Atp9 oligomeriza-
tion and, therefore, ATP synthase assembly (Zeng et al., 2008). Oligomerization of
Atp9 is an important step in complex V biogenesis and happens independently from
all other subunits. Interestingly, Atp9 membrane insertion is Oxa1-independent,
implying that either Atp9 does not need a membrane channel for insertion, or most
likely the required protein is not yet identified. However, Oxa1 is required for Atp9
ring assembly with Atp6 and Atp8 (Jia et al., 2007).
Biogenesis of Atp6 and Atp8. Atp6 and Atp8 are encoded on a bicistronic
mRNA but it seems that they are translated independently. Atp22 was character-
ized as an Atp6-specific translational activator (Helfenbein et al., 2003; Zeng et al.,
2007a). In the absence of ATP22, Atp6 is no longer produced, however, Atp8 is still
translated. Atp8 translation is activated by another, most likely not yet identified
protein. Overall, much more is known about early Atp6 biogenesis, whereas our
knowledge about Atp8 is significantly limited (see Fig. 1.7).
An interesting mechanism exists to coordinate expression of Atp6 and Atp8
with nuclear-encoded ATP synthase subunits. It was shown that mutants devoid
of a fully-assembled F1 fail to express Atp6 and Atp8, but translation of both pro-
teins could be rescued by the overexpression of Atp22 (Rak and Tzagoloff, 2009).
Recently, a novel protein was characterized to be involved in the regulation of F1-
dependent Atp6/Atp8 expression, called Smt1 (Rak et al., 2016). It was shown that
in smt1Δ, Atp6 and Atp8 translation is no longer dependent on a fully-assembled
F1. Smt1 is present in ATP6/ATP8 mRNA containing complexes and probably
interacts with the ATP6/ATP8 mRNA. The authors proposed that Smt1 acts as an
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inhibitor of Atp6 and Atp8 translation by competing with Atp22 for mRNA binding.
The fully assembled F1 must therefore interact with Smt1 to trigger ATP6/ATP8
mRNA release and to enable Atp22 activation of Atp6 translation. Thus, in the
absence of Smt1, ATP6/ATP8 mRNA is not repressed and F1-dependent activation
of translation is not required.
Another observation that linked Atp6 expression to that of the nuclear-encoded
structural subunits came from the analysis of mitochondria that were depleted of
Atp14 (Goyon et al., 2008). Atp14 is a small subunit of the peripheral stalk and
is not directly associated with the IMM. Cells, in which Atp14 levels were reduced
to 3%, showed a significant reduction of Atp6, whereas Atp8 and Atp9 were not
affected. It was shown that Atp6 synthesis, as well as stability, were severely affected.
Moreover, mutant mitochondria showed a significant reduction of mature complex V
and accumulation of the unassembled F1 module. This data indicates that not only
F1, but also the peripheral stalk, influences translation of mitochondrial-encoded
Atp6.
S. cerevisiae Atp6 is synthesized with a 10 amino acid N-terminal extension
that is processed after the protein is inserted into the inner mitochondrial membrane
and the N-terminus is exposed to the IMS (Michon et al., 1988). The cleavage is
performed by Atp23, a highly conserved protease of the IMS, which is peripherally
associated to the inner mitochondrial membrane (Osman et al., 2007; Zeng et al.,
2007c). It was shown that Atp23 is imported and folded by Mia40, however, the Cys
residues of Atp23 are dispensable for its import (Weckbecker et al., 2012). Deletion
of Atp23 results in accumulation of unprocessed Atp6 and absence of a mature
complex V.
Atp23 is a metalloprotease with the catalytic center formed by Histidine residues.
Surprisingly, the catalytic activity of Atp23 and therefore the processing of Atp6 is
not required for ATP synthase biogenesis (Osman et al., 2007; Zeng et al., 2007c).
However, the protease is essential, implying that apart from Atp6 processing it is
required for Atp6 assembly. This assumption is supported by the observation that
Atp6 devoid of a leader peptide assembles less efficiently into complex V compared
to wild type Atp6 (Zeng et al., 2007b). Though the steady-state amounts of lead-
erless Atp6 are not affected, amounts of mature ATP synthase are reduced almost
two-fold. Thus, the leader peptide carries information required for Atp6 assembly.
Therefore, it is tempting to speculate that this peptide is required for Atp6-Atp23
interaction, and is needed for Atp23 to facilitate Atp6 assembly.
Atp10 is another protein involved in the early biogenesis of the F1Fo-ATP syn-
thase (Ackerman and Tzagoloff, 1990a; Tzagoloff et al., 2004). It is a 30-kDa inner
membrane protein that does not co-fractionate with mature complex V and, there-
fore, is not a structural subunit. Deletion of ATP10 does not affect Atp6 translation,
but significantly increases its turnover. Atp10 can be cross-linked to Atp6 (Tzagoloff
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Figure 1.7 Schematic representation of early Atp6/Atp8 biogenesis. Atp6 and Atp8 are
encoded on a bicistronic mRNA. Smt1 binds ATP6/ATP8 transcript to repress its
translation. 1. Assembled F1 module presumably interacts with Smt1 and triggers
mRNA release. 2. Atp22 interacts with the 5’ UTR of the released mRNA to ac-
tivate its translation. Pre-Atp6 is inserted into the IMM co-translationally by Oxa1
and associates with Atp10 for stabilization. 3. Atp23 cleaves the N-terminal signal
sequence of Atp6. It is not known whether it associates stably with Atp10. 4. The
processed Atp6 remains associated with Atp10 and is already competent to assemble
with Atp8. It is likely that Atp23 remains associated with this intermediate, but
experimental evidence for this is missing. 5. Atp8 assembles with Atp6 and Atp10
to form an Atp6/Atp8 module, capable of interaction with the nuclear-encoded sub-
units (6.). IMM, inner mitochondrial membrane; IMS, inter membrane space; UTR,
untranslated region.
et al., 2004), suggesting that this direct interaction is required for Atp6 stabiliza-
tion. Interestingly, apart from its chaperone function, Atp10 might act as an Fo
assembly factor. Overexpression of Atp23 suppresses the Atp10 deletion phenotype,
most probably because Atp10 and Atp23 have partly overlapping functions in Atp6
stabilization and assembly (Zeng et al., 2007c). However, a physical interaction
between Atp10 and Atp23 has not yet been shown. Recently, it was reported that
Atp10 remains associated with Atp6 as long as it binds Atp8 and peripheral stalk
subunits to form a larger assembly intermediate (Rak et al., 2011).
1.5.6 Assembly of the yeast F1Fo-ATP synthase
Yeast mitochondrial F1Fo-ATP synthase assembles in a modular way from pre-
assembled intermediates with F1 assembling independently from Fo (Schatz, 1968;
Tzagoloff, 1969; Rak et al., 2011). According to Rak et al., 2011, two major assem-
bly intermediates are formed from both nuclear and mitochondrial encoded subunits












Figure 1.8 Model of F1Fo-ATP synthase assembly. Assembly of F1Fo-ATP synthase starts from Atp9 oligomerization. The Atp9 ring interacts with
a preassembled F1 part to form a distinct assembly intermediate. On the other hand, Atp6 and Atp8, together with Atp10, associate with the
peripheral stalk to form the Atp6/Atp8 module. It is currently unknown how Atp5 is assembled, however, it is thought not to be a part of the
Atp6/Atp8 module. Atp9 ring/F1 joins with the Atp6/Atp8 assembly module in the last assembly step to form the mature enzyme. It is not




The soluble F1 module is formed independently from all other intermediates
(Schatz, 1968; Tzagoloff, 1969). Atp1 and Atp2 subunits oligomerize in a hexamer
with the help of Atp12 and Atp11 chaperones, respectively (Ackerman and Tzagoloff,
1990b; Ackerman and Tzagoloff, 2002). In the absence of either protein, Atp1 and
Atp2 form insoluble aggregates in the mitochondrial matrix and fail to assemble.
Both chaperones bind their client proteins to form Atp1-Atp12 and Atp2-Atp11
heterodimers in order to prevent formation of Atp1-Atp1 and Atp2-Atp2 homod-
imers (Wang, 2000; Wang et al., 2000). The reported 3D structure of Atp12 from
Paracoccus denitrificants revealed that the C-terminus of Atp12 is similar to the
coiled-coil tail of Atp3. Therefore, binding of Atp3 might trigger Atp12 release
and promote Atp1-Atp2 interaction (Ludlam, 2009). Two more proteins are re-
quired for efficient F1 assembly under heat stress conditions - Fmc1 and Hsp90
(Lefebvre-Legendre, 2001; Francis and Thorsness, 2011). Fmc1 is most likely an
Atp12-specific chaperone, as Fmc1 deletion can be compensated by overexpression
of Atp12 (Lefebvre-Legendre, 2001). Once assembled, F1 binds to the Atp9 ring in
order to form the first large assembly intermediate (Rak et al., 2011).
Another intermediate is formed by Atp6/Atp8 and components of the periph-
eral (lateral) stalk. According to Rak et al., 2011, Atp6 interacts with Atp8 and
Atp10, but not Atp23, in order to form an Atp6/Atp8 module. This module further
associates with Atp4, Atp7 and Atp14 lateral stalk subunits. Assembly of Atp5 is
not clearly understood and likely happens independently.
According to the described assembly model, the pore-forming subunits, Atp9
and Atp6, assemble only in the last step after the nuclear-encoded subunits are
already positioned. Such a mechanism ensures that when the Atp9 ring interacts
with Atp6, the proton translocation across the membrane will be definitely cou-
pled to ATP synthesis and a futile membrane potential dissipation will be avoided.
However, it is not known whether additional factors are involved in preventing a
premature Atp6/Atp9 interaction.
The fully assembled F1Fo-ATP synthase dimerizes via Atp4 transmembrane
helixes (Davies et al., 2012; Davies et al., 2014). Moreover, dimerization requires
the incorporation of Atp20 and Atp21 (Davies et al., 2012), which is facilitated
by subunits Atp18 and Atp19 (Wagner et al., 2010). Moreover, complex V forms
higher oligomeric structures, but little is known about the mechanism and regulation
of their formation (Strauss et al., 2008; Davies et al., 2012).
1.5.7 Role of the INA complex in F1Fo-ATP synthase assembly
Recently, a novel Inner Membrane Assembly Complex (INAC) was identified
that facilitates F1Fo-ATP synthase assembly (Lytovchenko et al., 2014). The com-
plex consists of two inner membrane proteins, Ina22 and Ina17. Ina22 and Ina17 are
highly conserved in the fungal kingdom, but homologs have so far not been identified
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in higher eukaryotes. Both proteins interact with each other via coiled-coil domains,
located in the mitochondrial IMS. Interestingly, Ina22 becomes highly unstable upon
INA17 deletion, implying that Ina17 might fulfill a chaperone-like function.
Absence of either protein leads to a respiration defect, which is more pro-
nounced at high temperatures. Deletion of the INA complex components reduces
the amounts of mature F1Fo-ATP synthase and leads to a significant accumulation
of unassembled F1. As the steady-state levels of individual structural subunits of
complex V were not affected in ina mutants, the authors assumed that the assem-
bly process is impaired. However, INAC is obviously not essential for F1Fo-ATP
synthase biogenesis as the mature complex is still present in mutant mitochondria,
albeit at lower levels. Importantly, a detailed analysis of respiratory chain complexes
in ina mutants did not reveal their deficiency.
Quantitative mass spectrometry analysis of Ina22ProtA-containing protein com-
plexes revealed that INAC physically associates with the nuclear-encoded F1Fo-ATP
synthase subunits and with the Cbp3, Cbp6 and Cbp4 - proteins involved in biogen-
esis of cytochrome b. This finding pointed not only to a direct association of INAC
with ATP synthase, but also to a possible role of the INA complex in biogenesis of
complex III. However, the latter was not investigated further.
Surprisingly, when incorporation of nuclear-encoded radiolabeled F1Fo-ATP
synthase subunits into the mature enzyme was analyzed, it appeared that assembly
of the peripheral stalk was affected the most, whereas assembly of the F1 compo-
nents was only mildly reduced. This observation, together with other data, led to
the conclusion that INAC facilitates assembly of the peripheral stalk. However, the
exact mechanism of how INAC facilitates peripheral stalk biogenesis in context of
Atp6/Atp8 module assembly and formation of Atp9 ring/F1 intermediate was not
investigated in detail. Moreover, it is not clear and therefore tempting to speculate




1.6 Aim of this study
The F1Fo-ATP synthase is one of the most fascinating molecular machines
present in the cell. It has been preserved by virtually all cells in the course of evolu-
tion. Although structural differences exist among F1Fo-ATP synthases of different
origin, the mechanism of ATP synthesis is conserved.
During the past decades a lot has been done to unravel the structural composi-
tion of mitochondrial F1Fo-ATP synthases and the mechanism of ATP production.
However, we start to understand only now how these complexes of dual genetic
origin come into life. Still, much information is missing about how the individual
assembly intermediates of the F1Fo-ATP synthase are formed and linked together.
Moreover, very little is known about the regulatory mechanisms that keep complex
V biogenesis under control.
Recently, the INA complex was discovered that facilitates assembly of the pe-
ripheral stalk of the F1Fo-ATP synthase. The physical interaction between INAC
and nuclear-encoded subunits of complex V was characterized, however, it was not
put into context of the whole F1Fo-ATP synthase assembly pathway. Therefore, a
possible interaction of the INA complex with other proteins of the analyzed F1Fo-
ATP synthase assembly machinery is investigated in this study. Moreover, the order
of sequential steps in complex V assembly is examined in more detail to create a
comprehensive picture of the F1Fo-synthase biogenesis. Most importantly, it is ad-
dressed whether the INA complex participates in the biogenesis of Atp6, Atp8 and
Atp9 and liaises nuclear and mitochondrial encoded subunits during their assembly.
The current model of F1Fo-ATP synthase assembly postulates the formation of
two distinct assembly intermediates, each containing one half of the Fo membrane
proton channel. Although formation of this channel is, without a doubt, the most
crucial step in complex V biogenesis, surprisingly little is known about the machinery
that mediates it. Therefore, I set out to unravel the role of INAC in the final
assembly step, namely the connection of the above mentioned intermediates and
formation of the membrane proton path.
Finally, a possible function of INAC in the biogenesis of complex III will be
investigated, as well a possible connection for complex V and III assembly.
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2. Results
2.1 Deletion of INA complex subunits affects biogenesis of
mitochondrial-encoded F1Fo-ATP synthase components
2.1.1 Translation of Atp6 and Atp8 is upregulated in ina mutants,
whereas Atp9 is destabilized
Loss of the INA complex, consisting of Ina17 and Ina22, leads to impaired res-
piration and therefore slower yeast growth on non-fermentable carbon sources (Ly-
tovchenko et al., 2014). The observed phenotype is caused by an impaired assembly
of the main energy-producing protein complex in the cell, the F1Fo-ATP synthase.
Whereas steady-state levels of the nuclear-encoded subunits of the F1Fo-ATP syn-
thase are not affected in ina mutants, their assembly rate is severely reduced, result-
ing in the accumulation of free unassembled F1-module. Interestingly, assembly of
the peripheral stalk in ina mutant mitochondria was affected the most. According
to a recently proposed F1Fo-ATP synthase assembly model, the nuclear-encoded
peripheral stalk associates with the mitochondrial-encoded Atp6/Atp8 module in
order to form a single assembly intermediate (Rak et al., 2011). Therefore, we
asked whether impaired peripheral stalk assembly in ina mutants affects Atp6/Atp8
biogenesis or, alternatively, if impaired Atp6/Atp8 biogenesis is a prerequisite for
the observed F1Fo-ATP synthase assembly defect. To address this, we performed
pulse-labeling of mitochondrial-encoded proteins with [35S] methionine and analyzed
translation products by Urea SDS-PAGE and digital autoradiography. Interestingly,
a drastic increase of Atp6 amounts, compared to wild type, was observed in ina22Δ
and ina17Δ, whereas translation of other subunits (e. g. Cox1) was not affected (Fig.
2.1A). To distinguish whether the increased Atp6 abundance in the cell was caused
by an increased translation rate or increased stability, we chased newly-translated
mitochondrial gene products in wild type and mutant strains. Clearly, Atp6 stabil-
ity in ina mutants was not increased sufficient enough to explain its significantly
higher abundance (Fig. 2.1B). Therefore it was concluded that translation of Atp6
is upregulated in ina22Δ and ina17Δ. Next we asked whether the translation of
two other mitochondrial-encoded subunits of F1Fo-ATP synthase, namely Atp8 and
Atp9, is also affected in ina mutants. Therefore, mitochondrial translation products
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Figure 2.1 Atp6 translation is upregulated in ina22Δ and ina17Δ. A. Mitochondrial-
encoded proteins were radiolabeled in vivo and analyzed by Urea SDS-PAGE and
digital autoradiography. Atp6 and Cox1 signals after a 20 min pulse were normalized
to Cox3 signal and protein amounts in mutant mitochondria were quantified (wild
type = 100%). (n=3, ±SEM). B. Mitochondrial-encoded proteins were radiolabeled
in vivo for 10 min. Labeling was stopped with an excess of cold methionine, samples
were incubated for an additional 30 or 90 min and analyzed as in A. Atp6 and Cox3
signals after a 90 min chase were quantified as the percentage of their starting signals.
(n=3, ±SEM).
were labeled in vivo as in Figure 2.1A and analyzed by Tris-Tricine SDS-PAGE in
order to separate Atp8 and Atp9. Clearly, Atp8 amounts were drastically increased
in mutant cells (Fig. 2.2A), similar to the increased abundance of Atp6. However,
we did not detect any significant changes for Atp9 or other mitochondrial-encoded
components of the respiratory chain. Surprisingly, when a similar analysis of mi-
tochondrial translation was performed in organello, a significant decrease in Atp9
translation as well as amounts of formed Atp9 ring was detected in ina mutants
(Fig. 2.2B). Most likely, Atp9 stability depends on imported nuclear-encoded pro-
teins with a high turn-over rate. In purified mitochondria these factors are not
delivered to the organelle and this causes a decrease of Atp9 amounts.
To summarize, it was established that Atp6 and Atp8 are significantly up-
regulated in ina mutants, whereas Atp9 production is not changed. However, we
speculate that Atp9 stability is decreased in ina mutants.
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Figure 2.2 Atp8 and Atp9 levels are changed in ina mutants. A. Mitochondrial trans-
lation products were radiolabeled in vivo and analyzed by Tris-Tricine PAGE and
autoradiography. Signals in ina22Δ and ina17Δ were normalized to Var1 and quan-
tified as the percentage of wild type. (n=5, ±SEM). B. Mitochondrial translation
products were radiolabeled in organello for 20 min and analyzed by SDS-PAGE and
autoradiography. After normalization to Cox1, Atp9 and cytochrome b (Cytb) signals
in ina22Δ and ina17Δ mitochondria were quantified as the percentage of wild type.
(n = 3, ±SEM).
2.1.2 INA complex does not associate with mitochondrial ribosomes
Translation of mitochondrial-encoded proteins in yeast is under the strict con-
trol of translational regulators that associate with mitochondrial ribosomes in order
to coordinate expression of mitochondrial and nuclear-encoded subunits of the res-
piratory chain (Richter-Dennerlein et al., 2015). Taking into account the significant
changes in expression of mitochondrial-encoded F1Fo-ATP synthase components in
ina mutants, we did not exclude the possibility that INAC associates with mitochon-
drial ribosomes in order to regulate expression of mitochondrial-encoded proteins.
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Therefore, we centrifuged mitochondrial lysates through a sucrose cushion in order
to pellet mitochondrial ribosomes and the proteins associated with them, and an-
alyzed the ribosome-containing pellet and supernatant fraction by SDS-PAGE and
Western blotting. As expected, Cbp3, a cytochrome b translational activator, was
sedimented with ribosomes (see Mrpl4 and Mrpl36) in a salt-dependent manner (Gr-
uschke et al., 2011) (Fig. 2.3). Importantly, neither Ina17 nor Ina22 were recovered
from the ribosome-containing pellet, implying that the INA complex does not as-
sociate with mitochondrial ribosomes and therefore upregulation of Atp6 and Atp8
translation might be an indirect effect of INAC knockout.
Figure 2.3 INA complex does not associate with mitochondrial ribosomes. Wild type
mitochondria were lysed in a buffer containing 1% Triton-X100 and either 50 or 150
mM KCl and centrifuged through a sucrose cushion. Total (T), pellet (P) and super-
natant (S) fractions were precipitated with 12% TCA and analyzed by SDS-PAGE
and Western blotting with the indicated antibodies.
2.1.3 Atp6 processing is impaired in ina22Δ
In yeast mitochondria, Atp6 is synthesized as a precursor with a 10 amino acid
N-terminal extension, which is processed by Atp23 on the intermembrane space
side of the inner mitochondrial membrane (Osman et al., 2007; Zeng et al., 2007c).
During the initial analysis of Atp6 translation in ina mutants, we noticed the ac-
cumulation of an additional radiolabeled product migrating above Atp6 in ina22Δ
(Fig. 2.1A, lanes 7-9). To investigate this further, a radiolabeling of mitochondrial-
encoded proteins was performed in wild type and mutant mitochondria, followed by
a separation of precursor and mature form of Atp6 by Urea SDS-PAGE. While Atp6
processing appeared unaffected in ina17Δ, a significant amount of preAtp6 accumu-
lated upon INA22 deletion (Fig. 2.4A, lanes 7-9). To exclude that Atp23 levels
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Figure 2.4 Atp6 processing is affected in ina22Δ. A. Mitochondrial-encoded proteins were
radiolabeled in vivo and analyzed by Urea SDS-PAGE and digital autoradiography. B.
Wild type and ina22Δ mitochondria were solubilized in SDS-sample buffer, subjected
to SDS-PAGE and Western blotting with the indicated antibodies. C. Wild type and
ina22Δ mitochondria were subjected to in organello labeling for 20 min and proteins
were co-immunoprecipitated with either control or anti-Atp23 antibodies. Input (1%)
and elution (100%) were analyzed by Urea SDS-PAGE, digital autoradiography and
Western blotting (WB) with anti-Atp23 antibodies.
were decreased in ina22Δ and caused the observed processing defect, we analyzed
proteins in wild type and ina22Δ mutant mitochondria by SDS-PAGE and Western
blotting. Surprisingly, the amount of Atp23 in ina22Δ mitochondria was similar
to the wild type control (Fig. 2.4B) and therefore Atp23 deficiency could not be
the reason for Atp6 precursor accumulation. Another possible explanation for the
observed Atp6 processing defect could be an impaired interaction between Atp6 and
Atp23. Thus, we performed Atp23 immunoprecipitation from wild type and ina22Δ
mutant mitochondria in which mitochondrial-encoded proteins were labeled with
[35S] methionine. Similar amounts of Atp6 were co-immunoprecipitated with Atp23
in ina22Δ and wild type mitochondria (Fig. 2.4C), implying that INA22 deletion
does not affect Atp6-Atp23 interaction. Therefore, we concluded that neither Atp23
levels, nor Atp23 association with Atp6, is affected upon INA22 deletion and that
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preAtp6 accumulation requires another explanation.
2.1.4 Atp23 overexpression rescues the Atp6 processing defect in ina22Δ
Recent proteomics studies suggest that only 96 molecules of Atp23 are present
in the cell – a very low number compared to 20100 molecules of Yme1, another
mitochondrial protease (Kulak et al., 2014). Taking into consideration more than
a two-fold upregulation of Atp6 expression in ina22Δ mutant cells, we wondered
whether the detected Atp6 processing defect was due to limited Atp23 amounts
in mitochondria. If this were the case, an overexpression of Atp23 should restore
Atp6 processing in ina22Δ. Therefore, a glyceraldehyde 3-phosphate dehydrogenase
promoter was inserted upstream of the ATP23 gene in wild type and ina22Δ to
upregulate protein expression. A steady-state analysis of mitochondrial protein lev-
els in wild type and mutant strains confirmed that this led to a significant increase
of Atp23 amounts (Fig. 2.5A). Moreover, this drastic overexpression did not cause
protein aggregation in the cytoplasm, as Atp23 was still efficiently imported into mi-
tochondria. Next, we assessed Atp6 processing by pulse-labeling of mitochondrial-
encoded proteins and analysis by Urea SDS-PAGE and autoradiography. Strikingly,
Atp23 overexpression completely restored Atp6 processing in ina22Δ (Fig. 2.5B).
However, it only partially rescued the increased Atp6 production rate in ina22Δ
cells, as still 50% more protein was synthesized in mutant compared to wild type
(Fig. 2.5B, right panel). Therefore, it was concluded that accumulation of preAtp6
in ina22Δ was caused by rate limited Atp23 levels and Atp23 overexpression com-
pletely restores the Atp6 processing defect, but not the translational upregulation.
2.1.5 Atp23 overexpression partially rescues F1Fo-ATP synthase assem-
bly defects in ina22Δ
According to Rak et al., 2011, the peripheral stalk of the F1Fo-ATP synthase
associates with Atp6 and Atp8 in order to form a discrete assembly intermediate.
As changes in Atp6 and Atp8 translation, as well as Atp6 processing, were detected
in ina mutants, we wondered whether the affected biogenesis of Atp6/Atp8 was
contributing to the impaired peripheral stalk assembly in ina mutants. Having seen
that an overexpression of Atp23 completely restored Atp6 processing and partially
decreased Atp6 upregulation in ina22Δ, we asked if it would also have an effect
on F1Fo-ATP synthase assembly. Therefore, we assessed F1Fo-ATP synthase levels
in wild type, ina22Δ and Atp23↑ina22Δ mutant mitochondria by BN-PAGE and
subsequent Western blotting or in-gel activity staining. Western blot analysis with
anti-Atp4 antibodies clearly showed that Atp23 overexpression restored F1Fo-ATP
synthase levels in ina22Δ (Fig. 2.6A, lanes 1-4). Moreover, in-gel activity staining
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Figure 2.5 Atp23 overexpression rescues the Atp6 processing defect in ina22Δ. A.
Steady-state protein levels in wild type and mutant mitochondria were analyzed by
SDS-PAGE and Western blotting with the indicated antibodies. B. Mitochondrial-
encoded proteins were radiolabeled in vivo for 10 min and analyzed by Urea SDS-
PAGE and digital autoradiography, or by Western blotting (WB) with the indicated
antibodies. Quantification was performed as in Fig. 2.1A. (n = 3, ±SEM).
confirmed reduced amounts of unassembled F1 in Atp23↑ina22Δ (Fig. 2.6A, lanes 5-
8). To check whether this improvement was due to recovered assembly of F1Fo-ATP
synthase, the Atp4 precursor protein was synthesized in vitro in the presence of [35S]
methionine, imported into wild type and mutant mitochondria and its incorporation
into complex V was analyzed by BN-PAGE and autoradiography. As can be seen
from the result, Atp4 assembly is severely compromised in ina22Δ mitochondria,
while Atp23 overexpression leads to its partial recovery, as more complex V could
be detected in Atp23↑ina22Δ (Fig. 2.6B).
Another prominent feature of ina mutants is decreased F1Fo-ATP synthase
oligomycin sensitivity due to increased levels of free F1. To address whether im-
proved F1Fo-ATP synthase assembly and decreased amounts of unassembled F1 in
Atp23↑ina22Δ correspond to restored oligomycin sensitivity, we performed ATPase
activity measurements in wild type and mutant strains. Strikingly, oligomycin in-
sensitivity of ina22Δ was reduced almost two-fold upon Atp23 overexpression (Fig.
2.6C). Taken together, these data imply that Atp23 overexpression partially rescues
F1Fo-ATP synthase assembly in ina22Δ mutant.
Atp23 has a dual function in Atp6 processing and assembly (Osman et al.,
2007). It was shown that in yeast expressing catalytically-inactive Atp23 the ma-
ture F1Fo-ATP synthase is still assembled, implying that the proteolytic activity of
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Figure 2.6 Atp23 overexpression partially rescues F1Fo-ATP synthase assembly in
ina22Δ. A. Mitochondria were analyzed by Blue Native (BN)-PAGE, followed by
Western blotting with anti-Atp4 antibodies (lanes 1-4), in-gel ATPase activity staining
(Complex V, lanes 5-8), or Coomassie staining (lanes 9-12). B. Radiolabeled Atp4 pre-
cursor protein was imported into wild type and mutant mitochondria with or without
membrane potential. Samples were analyzed by BN-PAGE (top panel) or SDS-PAGE
(bottom panel) and digital autoradiography. p, precursor; m, mature; WT, wild type
C. In organello ATPase activity measurement was performed as described in Materi-
als and Methods in wild-type and mutant mitochondria, with or without addition of
50 μM oligomycin. Activity is depicted as nmoles of released phosphate per min per
mg of mitochondrial proteins (n = 5, ±SEM).
Atp23 is not essential (Osman et al., 2007). However, Atp23 function in assembly of
complex V is vital. We have observed both Atp6 processing rescue, as well as an im-
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Figure 2.7 Atp23H128A overexpression does not restore the F1Fo-ATP synthase as-
sembly defect in ina22Δ. A. Mitochondrial-encoded proteins in wild type and
mutant mitochondria were radiolabeled for 10 minutes and analyzed by Urea SDS-
PAGE and autoradiography. B. Steady-state protein levels in wild type and mutant
mitochondria were analyzed by SDS-PAGE and Western blotting with the indicated
antibodies. C. Wild type and mutant mitochondria were solubilized, analysed by BN-
PAGE and either in-gel activity staining (Complex V) or Coomassie staining. D. Wild
type and mutant mitochondria were analyzed by BN-PAGE and Western blotting with
indicated antibodies.
provement of F1Fo-ATP synthase assembly in ina22Δ upon Atp23 overexpression.
To assess whether overexpression of catalytically-inactive Atp23 would still result
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in ina22Δ phenotype rescue, we generated a strain overexpressing Atp23 with a
point mutation in its catalytic site (Atp23H128A↑ ) in the ina22Δ background. In
vivo pulse-labeling analysis of mitochondrial-encoded proteins shows that preAtp6
is synthesized in this strain, however, it is not processed to mature Atp6 (Fig. 2.7A,
lane 5). Surprisingly, a Western blot analysis of mitochondrial steady-state pro-
tein levels showed that Atp23H128A is rather unstable, as its amounts were reduced
compared to the amounts of overexpressed wild type Atp23 (Fig. 2.7B). Further BN-
PAGE and in-gel activity staining analysis of wild type and mutant mitochondria
revealed that overexpression of Atp23H128A reduced neither the levels of unassembled
F1 (Fig. 2.7C), nor restored the steady-state levels of mature F1Fo-ATP synthase
(Fig. 2.7D) in ina22Δ mitochondria. Therefore we conclude that overexpression of
Atp23H128A does not rescue the ina22Δ phenotype. However, we could not distin-
guish whether it was due to the impaired Atp6 processing or increased Atp23H128A
instability.
2.2 The C-terminus of Ina22 is highly unstable
In order to avoid using tagged variants of Ina17 and Ina22, we generated an-
tibodies against the IMS domain of Ina22 and the matrix domain of Ina17. In-
terestingly, during initial immunoprecipitations two distinct Ina22 fragments, which
represent either products of protein processing or degradation, were co-isolated along
with the full-length Ina22 from wild type mitochondria (Fig. 2.8A). Notably, these
fragments were also isolated from ina17Δ mitochondria, implying that the observed
processing is not Ina17-dependent (Fig. 2.8A, lane 7). Moreover, the fragments were
co-immunoprecipitated with Ina17, meaning that they still contain the coiled-coil
region required for Ina17-Ina22 interaction (Lytovchenko et al., 2014). Importantly,
the same fragments were not reproducibly detected in intact mitochondria and were
usually highly enriched after affinity purification. The latter implies that Ina22 is
much more unstable during isolation conditions, which might be due to increased
protein instability or protease processing. In order to identify the protease(s) re-
sponsible for Ina22 processing, we screened yeast mutants, in which known IMS
proteases were deleted, for Ina22 processing defects. Unfortunately, no potential
candidates were identified (data not shown; performed in collaboration with Dr.
Nora Vögtle).
To distinguish between C- and N-terminal processing, Ina22 was immunopre-
cipited from WT, ina22Δ and Ina22HA mitochondria containing a C-terminal HA
tag. Only full-length Ina22 could be detected with anti-HA antibodies in both the
input and elution fractions (Fig 2.8B, upper panel), whereas decoration with anti-
Ina22 antibodies confirmed the presence of two additional fragments in the elution
(Fig. 2.8B, lower panel). Thus, it was clarified that Ina22 undergoes C-terminal pro-
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Figure 2.8 Ina22 undergoes C-terminal processing. A. Wild type, ina22Δ and ina17Δ
mitochondria were solubilized and protein complexes were co-immunoprecipitated
with anti-Ina22 and anti-Ina17 antibodies. Input and elution fractions were ana-
lyzed by SDS-PAGE and Western blotting with the indicated antibodies. Input =
1% of elution. B. ina22Δ, wild type and Ina22HA mitochondria were subjected to
co-immunoprecipitation with anti-Ina22 antibodies. Input and elution fractions were
analyzed by SDS-PAGE and Western blotting with either anti-HA or anti-Ina22 an-
tibodies. Input = 1% of elution. C. Ina22 was immunoprecipitated from wild type
and ina22Δ mitochondria with anti-Ina22 antibodies and the molecular weight of its
fragments was assessed by comparing their electrophoretic mobility (lanes 1-4) to the
mobility of in vitro generated radiolabeled Ina22 fragments (lanes 5-13). Samples were
analyzed by SDS-PAGE, digital autoradiography (AR) and Western blotting (WB).
D. Mitochondrial proteins in wild type and mutant mitochondria were analyzed by
SDS-PAGE and Western blotting with the indicated antibodies. The asterisk (*) in-
dicates an unspecific band. E. A serial dilution of yeast cells was spotted on YPD or
YPG plates. Plates were grown at the indicated temperatures for 2-5 days.
cessing. In order to define the length of the fragments, we generated in vitro a set of
C-terminally truncated radiolabeled Ina22 fragments (devoid of a predicted import
signal) and compared their electrophoretic mobility to the mobility of immunopre-
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cipitated Ina22 fragments (Fig. 2.8C). We identified that the processing takes place
approximately at amino acids 168 and 188 of Ina22. To further investigate the po-
tential function of the processing, we generated yeast mutants expressing truncated
Ina22, either 168 or 188 amino acids in length, and analyzed the steady-state levels of
selected mitochondrial proteins by SDS-PAGE and Western blotting. No alteration
of protein levels was observed in the mutant strains (Fig. 2.8D) and their growth on
non-fermentable media was not compromised (Fig. 2.8E). Therefore, we conclude
that the extreme C-terminus of Ina22 does not contribute to its function and that
the biological importance of the C-terminal processing/degradation remains to be
identified.
2.3 INAC interacts with the Atp6/Atp8 biogenesis machin-
ery
2.3.1 INAC associates with Atp23
After we identified that the early biogenesis of Atp6 and Atp8 was altered in ina
mutants, we asked whether Ina17 and Ina22 are directly involved in this process.
To address this, we assessed if Ina proteins associate with known components of
the Atp6/Atp8 assembly machinery, namely Atp23 and Atp10. First, we performed
immunoprecipitation of Ina22 and Ina17 with antibodies targeting the endogenous
proteins and analyzed elution fractions for the presence of Atp23. Clearly, Atp23
co-isolated with INAC, confirming their physical association (Fig. 2.9A).
To assess whether this interaction depends on mitochondrial-encoded proteins,
we generated a yeast stain devoid of Atp6 by deleting ATP22, gene encoding Atp6-
specific translational activator (Zeng et al., 2007a). Mitochondria from atp22Δ and
control wild type yeast strains were isolated and subjected to immunoprecipitation
with anti-Ina22 and anti-Ina17 antibodies. ATP22 deletion and the resulting ab-
sence of Atp6 significantly reduced the INAC-Atp23 interaction, but did not abolish
it (Fig. 2.9B). Nevertheless, the obtained results were hard to interpret as steady-
state levels of mitochondrial proteins in atp22Δ were significantly altered, most
probably due to the genetic instability of its mitochondrial genome. Therefore, to
confirm that the INAC-Atp23 association depends on mitochondrial-encoded pro-
teins, we asked whether upregulation of mitochondrial translation, and the subse-
quent accumulation of early assembly intermediates of complex V, would increase
INAC interaction with Atp23. Chloramphenicol treatment prior to mitochondrial
isolation was shown to result in accumulation of nuclear gene products within the or-
ganelle. The subsequent removal of chloramphenicol and release of the translational
block enhances mitochondrial gene expression (Tzagoloff, 1971; Osman et al., 2007;
Rak et al., 2011). Therefore, wild type yeast cells were grown with or without a 2-h
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Figure 2.9 INAC interacts with Atp23. A. Proteins from wild type mitochondria were co-
immunoprecipitated with control, anti-Ina22 or anti-Ina17 antibodies. Input and elu-
tion fractions were analyzed by SDS-PAGE and Western blotting with the indicated
antibodies. Input = 1% of elution. B. Proteins from wild type and atp22Δ mitochon-
dria were co-immunoprecipitated with control, anti-Ina22 and anti-Ina17 antibodies
and analyzed as in A. Input = 1% of elution.
preincubation with chloramphenicol. Mitochondria from these cells were isolated
and the translation of mitochondrial-encoded proteins was analyzed via in organello
labeling, SDS-PAGE and autoradiography. Mitochondrial translation was clearly
enhanced in chloramphenicol-pretreated samples compared to the non-treated con-
trol (Fig. 2.10A, lanes 1-3 versus 4-6). Importantly, when chloramphenicol was
not washed away during mitochondrial preparation, mitochondrial translation was
completely inhibited, confirming the specificity of treatment (Fig. 2.10A, lanes 7-
9). Next, the control and chloramphenicol-treated mitochondria were subjected to
immunoprecipitation with anti-Ina22 and anti-Ina17 antibodies. As can be seen,
more Atp23 co-isolated with INAC upon upregulation of mitochondrial translation
(Fig. 2.10B). This implies that their interaction is mediated by newly translated,
mitochondrial-encoded, F1Fo-ATP synthase subunits.
2.3.2 INAC interacts with Atp10
Atp10 was previously shown to associate with newly translated Atp6, to stabi-
lize it and to facilitate its assembly (Tzagoloff et al., 2004; Rak et al., 2011). For
verification of a possible Atp10-INAC interaction, we genomically fused protein A
from S. aureus to the C-terminus of Atp10. To address whether the protein remained
functional, we analyzed Atp10ProtA growth on a non-fermentable carbon source and
did not observe any differences compared to wild type (Fig. 2.11A). Moreover, a
BN-PAGE analysis of respiratory chain complexes in wild type and Atp10ProtA mito-
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Figure 2.10 Upregulation of mitochondrial translation increase INAC-Atp23 associ-
ation. A. Yeast cells were treated for 3 hours with 2 mg/ml chloramphenicol or
left untreated (C, control). Then, chloramphenicol was washed away and cells were
split in two parts for mitochondrial isolation. Mitochondria from the first part were
isolated according to the standard protocol (TA, translationally-activated). For the
mitochondria isolation from the second part, all buffers were supplemented with 2
mg/ml chloramphenicol (TR, translationally-repressed). Isolated mitochondria were
subjected to in organello radiolabeling and samples were analyzed by SDS-PAGE and
autoradiography. B. Mitochondrial-encoded products in control and translationally-
activated (TA) mitochondria were labeled in organello. Mitochondria were solubi-
lized and subjected to immunoprecpitation with control, anti-Ina22 and anti-Ina17
antibodies. Samples were analyzed by SDS-PAGE and autoradiography. Input=1%
of elution. “short” and “long” refers to different exposure time.
chondria confirmed their comparable steady-state amounts (Fig. 2.11B). Therefore,
we concluded that tagged Atp10 is functional. To assess the INAC-Atp10 interac-
tion and whether it is mediated by mitochondrial translation products, we isolated
Atp10ProtA-associated protein complexes from control and chloramphenicol-treated
mitochondria by IgG-affinity chromatography and analyzed them by SDS-PAGE and
Western blotting. As a result, Ina17 and Ina22 co-isolated with Atp10ProtA, confirm-
ing INAC association with the Atp6/Atp8 biogenesis machinery (Fig. 2.12A). Im-
portantly, a significant increase in their interaction was observed upon mitochondrial
translational upregulation, implying again that the INAC interaction with Atp10,
as well as with Atp23, involves mitochondrial gene products. Moreover, newly im-
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Figure 2.11 C-terminal tagging does not affect Atp10 function. A. A serial dilution of
yeast cells was spotted on YPD or YPG plates. Plates were grown at 37◦C for 5
days. B. Mitochondria isolated from wild type and Atp10ProtA strains were analyzed
by BN-PAGE and Western blotting with the indicated antibodies.
ported radiolabeled Atp10 was co-isolated with Ina22FLAG, confirming again their
interaction (Fig. 2.12B).
Surprisingly, Atp23 was co-isolated with Atp10ProtA, in contrast to previous
findings (Rak et al., 2011) (Fig. 2.12A). Our result proves a previously proposed
Atp23 function in the assembly of Atp6 (Osman et al., 2007), as it remains associated
with the Atp10/Atp6 complex during later assembly steps. Nonetheless, the Atp10-
Atp23 interaction was not changed upon mitochondrial translational upregulation,
implying that the Atp10-Atp23 association is more stable and that these two proteins
might interact with each other even in absence of Atp6.
To address whether INAC interacts with Atp10 and Atp23 in a distinct protein
complex, we purified Atp10ProtA complexes from chloramphenicol-pretreated mito-
chondria via IgG affinity chromatography. Bound protein complexes were eluted na-
tively via TEV-protease cleavage and analyzed by BN-PAGE and Western blotting.
Strikingly, an Atp23, Ina22 and Ina17-containing complex of 400 kDa was detected,
in which all three proteins co-migrated (Fig. 2.12C). However, protein complexes in
which only Atp23 was present, were much more abundant, implying again that the
Atp10-Atp23 interaction is much more robust, whereas the Atp10-INAC interaction
is transient in nature.
Thus, we conclude that INAC interacts with Atp23 and Atp10. Moreover, as we
did not know the exact nature of the isolated complex, we speculated that this is one




Figure 2.12 INAC associates with Atp10. A. Control and chloramphenicol-treated wild
type and Atp10ProtA mitochondria were subjected to IgG affinity chromatography
and analyzed by SDS-PAGE and Western blotting with the indicated antibodies.
Input = 1% of elution. TA, translational activation. B. Atp10 precursor (preAtp10)
was synthesized in vitro in the presence of [35S]Met and imported into wild type
or Ina22FLAG mitochondria. Mitochondria were then subjected to anti-FLAG affin-
ity chromatography. Input and elution fractions were analyzed by SDS-PAGE and
digital autoradiography (upper panel) or Western blotting with the indicated anti-
bodies. Input = 1% of elution. C. Protein complexes from Atp10ProtA and wild
type mitochondria were purified via IgG affinity chromatography, eluted natively via
TEV-cleavage and analyzed by BN-PAGE and Western blotting with the indicated
antibodies. Chloramphenicol-treated mitochondria were used.
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2.4 Stalling of F1Fo-ATP synthase assembly in ina mutants
2.4.1 Atp10 accumulates with Atp23 upon INA22 deletion
According to Rak et al., 2011, the peripheral stalk, Atp6, Atp8 and Atp10
together form a preassembled module that does not contain Atp23. However, our
data clearly show that Atp10 stably associates with Atp23 as part of multiple protein
complexes, some of which contain Ina proteins, as well as some that do not (Fig.
2.12C). According to our initial assumption, INAC associates with the Atp6/Atp8
module in order to facilitate peripheral stalk assembly.
Figure 2.13 Atp23 accumulates with Atp10 upon INA22 deletion. A. Atp10ProtA-
containing protein complexes were purified via IgG affinity chromatography from
Atp10ProtA, Atp10ProtAina22Δ and wild type mitochondria. Input and elution frac-
tions were analyzed by SDS-PAGE and Western blotting with the indicated antibod-
ies (left panel). The amount of Atp23 that was isolated from Atp10ProtA mitochon-
dria was set as 100% and Atp23 co-isolated from Atp10ProtAina22Δ mitochondria
was quantified (right panel). Signals were normalized to the amount of isolated
Atp10ProtA. Input = 1% of elution. n = 3, ±SEM. B. The experiment was per-
formed as in panel A, protein complexes were eluted via TEV protease cleavage and
elution fractions were analyzed by BN-PAGE and Western blotting with anti-Atp23
antibodies.
Thus, we wondered whether deletion of the INA complex would lead to a stall
of assembly and the accumulation of Atp10 and Atp23-containing assembly interme-
diates. Therefore, Atp10ProtA complexes were isolated from wild type and ina22Δ
mitochondria and analyzed by SDS-PAGE and Western blotting. As expected,
Atp23 accumulated with Atp10 in ina22Δ, strongly suggesting that they are part of
the same assembly intermediate prior to interaction with INAC (Fig. 2.13A). More-
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over, a BN-PAGE analysis of the elution fractions, followed by Western blotting
with anti-Atp23 antibodies clearly showed a prominent accumulation of the Atp10-
and Atp23-containing protein complex at around 230 kDa in ina22Δ mitochondria
(Fig. 2.13B). Thus, in contrast to previously published results, Atp10 and Atp23
interact with each other. Moreover, these two proteins are components of the same
F1Fo-ATP synthase assembly intermediate that accumulates upon INA22 deletion.
2.4.2 Atp23 association with the IMM is increased in ina22Δ
Atp23 is a protease of the intermembrane space that peripherally associates
with the inner mitochondrial membrane (Osman et al., 2007). Taking the known
Atp23 function in Atp6 processing and assembly into consideration, we wondered if
Atp6 helps to anchor Atp23 to the membrane. Keeping in mind that Atp6 trans-
lation in ina mutants is increased more than two-fold, it was interesting to assess
whether this leads to increased Atp23 association with the IMM. Therefore, ex-
traction of mitochondrial proteins using alkaline conditions was performed in wild
type and ina22Δ mitochondria. Upon sonication, Atp23 remained exclusively in
the membrane pellet fraction, similar to two other peripheral membrane proteins,
Tim44 and Cbp3 (Fig. 2.14A, lanes 1-3, 7-9). However, upon high pH treatment,
Atp23 was extracted from the membrane and therefore detected in the soluble frac-
tion (Fig. 2.14A). Remarkably, in ina22Δ mitochondria, more Atp23 remained
membrane associated compared to wild type (Fig. 2.14A, lanes 5-6 versus lanes
11-12), whereas association of Cbp3 and Tim44 was unchanged. To verify whether
increased Atp23 membrane association was due to the increased Atp6 abundance,
the same experiment was repeated in non-treated and chloramphenicol-treated mi-
tochondria that have elevated expression of all mitochondrial-encoded genes (Fig.
2.10A). Surprisingly, a similar result was obtained, namely more Atp23 remained
membrane-associated upon increased mitochondrial translation (Fig. 2.14B). To find
out whether this effect is Atp6-specific, carbonate extraction was performed from
wild type and atp22Δ mitochondria, devoid of Atp6. As expected, ATP22 deletion,
and subsequent Atp6 absence, decreased Atp23 association with the IMM. There-
fore, we concluded that Atp23 is anchored to the IMM via Atp6 and it accumulates
on the membrane upon INA22 deletion due to increased Atp6 translation. Taking
into consideration previous results, we assumed that Atp23 accumulates together
with Atp10 in an Atp6/Atp8-containing assembly intermediate.
2.4.3 The Atp6/Atp8 module accumulates upon INA22 deletion
All previously obtained results point to the fact that Atp10 and Atp23 associate
together in an assembly intermediate that will later assemble with the peripheral
stalk. Moreover, our data indicate that Atp10 accumulates with Atp23 in ina mu-
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Figure 2.14 Atp23 membrane association increases in ina22Δ. A. Wild type and ina22Δ
mitochondria were either sonicated or treated with carbonate buffer with pH 11.5.
Samples were centrifuged to separate pellet from soluble fraction. Proteins were
precipitated with 12% TCA and analyzed by SDS-PAGE and Western blotting with
the indicated antibodies. B. The experiment was performed and analyzed as in
panel A with control (-TA) and chloramphenicol-treated mitochondria (+TA). TA,
translational activation. C. The experiment was performed and analyzed as in panel
A with wild type and atp22Δ mitochondria. T, total; P, pellet; S, supernatant.
tants, implying that the assembly process is partially stalled at this point. If so,
newly-translated mitochondrial-encoded Atp6 and Atp8 should accumulate in the
same complex with Atp10 and Atp23 in ina22Δ.
To address whether this was the case, we radiolabeled mitochondrial-encoded
proteins in wild type, Atp10ProtA and Atp10ProtAina22Δ chloramphenicol-treated mi-
tochondria and performed an isolation of Atp10ProtA-containing protein complexes.
As a result, double the amount of Atp6 and Atp8 were co-isolated with Atp10 from
ina22Δ mitochondria compared to wild type (Fig. 2.15A), similar to the increase
of the Atp10-Atp23 interaction (Fig. 2.13A). This confirmed our initial assump-
tion about the accumulation of an Atp6/Atp8-containing assembly intermediate in
ina mutants. Moreover, to visualize accumulated Atp6 and Atp8-containing protein
complexes, we analyzed part of the Atp10ProtA elution by BN-PAGE and digital au-
toradiography. Interestingly, one prominent assembly intermediate of 400 kDa was
co-isolated from wild type and ina22Δ mitochondria, whereas several additional
smaller-size assembly intermediates accumulated in ina22Δ (Fig. 2.15B). Further
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Figure 2.15 Atp10 interaction with Atp6 and Atp8 is increased in ina22Δ. A.
Chloramphenicol-treated wild type, Atp10ProtA and Atp10ProtAina22Δmitochondria
were subjected to in organello labeling for 20 min and IgG-affinity chromatography.
Input and elution fractions were analyzed by SDS-PAGE and digital autoradiog-
raphy or Western blotting. The amounts of Cox3/Atp6 and Atp8, isolated from
Atp10ProtA mitochondria, were set to 100%. The levels of these proteins, isolated
from Atp10ProtAina22Δ mitochondria, were then quantified (right panel). Signals in
the elution fraction were normalized to the amount of isolated Atp10ProtA and to the
input fraction. Input = 1% of elution. n = 3, ±SEM. B. Experiment was performed
as in A, bound protein complexes were eluted via TEV-protease cleavage and ana-
lyzed by BN-PAGE and digital autoradiography. C. Part of the elution fraction of
the experiment presented in panel B was analyzed by BN-PAGE, second dimension
SDS-PAGE and digital autoradiography.
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Figure 2.16 F1 and the peripheral stalk accumulate with Atp10 in ina22Δ. A. Wild
type, Atp10ProtA and Atp10ProtAina22Δ mitochondria were subjected to IgG affinity
chromatography. Ninety percent of the elution fraction was analyzed by SDS-PAGE
and colloidal Coomassie staining (lanes 1-3). The remaining fraction was analyzed
by SDS-PAGE and Western blotting with the indicated antibodies (lanes 4-6). B.
Atp10ProtA-containing protein complexes were purified via IgG affinity chromatog-
raphy from Atp10ProtA, Atp10ProtAina22Δ and wild type mitochondria. Input and
elution fractions were analyzed by SDS-PAGE and Western blotting with the indi-
cated antibodies.
analysis of these complexes by second dimension SDS-PAGE confirmed that they
contained Atp6 and Atp8, but not Atp9 (Fig. 2.15C). Therefore, we confirmed that
Atp6, Atp8, Atp23 and Atp10 form a complex together prior to association with the
INA complex. Moreover, accumulation of this assembly intermediate in ina mutants
points to an assembly stall.
2.4.4 F1 and the peripheral stalk accumulate with Atp10 in ina22Δ
Once the Atp6/Atp8 assembly intermediate is formed, it is competent to assem-
ble with the peripheral stalk in order to form a large assembly module (Rak et al.,
2011). As the INA complex physically interacts with peripheral stalk components
and assembly of the peripheral stalk is severely impaired in ina mutants, it is the
most likely candidate to mediate peripheral stalk assembly. The observed accumu-
lation of the Atp10/Atp23/Atp6/Atp8-containing intermediate in ina22Δ supports
this hypothesis. Therefore, if the assumption is correct, peripheral stalk association
with the Atp6/Atp8 intermediate should be reduced in ina22Δ.
To test whether this was the case, Atp10 interaction with nuclear-encoded com-
plex V subunits was analyzed in wild type and ina22Δ mitochondria. For this,
Atp10ProtA-containing protein complexes were isolated via IgG affinity chromatog-
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raphy and analyzed by SDS-PAGE and Western blotting. Surprisingly, already
on a Coomassie stained SDS-PAGE, a prominent accumulation of various Atp10-
specific interaction partners was observed in ina22Δ (Fig. 2.16A, lanes 1-3). Further
Western blot analysis confirmed an unexpected significant accumulation of nuclear-
encoded F1 and peripheral stalk subunits with Atp10 upon INA22 deletion (Fig.
2.16A, lanes 4-6). To verify that this prominent accumulation was not caused by
altered steady-state levels of nuclear-encoded ATP synthase components, we per-
formed a similar experiment to analyze elution fractions together with the input.
Clearly, steady-state levels of F1 and peripheral stalk components in ina22Δ mito-
chondria were comparable to wild type, indicating that the observed findings are
meaningful.
In conclusion, the data clearly indicate that F1 associates first with the Atp6/Atp8
module rather than with the Atp9 ring, as was assumed before.
2.4.5 F1 and the peripheral stalk assemble with Atp6/Atp8 module.
Previous data indicated that the Atp6/Atp8 assembly module accumulates with
F1 and the peripheral stalk in ina22Δ. Thus, we asked whether they form a sta-
ble protein complex that could be isolated and analyzed. Therefore, Atp10ProtA-
containing complexes were isolated from WT and ina22Δ mitochondria. Complexes
were eluted via TEV-cleavage and analyzed by BN-PAGE and Western blotting with
antibodies raised against Atp2, a component of F1, and Atp4, a component of the
peripheral stalk. The obtained results indicate an extensive accumulation of Atp4-
containing protein complexes, as well as the Atp1-Atp2 dimer, a fully assembled F1
module and an Atp2-containing complex of around 232 kDa upon INA22 deletion
(Fig. 2.17A). Most likely, the 232 kDa Atp2-containing complex represents a not
fully assembled F1, making it tempting to speculate that the Atp6/Atp8 module
might serve as an assembly platform for F1 and the peripheral stalk. However, the
Atp2 and Atp4 containing complexes did not co-migrate on BN-PAGE. This implies
that either two distinct Atp10-containing assembly intermediates exist, associated
with the peripheral stalk or with F1, or that a single intermediate containing the
peripheral stalk and F1 dissociates to smaller subcomplexes under BN-PAGE con-
ditions.
To distinguish between these two scenarios, we performed a two-step affinity
purification of these complexes. Firstly, Atp10ProtA-containing assembly interme-
diates were natively isolated. Secondly, the obtained elution fractions were used
for immunoprecipitation with either anti-Atp2 antibodies or a control pre-immune
serum. The Western blot analysis of all elution fractions clearly showed that Atp2
remained associated with Atp4 and Atp5, two constituents of the peripheral stalk,
within a single Atp10-associated protein complex (Fig. 2.17B).
Therefore, we concluded that a large assembly intermediate accumulates in ina
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Figure 2.17 F1 and peripheral stalk assemble on Atp6/Atp8 module. A. Atp10
ProtA-
containing protein complexes were purified via IgG affinity chromatography from
Atp10ProtA, Atp10ProtAina22Δ and wild type mitochondria. Purified complexes were
eluted via TEV-protease cleavage and analyzed by BN-PAGE and Western blotting
with the indicated antibodies. B. Wild type, Atp10ProtA and Atp10ProtAina22Δ
mitochondria were subjected to IgG affinity chromatography. The obtained elution
fractions were further subjected to immunoprecipitation (IP) with either anti-Atp2
antibodies or a control preimmune serum (PI). 1% of the input fraction and all elu-
tion fractions were analyzed by SDS-PAGE and Western blotting with the indicated
antibodies. αβ, a dimer of Atp1 and Atp2.
mutants, which contains an Atp6/Atp8 module, associated with Atp23 and Atp10,
the peripheral stalk, and F1. This intermediate is transient in wild type mitochondria
and unstable during BN-PAGE analysis.
The currently proposed model of F1Fo-ATP synthase assembly postulates that
F1 associates with the Atp9 ring prior to association with the Atp6/Atp8/peripheral
stalk module (Rak et al., 2011). However, our data clearly indicates that F1 assem-
bles on the Atp6/Atp8 module, interacts with the peripheral stalk and therefore
this association must take place prior to Atp9 ring binding. We noticed that for
analyses of the Atp6/Atp8 module composition, Rak et al. (2011) used conditions,
different from ours. In contrast to our analyses, much higher salt concentration and
a higher pH were used by Rak et al. To assess if the high stringency buffer affected
the integrity of the Atp6/Atp8 module, we purified Atp10ProtA-containing complexes
by IgG affinity chromatography under high-stringent and low-stringent conditions
(see Materials and Methods), and analyzed them by SDS-PAGE and Western blot-
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Figure 2.18 F1 and Atp23 associate with the Atp6/Atp8 module. A. Wild type,
Atp10ProtA and Atp10ProtAina22Δ mitochondria were solubilized under low- and
high-stringent conditions and protein complexes were isolated via IgG affinity chro-
matography. The input and elution fractions were analyzed by SDS-PAGE and
Western blotting with the indicated antibodies. Input=1% of elution. B. Wild type
and Atp23HA mitochondria were subjected to in organello labeling and immunopre-
cipitation with control or anti-Atp23 antibodies, followed by SDS-PAGE and digital
autoradiography analysis. Input=2% of elution. WB, Western blotting.
ting (2.18A). As expected, F1 and peripheral stalk association with the Atp6/Atp8
module was drastically decreased under high-stringent conditions.
Our results indicate that Atp23 is a true constituent of the Atp6/Atp8 module,
in contrast to what has been previously published (Rak et al., 2011). We noticed
that for their experiments, Rak et al. used a C-terminally HA-tagged Atp23 variant.
Therefore, to address whether a C-terminal tag interfered with the protein function,
we performed an Atp23 immunoprecipitation after in organello labeling of mito-
chondrial gene products in wild type and Atp23HA mitochondria. To our surprise,
the C-terminal HA-tagging of Atp23 reduced protein stability and, subsequently, its
association with newly-synthesized Atp6 and Atp8 (2.18B). Therefore, we conclude
that Atp23 tagging interferes with Atp23 function.
2.4.6 F1Fo-ATP synthase assembly is stalled in ina22Δ prior to the last
step
To better understand how F1Fo-ATP synthase assembly proceeds upon INA22
deletion, a second dimension analysis (2D) of the mitochondrial protein complexes
was performed. For this, chloramphenicol-treated wild type and ina22Δ mitochon-
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Figure 2.19 F1Fo-ATP synthase assembly is stalled before the final step. A,B.
Chloramphenicol-treated wild type and ina22Δ mitochondria were subjected to in
organello labeling for 15 min. Protein complexes were analyzed by BN-PAGE and
second dimension Urea SDS-PAGE (A) or SDS-PAGE (B) followed by digital autora-
diography. Dashed boxes indicate accumulated Atp6/Atp8 assembly intermediates.
B. Chloramphenicol-treated wild type and ina22Δ mitochondria were analyzed by
BN-PAGE, second dimension SDS-PAGE and Western blotting with the indicated
antibodies. VM, monomer of complex V; VD, dimer of complex V. Dashed boxes
indicate Atp23-containing protein complexes.
dria were subjected to in organello labeling for 15 minutes and protein complexes
were separated by BN-PAGE in the first dimension and SDS-PAGE in the sec-
ond dimension. It was previously shown that 15 minutes is sufficient time for
mitochondrial-encoded complex V components to assemble into the mature enzyme
(Rak et al., 2011). Moreover, in order to efficiently separate Atp6 from Cox3 and
Atp8 from Atp9, two different gel systems were used for the second dimension pro-
tein separation, Urea SDS-PAGE and SDS-PAGE, respectively.
After 15 minutes, enough mitochondrial-encoded F1Fo-ATP synthase compo-
nents assembled into the mature enzyme, as Atp9, Atp6 and Atp8 were clearly
incorporated into complex V monomers and dimers in wild type mitochondria (Fig.
2.19A and B, upper panels). However, the same was not observed in ina22Δ mito-
chondria. No complex V monomers or dimers were formed after 15 minutes upon
INA22 deletion. Moreover, an accumulation of a prominent assembly intermediate,
containing Atp6 and Atp8 was observed in ina22Δ (Fig. 2.19A, B, lower panels).
Further Western blot analysis of wild type and ina22Δ mitochondria clearly indi-
cated that Atp23 accumulates in the same complex as Atp6 and Atp8 (Fig. 2.19C)
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upon INA22 deletion. The latter is in agreement with all previously obtained data
and points again to a stall in F1Fo-ATP synthase assembly in the absence of Ina22.
2.5 Ina22 associates with two major F1Fo-ATP synthase as-
sembly intermediates to link them together
2.5.1 Ina22 interacts with newly translated mitochondrial-encoded pro-
teins
All previously obtained data indicate that the Atp6/Atp8 module of the F1Fo-
ATP synthase accumulates upon INA22 deletion due to its impaired assembly into
mature complex V. Moreover, our results point to a novel INAC interaction with
Atp10 and Atp23, the Atp6 and Atp8 assembly factors. Therefore, we hypothe-
sized that Ina22 association with Atp10 and Atp23 should take place within the
Atp6/Atp8 module. Thus, INAC should interact with newly translated Atp6 and
Atp8.
In order to verify Ina22 interaction with newly synthesized Atp6 and Atp8,
Ina22 co-immunoprecipitation of radiolabeled mitochondrial-encoded proteins from
control and chloramphenicol-treated mitochondria was performed (Fig. 2.20). The
results showed that Ina22 associates with Atp6 and Atp8, as well as Atp9. Im-
portantly, small amounts of these proteins were co-isolated with Ina22 from a non-
treated sample, whereas their interaction was significantly increased upon trans-
lational activation. This indicates that Ina22 interacts with F1Fo-ATP synthase
assembly intermediates. Most interesting is that Ina22 association with the Atp9
ring was detected. From previously performed experiments it is known that nei-
ther Atp10 nor Atp23 stably associates with the Atp9 ring. Therefore, this finding
allowed us to speculate that INAC might also be involved in the latest F1Fo-ATP
synthase assembly step, namely Atp9 ring connection. Taken together, these data
confirm that Ina22 interacts with two major F1Fo-ATP synthase assembly interme-
diates.
Moreover, it was shown that Ina22 also interacts with cytochrome b, a structural
subunit of the cytochrome bc1 complex (Fig 2.20). Taking a previously published
SILAC analysis of the Ina22ProtA interactome into consideration, where Cbp proteins
were identified as Ina22 interaction partners (Lytovchenko et al., 2014), we did
not exclude that INAC might be involved in the biogenesis of complex III of the
respiratory chain and investigated this further (see section 2.6).
2.5.2 Ina22 interaction with F1Fo-ATP synthase is Ina17-independent
The INA complex has two constituents, namely Ina22 and Ina17. It was previ-
ously shown that the Ina17 interaction with F1Fo-ATP synthase is Ina22-dependent
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Figure 2.20 Ina22 interacts with newly translated mitochondrial-encoded proteins.
Control and chloramphenicol-treated wild type mitochondria were subjected to in
organello labeling for 20 minutes, followed by immunoprecipitation with either Ina22
antibodies or pre-immune serum. Isolated proteins were analyzed by SDS-PAGE and
digital autoradiography. Input=1% of elution. TA, translational activation. WB,
Western blotting.
(Lytovchenko et al., 2014). However, it was not investigated whether Ina22 in-
teracts with complex V components in an Ina17-dependent manner. To address
this, we performed Ina22 immunoprecipitation from ina17Δ mitochondria. Unfor-
tunately, Ina22 becomes highly unstable upon INA17 deletion, which makes the
results difficult to interpret (data not shown). To overcome this, we overexpressed
INA22 in ina17Δ genetic background to restore Ina22 protein amounts. Impor-
tantly, overexpressed Ina22 was still imported into mitochondria (Fig. 2.21B, lanes
1-2). Next, to address Ina22 association with newly translated Atp6, Atp8 and Atp9,
we radiolabeled mitochondrial-encoded proteins in wild type and Ina22↑ina17Δ mi-
tochondria and performed Ina22 immunoprecipitation. Surprisingly, a significant
(around two-fold) increase of Ina22 association with Atp6 and Atp8 was detected,
whereas its interaction with Atp9 remained unchanged (Fig. 2.21A). As levels of
all co-isolated proteins were normalized to the amounts of Ina22 in the elution
and input fractions, we excluded that this resulted from elevated Ina22 levels upon
overexpression. Moreover, a Western blot analysis of Ina22 immunoprecipitation
from wild type and Ina22↑ina17Δ mitochondria showed that Ina22 can still interact
with nuclear-encoded complex V subunits, namely Atp2, upon INA17 deletion (Fig.
2.21B). Therefore we concluded that although Ina22 undergoes degradation in the
absence of Ina17, the remaining Ina22 protein is still able to associate with F1Fo-
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Figure 2.21 Ina22 interaction with the F1Fo-ATP synthase is Ina17-independent. A.
Mitochondrial-encoded proteins in wild type and Ina22↑ina17Δ mitochondria were
radiolabeled in organello for 20 min and co-immunoprecipitated with control or anti-
Ina22 antibodies. Input and elution fractions were analyzed by SDS-PAGE, digital
autoradiography and Western blotting (WB). For quantification, Atp6/Cox3, Atp8
and Atp9 signals in the elution fractions were normalized to isolated Ina22 and to the
corresponding signals in the input fraction. The results represent the percentage of
protein amounts co-isolated from Ina22↑ina17Δ mitochondria relative to wild type
mitochondria (100%). Input = 1% of elution. n = 3, ±SEM. B. Proteins from wild
type and Ina22↑ina17Δ mitochondria were co-immunoprecipitated with anti-Ina22
antibodies. Input and elution fractions were analyzed by SDS-PAGE and Western
blotting with the indicated antibodies. Input = 1% of elution.
59
RESULTS
ATP synthase in order to facilitate its assembly. The latter result is in agreement
with previous data, showing a less severe complex V assembly defect upon INA17
deletion, compared to INA22 deletion. Furthermore, there is no Atp6 processing
defect upon INA17 deletion. Therefore, we conclude that Ina17 functions as an
Ina22 chaperone and the observed F1Fo-ATP synthase assembly defect in ina17Δ is
a secondary effect from decreased Ina22 levels.
2.5.3 Ina22 interacts with the Atp9 ring and the Atp6/Atp8 module
In contrast to the previously published assumption that the Atp9 ring associates
with F1 in order to form a single assembly intermediate (Rak et al., 2011), our data
indicates that F1 rather associates with the Atp6/Atp8 module. Therefore, we shed
a new light on the order of F1Fo-ATP synthase assembly. However, the question of
which assembly factors mediate the last assembly step remain open.
Up to now, none of the known assembly factors involved in the Atp6/Atp8 mod-
ule biogenesis were shown to associate with the Atp9 ring and therefore to possibly
mediate the last F1Fo-ATP synthase assembly step. However, our data indicate that
Ina22 interacts with both the newly translated Atp9 ring and Atp6/Atp8. Therefore,
in order to show that INAC might mediate Atp9 ring assembly with the Atp6/Atp8
module, it was necessary to address if Ina22 interacts with the Atp9 ring and with
Atp6/Atp8 within two distinct assembly intermediates.
Figure 2.22 Ina22 interacts with the Atp9 ring and the Atp6/Atp8 module. A.
Chloramphenicol-treated wild type and Ina22FLAG mitochondria were subjected to
in organello labeling for 20 min, anti-FLAG affinity chromatography and anal-
ysis by SDS-PAGE and digital autoradiography. Input = 1% of elution. B.
Chloramphenicol-treated wild type and Ina22FLAG mitochondria were subjected to
in organello labeling, anti-FLAG affinity chromatography and further analysis by
BN-PAGE and digital autoradiography. C. Part of the Ina22FLAG elution fraction
of the experiment presented in panel B was subjected to BN-PAGE, second dimension




Therefore, we performed a native isolation of Ina22-containing protein com-
plexes. To do so, Ina22 was tagged with a C-terminal FLAG-tag that allows a
very efficient isolation of protein complexes. To verify whether a FLAG-tag affects
Ina22 association with newly translated F1Fo-ATP synthase components, wild type
and Ina22FLAG mitochondria were subjected to in organello labeling, followed by
Ina22FLAG affinity purification. Importantly, the FLAG-tag did not alter Ina22 as-
sociation with mitochondrial-encoded complex V subunits, despite the increased un-
specific background binding (Fig. 2.22A). Next, we performed a similar Ina22FLAG
isolation and eluted the isolated protein complexes natively with FLAG peptide.
BN-PAGE analysis of the elution fractions showed that Ina22 associates with sev-
eral assembly intermediates (Fig. 2.22B), however, it was not possible to distinguish
which mitochondrial-encoded proteins were constituents of these complexes. There-
fore, we analyzed elution fractions by second dimension SDS-PAGE (2D). Strikingly,
a 2D analysis revealed that two major F1Fo-ATP synthase assembly intermediates
were co-isolated with Ina22FLAG, one of them contained the Atp9 ring, and another
one contained Atp6, Atp8 and Atp23 (Fig. 2.22C). Surprisingly, more Atp9 ring
was co-purified with Ina22 compared to the amounts of co-purified Atp6 and Atp8.
The latter implies that INAC interaction with the Atp6/Atp8 module might indeed
occur only transiently, as seen before (Fig. 2.12), and that Ina22 association with
the Atp9 ring is more stable.
In conclusion, we established that Ina22 interacts with two main F1Fo-ATP syn-
thase assembly intermediates and therefore is the most likely candidate to mediate
their assembly.
2.5.4 Ina22 can be cross-linked to the Atp9 ring and the peripheral stalk
In the previous section, it was shown that Ina22 is present in two main F1Fo-
ATP synthase assembly intermediates. To establish whether Ina22 interacts with
newly translated F1Fo-ATP synthase components directly, we performed in organello
chemical crosslinking after radiolabeling of mitochondrial-encoded proteins in wild
type and Ina22FLAG mitochondria and isolated Ina22FLAG under denaturing condi-
tions. As a result, Atp9 was crosslinked to Ina22FLAG, confirming their direct in-
teraction (Fig. 2.23A). Surprisingly, no Ina22 crosslink was obtained to either Atp6
or Atp8 under the same conditions. This implies that either the chosen crosslinker
was not suitable for Ina22 crosslinking to Atp6 or Atp8, or that their interaction is
mediated by other proteins, for example peripheral stalk components. To test this,
we tried to crosslink Ina22 to Atp4, a membrane-embedded component of the pe-
ripheral stalk. Indeed, we successfully obtained an Ina22 crosslink to Atp4, implying
that the Ina22-Atp6/Atp8 interaction might indeed be mediated by the peripheral
stalk. (Fig. 2.23B).
In summary, Ina22 directly associates with the Atp9 ring and components of
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Figure 2.23 Ina22 can be crosslinked to Atp9 ring and Atp4. A. Wild type and Ina22FLAG
mitochondria were subjected to chemical crosslinking with DSP and Ina22FLAG was
purified under denaturing conditions. Input and elution fractions were analyzed by
SDS-PAGE and digital autoradiography. B. Wild type and Ina22FLAG mitochondria
were subjected to chemical crosslinking with DSS and Ina22FLAG was purified under
denaturing conditions. Elution fractions were analyzed by SDS-PAGE and Western
blotting with anti-FLAG or anti-Atp4 antibodies.
the peripheral stalk to link two assembly intermediates in the final assembly step.
2.6 INAC function in assembly of cytochrome bc1 complex
2.6.1 The INA complex interacts with Cbp proteins
Previously, Ina22ProtA protein complexes were purified via IgG affinity chro-
matography and analyzed by quantitative mass spectrometry after Stable Isotope
Labeling with Amino acids in Cell culture (SILAC) (Lytovchenko et al., 2014). Aside
from nuclear-encoded subunits of F1Fo-ATP synthase, three cytochrome b assem-
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bly factors were identified, namely Cbp3, Cbp6 and Cpb4. These findings point to
a putative INAC role in the assembly of complex III of the respiratory chain, also
called the cytochrome bc1 complex. However, further analysis of ina mutants did not
reveal any defect in mature complex III in either ina22Δ or ina17Δ mitochondria
and therefore the role of INAC association with Cbps was not investigated further.
Figure 2.24 The INA complex interacts with Cbp proteins. Wild type mitochondria
were solubilized and subjected to immunoprecipitation with control, anti-Ina22, anti-
Ina17, anti-Cbp3 and anti-Cbp4 antibodies. Results were analyzed by SDS-PAGE
and Western blotting with the indicated antibodies. Input = 1% of elution.
Our recently obtained data, however, revealed that Ina22 interacts with newly-
translated cytochrome b (Fig 2.20). Therefore we were interested in having a closer
look at INAC association with the complex III assembly machinery.
First of all, we confirmed INAC interaction with Cbps by immunoprecipitating
endogenous proteins with antibodies raised against Ina22, Ina17, Cbp3 and Cbp4.
Analysis of elution fractions by SDS-PAGE and immunoblotting confirmed that the
INA complex indeed associates with the cytochrome b assembly machinery (Fig.
2.24). Interestingly, significantly less Cbp3 and Cbp4 were co-isolated with Ina17
compared to Ina22, but approximately the same amounts of Ina22 and Ina17 were
co-isolated with Cbp3 and Cbp4. Therefore, we concluded that antibodies, raised
against the matrix domain of Ina17, do not bind efficiently to Ina17 associated with
Cbp proteins, as the matrix domain might be involved in these interactions. To
conclude, the endogenous INA complex physically associates with early cytochrome
b assembly machinery.
2.6.2 INAC interacts with Cbps in a cytochrome b – dependent manner
Cytochrome b (Cytb) is the only mitochondrial-encoded component of the res-
piratory chain complex III. Its expression in mitochondria is controlled by various
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nuclear-encoded factors, one of those being Cbp1. Cbp1 interacts with the 5’-end
of COB mRNA to regulate its stability (Dieckmann et al., 1982; Islas-Osuna et al.,
2002). Upon CBP1 deletion, COB mRNA becomes highly unstable and the mature
protein is therefore not synthesized.
Figure 2.25 The Ina22 interaction with Cbps is cytb-dependent. A. Wild type and mu-
tant mitochondria were solubilized and analyzed by SDS-PAGE and Western blot-
ting with the indicated antibodies. B. Wild type and cbp1Δ mitochondria were
solubilized and subjected to immunoprecipitation. Input and elution fractions were
analyzed by SDS-PAGE and Western blotting with the indicated antibodies. Input
= 1% of elution.
To test whether INAC interaction with Cbps requires cytochrome b, a yeast
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strain lacking the CBP1 gene was generated in an intronless background. Mito-
chondria from control wild type and cbp1Δ strains were isolated and analyzed by
SDS-PAGE and Western blotting. CBP1 deletion resulted in downregulation of
complex III, since less complex III structural components (Qcr8, Rip1, Cor1) were
present in mutant mitochondria compared to wild type (Fig. 2.25A). However,
CBP1 deletion did not alter levels of Cbp3 and Cbp4, as well as structural subunits
of F1Fo-ATP synthase. Surprisingly, a slight upregulation of Ina22 and Ina17 was
observed in cbp1Δ mitochondria.
Next, we used wild type and cbp1Δ mitochondria for immunoprecipitations
with control, anti-Ina22, anti-Cbp3 and anti-Cbp4 antibodies. Analysis of the elu-
tion fractions by SDS-PAGE and Western blotting showed that CBP1 deletion, and
the subsequent absence of cytochrome b, completely abolishes the Ina22 interaction
with Cbp proteins. Importantly, the absence of cytochrome b did not change Ina22
association with either Ina17 or Atp5, but significantly decreased Cbp3-Cbp4 inter-
action, in agreement with previously published data (Gruschke et al., 2011) (Fig.
2.25B).
To conclude, Ina22 interacts with Cbp proteins in a cytochrome b-dependent
manner.
2.6.3 A C-terminal protein A tag does not alter the function of Cbp
proteins
For isolation of native Cbp-containing protein complexes, Cbp3, Cbp4 and
Cbp6 proteins were tagged with a Protein A tag at their C-terminus. To analyze if
Cbp tagging affected complex III biogenesis, we checked the growth behavior of the
generated strains on non-fermentable carbon sources. Growth of yeast expressing
tagged Cbp proteins was comparable to the growth of a wild type strain on both
fermentable (YPD) and non-fermentable (YPG) media at all temperatures tested
(Fig. 2.26A). Moreover, to make sure that cytochrome b translation was not affected,
mitochondrial-encoded proteins in wild type, Cbp3ProtA, Cbp4ProtA and Cbp6ProtA
strains were pulse-labeled with [35S] methionine and analyzed by SDS-PAGE and
autoradiography. No cytochrome b biogenesis defect was detected (Fig. 2.26B) and
therefore we concluded that tagged Cbp proteins remain functional.
2.6.4 INAC interacts with Cbps in a discrete protein complex
Though we confirmed that tagged Cbp proteins were functional in cytochrome
b biogenesis, their ability to interact with the INA complex had not been shown.
Therefore, we subjected wild type, Cbp3ProtA, Cbp4ProtA and Cbp6ProtA mitochon-
dria to IgG affinity chromatography and analyzed their association with INAC and
other components of complex III by Western blotting. Qcr8, an early structural sub-
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Figure 2.26 C-terminal protein A tag does not alter the function of Cbp proteins. A.
A serial dilution of yeast cells was spotted on fermentable (YPD) or non fermentable
(YPG) media and grown at the indicated temperatures for 2-5 days. WT, wild type.
B. Mitochondrial-encoded proteins in the indicated strains were pulse-labeled with
[35S] methionine and analyzed by SDS-PAGE and autoradiography. WT, wild type.
unit of complex III, was co-isolated only with Cbp4, in agreement with published
data (Gruschke et al., 2012) (Fig. 2.27A). Moreover, Cor1, a late complex III struc-
tural subunit, was not co-isolated with any of the Cbp proteins, also in agreement
with previous work (Gruschke et al., 2012). Importantly, neither of the tested com-
plex V structural subunits (Atp2, Atp3, Atp5, Atp10) were co-purified with Cbps in
sufficient amounts for detection by Western blotting. Therefore, we confirmed that
Cbp proteins do not physically associate with components of the F1Fo-ATP syn-
thase. However, both Ina17 and Ina22 were co-isolated with Cbp3ProtA, Cbp4ProtA
and Cbp6ProtA. It is worth mentioning that less Ina17 and Ina22 were isolated with
Cbp4 compared to Cbp3 and Cbp6. Therefore, we do not exclude that the Protein
A tag on Cbp4 might affect this association.
To address if INAC interacts with Cbps in a distinct protein complex, we sub-
jected wild type, Cbp3ProtA, Cbp4ProtA and Cbp6ProtA mitochondria to IgG affinity
chromatography and eluted bound protein complexes natively via protease cleavage.
Analysis by BN-PAGE and Western blotting with antibodies raised against Ina17
and Ina22 revealed a single protein complex of approximately 350 kDa, containing
Ina17 and Ina22, that co-purified with Cbp3, Cbp4 and Cbp6 (Fig. 2.27B). Lesser
amounts of this complex were isolated via Cbp4, implying again that either less
Cbp4 is present or Protein A tagged Cbp4 does not associate with the complex
efficiently.
To summarize, Cbp proteins interact with INAC in a distinct protein complex,
which does not contain structural subunits of F1Fo-ATP synthase.
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Figure 2.27 INAC-Cbps containing protein complex can be natively isolated. A. Wild
type, Cbp3ProtA, Cbp4ProtA and Cbp6ProtA mitochondria were subjected to IgG
affinity chromatography. Bound protein complexes were eluted with low pH and
analyzed by SDS-PAGE and Western blotting with the indicated antibodies. Input
= 2% of elution. B. Wild type, Cbp3ProtA, Cbp4ProtA and Cbp6ProtA mitochondria
were subjected to IgG affinity chromatography and bound protein complexes were
eluted natively via TEV protease cleavage. Elution fractions were analyzed by BN-
PAGE and Western blotting with the indicated antibodies.
2.6.5 Newly translated cytochrome b is present in INAC*CBP complex
Our previously obtained data indicate that INAC interaction with Cbps requires
the presence of cytochrome b. Therefore, we wondered if the newly identified com-
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Figure 2.28 Newly translated cytochrome b is present in the INAC-CBP complex.
A. Wild type and Cbp3ProtA mitochondria were subjected to in organello labeling
and IgG affinity chromatography. Bound protein complexes were eluted natively via
TEV protease cleavage and analyzed by SDS-PAGE and digital autoradiography or
Western blotting with anti-Cbp3 antibodies. Input = 1% of elution. WB, Western
blot. B. Part of the elution of the experiment presented in panel A was analyzed
by BN-PAGE and either Western blotting (WB) with anti-Cbp3 antibodies, or au-
toradiography. C. Part of the elution of the experiment presented in panel A was




plex, containing Cbp proteins together with Ina17 and Ina22, includes newly trans-
lated cytochrome b. Thus, we subjected wild type and Cbp3ProtA mitochondria to in
organello labeling and IgG affinity chromatography. Bound protein complexes were
eluted natively via TEV protease cleavage and further analyzed. SDS-PAGE anal-
ysis, followed by autoradiography confirmed that the Protein A tag was efficiently
cleaved and sufficient amounts of cytochrome b were co-isolated with Cbp3ProtA
(Fig. 2.28A). Next, we analyzed eluted protein complexes by BN-PAGE. As can
be seen from the results, several cytochrome b-containing complexes were isolated
with Cbp3, which most probably represent early complex III assembly intermediates
(Fig. 2.28B). Based on previously reported data, it is known that Cbp3 associates
with newly translated cytochrome b while associated with ribosomes and within
assembly intermediate I (Gruschke et al., 2012). However, when another gradient of
BN-PAGE was used, it was possible to clearly separate two Cbp3-cytochrome b con-
taining protein complexes. Next, to analyze components of the isolated complexes
in more detail, we separated the Cbp3ProtA elution fraction by BN-PAGE and second
dimension SDS-PAGE. A digital autoradiography analysis confirmed the presence
of two distinct co-isolated cytochrome b - containing complexes (Fig. 2.28C). The
first complex, of smaller size, contained cytochrome b, Cbp3 and Cbp4 and likely
represents intermediate I of complex III assembly. A second complex, of a larger size
additionally contains Ina17 and Ina22 and therefore represents a previously uniden-
tified INAC*CBP macromolecular assembly. Moreover, we observed that Ina17 and
Ina22 co-migrate with Cbp3 in a complex of approximately 100 kDa. However, as
this complex did not contain newly translated cytochrome b, we assumed that it is
most likely a degradation product of the larger complex.
Cbp3 was previously shown to stably associate with Cbp6, even upon solubi-
lization in 1% Triton (Gruschke et al., 2011), and therefore it is highly unlikely that
a free Cbp6 pool exists in the cell. To address whether the identified INAC*CBP
complex contains Cbp6, we analyzed protein complexes in wild type and cbp6Δ mi-
tochondria by second dimension SDS-PAGE and Western blotting. In intact wild
type mitochondria, we observed that Cbp3 co-migrates with Ina17 and Ina22 in the
newly identified INAC*CBP complex (Fig. 2.29). As expected, upon Cbp6 dele-
tion, Cbp3 shifts from both INAC*CBP complex and intermediate I to a free pool.
Importantly, Ina17 and Ina22 shift to lower molecular weight complexes as well.
Taken together, the data indicate that Cbp6 is also a component of the INAC*CBP
complex and is required for its integrity.
2.6.6 The INAC*CBP complex is destabilized upon complex III assem-
bly stalling
Assembly of complex III is a step-wise process. It starts with translation of
cytochrome b and its correct hemylation, and continues with the addition of nuclear-
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Figure 2.29 The INAC*CBP complex is unstable upon CBP6 deletion. Wild type and
cbp6Δ mitochondria were solubilized and protein complexes were analyzed by BN-
PAGE and second dimension SDS-PAGE, followed by Western blotting with the
indicated antibodies.
encoded structural subunits (Gruschke et al., 2011; Gruschke et al., 2012). Impor-
tantly, Cbp3 and Cbp6 remain associated with cytochrome b only during the initial
steps of complex III assembly, before the first structural subunits, namely Qcr8 and
Qcr7, are added. Deletion of QCR8 was shown to stall complex III assembly and
to trap cytochrome b, Cbp3, Cbp6 and Cbp4 in the intermediate I (Gruschke et al.,
2012). To analyze what happens to the INAC*CBP complex upon QCR8 deletion
and the accumulation of intermediate I, we isolated mitochondria from wild type
and qcr8Δ strains and analyzed mitochondrial protein complexes by second dimen-
sion SDS-PAGE and Western blotting. As before, we detected a co-migration of
INAC and Cbp3 protein within the INAC*CBP complex (Fig. 2.30). However,
upon QCR8 deletion, Cbp3 from the INAC*CBP complex shifts to intermediate
I, whereas INA proteins shift to lower molecular weight complexes. Therefore, we
established that the CBP*INAC interaction indeed does not take place within com-
plex III assembly intermediate I. Moreover, upon stalling of complex III assembly
at early stages, the INAC*CBP complex is destabilized.
2.6.7 INAC does not associate with known cytochrome b translational
activators
Based on all previously collected data, it is clear that INAC associates only
with cytochrome b and its early assembly factors, but not with structural subunits of
70
RESULTS
Figure 2.30 INAC*CBP complex is destabilized upon complex III assembly stalling.
Wild type and qcr8Δ mitochondria were solubilized and protein complexes were ana-
lyzed by BN-PAGE and second dimension SDS-PAGE, followed by Western blotting
with the indicated antibodies.
complex III. Therefore, we screened the literature for other proteins that are involved
in the early biogenesis of complex III and found that translation of cytochrome b
is under the control of two ribosome-associated translational activators, Cbs1 and
Cbs2 (Rödel, 1986). Though it was shown that Cbp proteins do not interact with
Cbs1 and Cbs2 (Gruschke et al., 2011), we addressed whether an interaction between
INAC and Cbs1 or Cbs2 takes place.
For this, Cbs1 and Cbs2 were genomically fused with a Protein A tag at their
C-terminus. To exclude that tagging affected protein functionality, a growth test
was performed for wild type, Cbs1ProtA and Cbs2ProtA strains on fermentable and
non-fermentable carbon sources. Strains expressing tagged Cbs proteins grew com-
parable to wild type (Fig. 2.31A). Moreover, Western blot analysis of wild type,
Cbs1ProtA and Cbs2ProtA mitochondria did not reveal any severe alterations in mi-
tochondrial protein levels (Fig. 2.31B). Therefore, we concluded that the generated
strains are functional.
To address the INAC-Cbs interaction, we subjected wild type, Cbs1ProtA and
Cbs2ProtA mitochondria to IgG affinity chromatography and analyzed purified pro-
tein complexes by SDS-PAGE and Western blotting. Moreover, we used Cbp3ProtA
mitochondria as a positive control for complex isolation. Whereas Ina17 and Ina22
were co-isolated with Cbp3, no Ina17 or Ina22 was detected in Cbs1ProtA and
Cbs2ProtA elutions. This finding confirms the absence of INAC interaction with
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Figure 2.31 INAC does not associate with cytochrome b translational activators Cbs1
and Cbs2. A. A serial dilution of yeast cells was spotted onto plates containing
fermentable (YPD) or non-fermentable (YPG, YPGal) carbon source and grown
at indicated temperatures for 2-5 days. B. Wild type, Cbs1ProtA and Cbs2ProtA
mitochondria were solubilized and analyzed by SDS-PAGE and western blotting with
the indicated antibodies. C. Wild type, Cbs1ProtA and Cbs2ProtA mitochondria were
subjected to IgG affinity chromatography and the elution fractions were analyzed by
SDS-PAGE and Western blotting with the indicated antibodies. Input = 1% of
elution.
cytochrome b translational activators and, therefore, excludes the possibility that
the INA complex might be involved in translational regulation of cytochrome b.
2.6.8 Proof of INAC*CBP interaction
All previously performed experiments did not reveal a defect in complex III
biogenesis upon deletion of INA complex components (Lytovchenko et al., 2014).
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The steady-state levels of complex III, as well as the activity of the mature enzyme
in ina mutants, never differed from that of wild type mitochondria. Moreover,
detailed analyses of cbp mutants did not indicate any impairment of F1Fo-ATP
synthase (Gruschke et al., 2011; Gruschke et al., 2012). However, our data clearly
show that the INA complex associates with Cbp3, Cbp6, Cbp4 and newly translated
cytochrome b. The absence of a clear phenotype for either complex III or V in ina
and cbp mutants respectively makes the function of this association unclear.
Figure 2.32 INAC interaction with Cbps is not a post-lysis artifact. [35S]Ina22 was im-
ported into wild type and Cbp3ProtA mitochondria (lanes 6 and 7). Mitochondria
were lysed separately and the two lysates were mixed (lane 8). Then, the mixed mi-
tochondrial lysate was subjected to affinity chromatography with either anti-Cbp3
antibodies (lane 10), IgG coupled beads (lane 9) or control serum (lane 11) raised
against Pam18. Samples were analyzed by SDS-PAGE, followed by autoradiogra-
phy (upper panel) and Western blotting with the indicated antibodies (three lower
panels). Please note that anti-Ina22 antibodies recognize radioactively labeled Ina22.
Therefore, we asked whether the observed interaction of the INA complex with
Cbp proteins indeed happens in vivo or whether we observe an unspecific protein ag-
gregation in post lysis mitochondria. To check if the latter was the case, the following
experiment was performed. First, in vitro synthesized radioactively labeled Ina22
was imported into WT and Cbp3ProtA mitochondria and the mitochondria were sub-
jected to IgG affinity chromatography. Clearly, imported Ina22 was co-isolated with
Cbp3 (Fig. 2.32, lanes 1-5), showing that [35S]Ina22 can be co-isolated with Cbp3
in principle. Next, [35S]Ina22 was imported into wild type, but not into Cbp3ProtA
mitochondria. After this, mitochondria were solubilized separately and the lysate
of wild type mitochondria (with imported Ina22) was mixed with Cbp3ProtA lysate
(with no radiolabeled Ina22). The obtained mixed lysate (Fig. 2.32, lane 8) was sub-
jected to affinity chromatography, either with beads coupled to IgG (should isolate
Cbp3ProtA), antibodies against endogenous Cbp3 (should isolate both tagged and
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non-tagged Cbp3), or control serum (α-Pam18, would still react with Protein A).
Elution fractions were analyzed by SDS-PAGE, followed by autoradiography and
Western blotting. As the result shows, imported Ina22 was co-imunoprecipitated
only with endogenous Cbp3 protein, but not with Cbp3ProtA (Fig. 2.32. lanes 9
and 10). The latter proves that the Cbp3-Ina22 interaction does not happen due
to protein aggregation in post lysis mitochondria and therefore confirms that the
newly identified INAC*CBP complex is not an artifact.
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3. Discussion
The mitochondrial F1Fo-ATP synthase is the terminal enzyme of OXPHOS
system that uses the proton gradient across the inner mitochondrial membrane to
drive ATP synthesis. Structurally, this enzyme can be divided into two parts –
the hydrophilic F1, which produces ATP, and the hydrophobic Fo, which forms a
membrane proton channel and transmits the energy from proton movement to the
catalytic centers. The proton channel is formed by mitochondrial-encoded Atp6
and Atp9 proteins and, on its own, is not involved in ATP synthesis. Nuclear-
encoded subunits are required to couple proton movement across the membrane
to ATP production. Without this coupling, the proton gradient across the inner
mitochondrial membrane would dissipate without productive ATP synthesis and,
therefore, only heat would be generated. Some hibernating animals, as well as
children, actually use an uncoupled mitochondrial respiration in brown fat tissue
for this purpose (Nicholls et al., 1978; Kozak et al., 1988; Kalinovich et al., 2017).
However, in the majority of eukaryotic cells, uncoupled respiration has deleterious
consequences.
It is not surprising that expression and assembly of nuclear- and mitochondrial-
encoded F1Fo-ATP synthase subunits should be coordinated in order to avoid the
overproduction of individual F1 and Fo modules. When present in excess in mito-
chondria, the F1 and Fo modules will hydrolyze ATP and dissipate the membrane
potential, respectively. Moreover, the biogenesis of the Atp9/Atp6 channel requires
special regulation, as its formation prior to association with nuclear-encoded sub-
units is highly unfavorable. According to the recently proposed model of F1Fo-ATP
synthase assembly, Atp9 associates with Atp6 in a final assembly step, when nuclear-
encoded subunits are already positioned (Rak et al., 2011). However, the mechanism
by which the last step is controlled remains unidentified.
The recent identification of the INA complex partially shed some light on how
F1 might be connected to Fo. In this study, we extend upon previous knowledge
and show that not only is the INA complex required for peripheral stalk and F1
biogenesis, but it is also involved in the formation of the Atp6/Atp9 proton channel,
the final and most important step of F1Fo-ATP synthase assembly.
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3.1 Altered expression of mitochondrial-encoded F1Fo-ATP
synthase components in ina mutants
In this study, we show that deletion of the INA complex alters expression of the
mitochondrial-encoded F1Fo-ATP synthase subunits Atp6, Atp8 and Atp9. Impor-
tantly, neither expression nor stability of the other mitochondrial-encoded subunits
of the respiratory chain was affected, implying that the observed effect is F1Fo-ATP
synthase-specific. In vivo pulse-labeling with [35S] methionine showed that the levels
of Atp6 and Atp8 increase almost two-fold upon INA22 or INA17 deletion. As sta-
bility of the newly-translated proteins increased only slightly compared to wild type,
we concluded that their production was strongly enhanced and therefore resulted
in greater protein abundance. Considering that Atp6 and Atp8 are encoded on the
same bi-cistronic mRNA and are present in a one to one stochiometry within the
mature complex V, their similar expression levels in various mutants is not surprising
and was reported before (Rak and Tzagoloff, 2009; Rak et al., 2016).
Analyses of Atp9 levels in ina mutants gave contradicting results. In vivo
pulse-labeling experiments did not reveal significant differences between the mutants
and the wild type. However, when Atp9 was analyzed after in organello pulse-
labeling with [35S] methionine, we clearly saw a strong reduction in Atp9 levels, of
both its monomeric and its oligomeric form. The reason for these results remains
unclear. We can speculate that the Atp9 protein is highly unstable and, therefore,
its oligomerization and efficient assembly into complex V is required to reduce its
turnover. It is not unlikely that the half-life of Atp25 or of the Aep1/Aep2 proteins,
required for Atp9 expression and stability (Zeng et al., 2008; Finnegan et al., 1995;
Payne et al., 1993; Ziaja et al., 1993), might be very short and so their constant
import into mitochondria is required for efficient Atp9 biogenesis. While the required
factors are constantly supplied by the cytoplasmic translation system in vivo, their
translation and import into purified mitochondria in vitro is of course not possible.
Thus, while the Atp9 ring is efficiently assembled into F1Fo-ATP synthase and
therefore stabilized in wild type mitochondria, its impaired assembly in ina mutants,
in combination with reduced amounts of stabilizing factors in purified mitochondria,
might contribute to the observed two-fold decrease in Atp9 levels. However, we do
not exclude that some yet unidentified Atp9 biogenesis factors contribute to the
observed phenotype in ina mutants.
Neither our results, nor a previously performed extensive analysis of mitochon-
drial ribosome-associated proteins, showed INAC association with the mitochondrial
translation system (Kehrein et al., 2015). Therefore, we exclude INAC association
with mitochondrial ribosomes and its direct regulation of Atp6/Atp8 translation.
However, based on previously published data, it is known that Atp6/Atp8 expres-
sion depends to a large extent on nuclear-encoded F1Fo-ATP synthase subunits
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(Goyon et al., 2008; Rak and Tzagoloff, 2009; Rak et al., 2016). The mechanism of
Atp6/Atp8 translational regulation by a preassembled F1 has been described (Rak
and Tzagoloff, 2009; Rak et al., 2016). A preassembled F1 is required to inhibit
Smt1, a suppressor of Atp6/Atp8 translation, and therefore to stimulate Atp22 in-
teraction with the ATP6/ATP8 mRNA (Rak et al., 2016). Taking significantly
increased levels of free F1 in ina mutants into consideration, it can be speculated
that these higher F1 levels contribute to a stronger translational stimulation. How-
ever, this hypothesis requires further verification, as a direct dependence between
the levels of free F1 and Atp6/Atp8 translation rate was not previously shown.
Moreover, we can not exclude that ATP6/ATP8 mRNA levels are elevated
in ina mutants which results in higher translation rates. Though no evidence for
a potential role of INAC in ATP6/ATP8 transcription or mRNA maturation has
been obtained so far.
To conclude, deletion of the INA complex components indirectly affects trans-
lation of Atp6, Atp8 and Atp9. Further analysis is required to shed a light on the
mechanistic details of the observed phenotype.
3.2 Atp6 processing defect as a marker for impaired Fo bio-
genesis
In the yeast S. cerevisiae, Atp6 is synthesized with a 10 amino-acid N-terminal
extension, which is cleaved by Atp23, a protease of the inter membrane space (Mi-
chon et al., 1988; Osman et al., 2007; Zeng et al., 2007c). Our analyses showed that
although no preAtp6 could be detected in wild type cells, a significant amount of
preAtp6 accumulates in the ina22Δ mutant, implying that early biogenesis of Atp6
is affected. To our surprise, no Atp6 processing defect was observed in ina17Δ,
though Ina17 and Ina22 form a stable complex and perform similar functions. It
was previously shown that Ina22 recruits Ina17 to the F1Fo-ATP synthase and
that Ina17 loses its interaction with complex V components upon INA22 deletion
(Lytovchenko et al., 2014). In this study, we show that Ina22 interacts with the
F1Fo-ATP synthase even in the absence of Ina17, although Ina22 amounts are dras-
tically reduced in ina17Δ. Therefore, this observation explains why the processing
of Atp6 was affected only in ina22Δ – most likely, upon INA17 deletion, the remain-
ing Ina22 is still functional in complex V biogenesis. In agreement with this, it has
always been observed that INA17 deletion results in a milder phenotype compared
to ina22Δ – the mutant strain grows relatively better on non-fermentable carbon
sources, less unassembled F1 and more mature complex V is present in the cell (Ly-
tovchenko et al., 2014). Therefore, we conclude that Ina22 has a more specific role
for F1Fo-ATP synthase biogenesis, whereas Ina17 is required mostly for Ina22 sta-
bilization. It is, however, not known whether a pool of Ina17, not-associated with
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Ina22, is present in the cell and whether it has some other functions apart form
Ina22 stabilization.
To understand why Atp6 processing is affected in ina22Δ, we performed an
extensive analysis of Atp23, the protease responsible for Atp6 processing, using
ina22Δ. To our surprise, steady-state amounts of Atp23 were not affected upon
INA22 deletion, implying that Atp23 deficiency can not explain preAtp6 accu-
mulation. To exclude the possibility that Ina22 might be involved in Atp23 re-
cruitment to its substrate, we analyzed Atp23 association with Atp6 in ina22Δ.
Co-imunoprecipitation analysis revealed that the Atp23-Atp6 association is not im-
paired in ina22Δ. Therefore, Ina22 does not directly affect Atp23 function in Atp6
processing.
The observation that Atp23 overexpression completely rescues Atp6 processing
in ina22Δ led us to assume that the processing defect might be caused by increased
Atp6 expression levels. Therefore, Atp23 levels in the cell might be limited and upon
increased Atp6 production, the protease can not cope with an excess of its substrate.
A similar processing phenotype was previously observed upon SMT1 deletion (Rak
et al., 2016). Smt1 is a repressor that coordinates Atp6 and Atp8 expression accord-
ing to the amount of available nuclear-encoded F1 module. Upon SMT1 deletion,
Atp6/Atp8 translation increases and a significant amount of preAtp6 remains un-
processed. The Atp6 processing defect in smt1Δ can also be rescued by Atp23
overexpression (Rak et al., 2016). This indicates that Atp23 levels are indeed rate
limiting. Therefore, problems with Atp6 processing in ina22Δ are an indirect effect
of imbalanced Atp6 and Atp23 amounts.
Atp23 has a dual function in Atp6 processing and assembly (Osman et al., 2007;
Zeng et al., 2007c). The processing is not essential, as yeast expressing catalytically-
inactive Atp23 are not affected in F1Fo-ATP synthase biogenesis (Osman et al.,
2007). Deletion of ATP23, however, results in the absence of mature complex V.
We saw that overexpression of Atp23 in ina22Δ partially rescues F1Fo-ATP synthase
assembly. First of all, the BN-PAGE analysis revealed that Atp23 overexpression
restores complex V levels in ina22Δ and less unassembled F1 is present in the mi-
tochondria. Accordingly, complex V partially regains its oligomycin sensitivity due
to these lower levels of free F1. Interestingly, the translation rate of Atp6 decreases
in ina22Δ upon Atp23 overexpression, which might support our initial assumption
about unassembled F1 in ina22Δ causing Atp6 translational upregulation. However,
Atp23 overexpression alone is not enough to completely restore F1Fo-ATP synthase
assembly in ina22Δ to wild type levels. Our analysis of Atp4 incorporation into com-
plex V clearly showed that F1Fo-ATP synthase assembly is still severely impaired
in ina22ΔAtp23↑, though it proceeds at a higher rate compared to ina22Δ. When
catalytically-inactive Atp23 was overexpressed, F1Fo-ATP synthase assembly was
rescued to a lesser extent compared to the overexpression of wild type Atp23. How-
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ever, we observed that the Atp23 catalytic mutant is unstable and due to this can
not be overexpressed to similar levels. Therefore, we could not conclude whether the
protease activity of Atp23 is important for complex V assembly rescue in ina22Δ.
Two factors may contribute to the complex V assembly defect in ina22Δ: (I)
Defects in Atp6 biogenesis and Fo assembly that can be rescued by Atp23 overex-
pression; (II) impaired downstream Atp9 ring assembly, that can not be restored by
higher protease levels.
3.3 INAC association with the Atp6/Atp8 biogenesis ma-
chinery
According to Rak et al., 2011, Atp6 associates with Atp8 and the peripheral
stalk within a complex V assembly intermediate. As INAC is required for proper
peripheral stalk assembly and physically associates with components of the periph-
eral stalk, we expected that INAC interacts at least transiently with the Atp6/Atp8
module. Until now, only Atp10 was shown to associate with Atp6/Atp8 and the
peripheral stalk during their assembly, and the presumption had been made that
Atp23 does not interact with the Atp6/Atp8 module (Rak et al., 2011). However,
we have now shown that Atp10 stably associates with Atp23 in several complex V
assembly intermediates containing newly translated Atp6 and Atp8. Therefore, our
results imply that Atp23 is a component of complex V assembly intermediates, in
contrast to what was previously published. An explanation for these controversial
results might be simple. Rak et al. used a C-terminally HA-tagged Atp23 variant
to analyze its interaction with the Atp6/Atp8 module. In our hands, C-terminal
tagging of Atp23 affects protein stability an therefore reduces its association with
the Atp6/Atp8 module. Therefore, in this study we analyzed endogenous untagged
Atp23 to exclude any possible side-effects.
We initially hypothesized that the interaction between Atp10 and Atp23 is
mediated by Atp6 and Atp8. However, our results showed that the association of
Atp10 with Atp23 does not increase upon mitochondrial translation upregulation.
This implies that either Atp10 interacts with Atp23 directly, or more likely, that
all Atp23 within mitochondria is recruited to Atp6/Atp8/Atp10 complex and no
free Atp23 pool exists. Therefore, Atp23 might be associated with Atp6 within two
functionally-distinct complexes - one required for Atp6 processing and the other
one needed for peripheral stalk assembly. We speculate that when the Atp9 ring
is connected, Atp23 is released from the Atp6/Atp8/peripheral stalk module and
can be recycled for Atp6 processing. Therefore, upon Atp6 translation upregula-
tion or complex V assembly stall, Atp23 accumulates with an Atp6/Atp8 inter-
mediate. However, experimental evidence for Atp23 “recycling” during F1Fo-ATP
synthase assembly is missing and this possible exciting mechanism should be inves-
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tigated further. Interestingly, feedback mechanisms were shown for the biogenesis
of mitochondrial-encoded Cox1 and cytochrome b that link their expression to as-
sembly (Mick et al., 2010; Gruschke et al., 2012). However, no similar mechanism
was discovered so far for complex V assembly. Therefore, it would be interesting to
verify whether any of the known F1Fo-ATP synthase assembly factors function in a
similar way, or whether some still unidentified proteins are involved.
Our data clearly showed that INAC associates with both Atp10 and Atp23
in a 400 kDa complex that contains newly translated Atp6 and Atp8. Interest-
ingly, INAC interaction with Atp10 and Atp23 is of a transient nature and becomes
strongly enhanced upon mitochondrial translational upregulation and accumulation
of complex V assembly intermediates. The latter means that, in contrast to Atp23,
free Ina17 and Ina22 pools exist in mitochondria from which the proteins are actively
recruited for complex V assembly and, most likely, Atp6 and Atp8 are required for
their recruitment. However, upon ATP22 deletion and Atp6 absence, Ina22 does not
completely lose its interaction with Atp23. We speculate that this interaction might
be maintained in the presence of Atp8. To verify this, the Ina22-Atp23 association
should be analyzed in mitochondria devoid of both Atp6 and Atp8. Unfortunately,
such an experiment can not be performed until an Atp8-specific translational acti-
vator is identified. Another explanation for the remaining Ina22-Atp23 interaction
in the absence of Atp6 might be that it does not require either Atp6 or Atp8. A
small pool of the INA complex might always remain associated with Atp23 and,
most probably, Atp10 to monitor complex V assembly state, and their interaction
is only stimulated in the presence of newly-translated Atp6 and Atp8.
It is unclear why a previously performed mass spectrometry analysis of Ina22ProtA-
isolated protein complexes after SILAC did not reveal the Ina22 interaction with
components of the Atp6/Atp8 assembly module (Lytovchenko et al., 2014). As
Atp6 and Atp8 are highly hydrophobic membrane proteins, it is possible that too
few peptides were generated for the proteins to be identified. Moreover, INAC inter-
action with the Atp6/Atp8 module is transient in nature, so most likely not enough
proteins were co-isolated under experimental conditions for detection. Last but not
least, we can not exclude that the Protein A tag at the Ina22 C-terminus is steri-
cally inaccessible within the Atp6/Atp8/peripheral stalk module. In either case, this
study confirms that endogenous non-tagged Ina22 associates with the Atp6/Atp8
intermediate during F1Fo-ATP synthase assembly.
3.4 F1Fo-ATP synthase assembly is stalled before its final
step in ina22Δ
To better understand the molecular mechanisms of INAC function, we asked
what happens to F1Fo-ATP synthase assembly intermediates upon INA22 deletion.
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We have shown that the Atp6/Atp8 module additionally contains Atp23 and tran-
siently associates with the INA complex. The observed accumulation of Atp23 with
Atp10 in ina22Δ indicates that the Atp23-Atp10 interaction happens prior to as-
sociation with the INA complex. Clearly, the accumulated Atp10-Atp23 containing
complex comprises of newly translated Atp6 and Atp8, and therefore it is a true
assembly intermediate. It is likely that this complex accumulates in ina22Δ for
two obvious reasons. First, the translation of Atp6 and Atp8 is upregulated almost
two-fold upon INA22 deletion, therefore, simply more intermediates are present in
the mitochondria. Second, the absence of the INA complex creates a bottle-neck in
the assembly line and therefore slows down further assembly steps.
In this study, we showed that in contrast to the previously published F1Fo-ATP
synthase assembly model (Rak et al., 2011), F1 interaction with the Atp6/Atp8 mod-
ule and the peripheral stalk precedes its association with Atp9 ring. Therefore, a
novel intermediate, containing Atp6/Atp8, the peripheral stalk and F1 is shown for
the first time. According to our results, Atp10 interacts with components of both
the peripheral stalk and F1 module transiently, meaning that the above mentioned
intermediate is short-lived under normal conditions and does not accumulate to de-
tectable levels in wild type cells, which explains why it was not identified before. In
contrast to the wild type situation, a significant amount of the peripheral stalk and
F1 accumulates with the Atp6/Atp8/Atp10/Atp23-containing complex in ina22Δ,
pointing to a stall in downstream complex V assembly. Even more surprising, we
showed that the not fully assembled peripheral stalk and F1 are positioned on the
Atp6/Atp8 module, suggesting that their de novo assembly occurs here. There-
fore, the biogenesis of the nuclear and mitochondrial-encoded parts of complex V is
spatially connected, implying the existence of a totally new regulatory mechanism.
A novel order in F1Fo-ATP synthase assembly opens up new questions that
should be addressed in the future. To start with, biogenesis of the peripheral stalk
and F1 on the Atp6/Atp8 module should be addressed. First, it is not known
whether assembly of the peripheral stalk de novo happens with the help of some
additional factors that were overlooked before. It can not be excluded that Atp10
and Atp23 might play a role in this process. As the Atp6/Atp8 module, peripheral
stalk, F1 and potential novel assembly factors accumulate in one complex in ina22Δ,
this intermediate can be isolated and analyzed further by mass spectrometry to
identify the missing components of the assembly process. Interestingly, our results
indicate that Atp5 is also present in this intermediate. Previously, it was shown that
Atp5 is not associated with the Atp6/Atp8/peripheral stalk module and therefore it
was not clear how exactly it assembles (Rak et al., 2011). Considering how important
Atp5 is for linking the peripheral stalk and F1 together, it is not surprising that it
assembles on the Atp6/Atp8 module. It would be interesting to address whether




A second question relating to F1Fo-ATP synthase assembly comes from the
knowledge that F1 de novo assembly requires Atp11 and Atp12, as well as chaperones
(Ackerman and Tzagoloff, 1990b; Francis and Thorsness, 2011). Therefore, it was
expected that Atp11 and Atp12 should associate with Atp23, Atp10 and Atp6/Atp8,
in order to assemble F1. However, it is enigmatic how this machinery is tethered
to the Atp6/Atp8 module and whether some scaffold-forming proteins are involved.
ina22Δ mitochondria might serve as a powerful tool for detailed characterization of
this assembly step.
Another open question is how exactly ATP6/ATP8 mRNA translation is reg-
ulated by the preassembled F1 module. Moreover, it is not known if translational
control is happening by a specialized protein complex or, alternatively, one of the
complex V assembly intermediates. If Atp6/Atp8 translational control is indeed
spatially separated from the assembly, where does F1 come from? The population
of F1 that assembles on the Atp6/Atp8 module is, most likely, used in the assembly.
Is this assembly hotspot the only place where F1 is made in the cell (and thus sup-
plied for complex V biogenesis and regulation of ATP6/ATP8 mRNA synthesis), or
does another one exit? The F1 module that is involved in translational regulation
might be assembled independently in another place in the mitochondrion. If the
latter is the case, it would be exciting to investigate whether an interplay between
these two potential F1 pools exists during complex V biogenesis and whether they
differ in their composition or associate with specialized proteins.
We showed that F1 dissociates from the Atp6/Atp8/Atp10/Atp23/F1/peripheral
stalk complex under BN-PAGE conditions. Therefore, the complex is unstable and
hard to detect by common biochemical approaches. This, and its low levels in wild
type mitochondria, might explain why it has not been identified before.
The above discussed data confirm that in the absence of Ina22, assembly of
the F1Fo-ATP synthase is stalled and that Atp6/Atp8, together with their assembly
factors Atp23 and Atp10, the peripheral stalk and F1 module, accumulate in one
complex. The only part which is missing in this assembly intermediate to complete
the mature complex V is an Atp9 ring. Our experimental results clearly state that
neither Atp10, nor Atp23, physically interact with the Atp9 ring and therefore these
two proteins can not mediate the last assembly step, namely Atp9 ring connection.
3.5 INAC mediates formation of the membrane proton chan-
nel in the last step of complex V formation
Immunoprecipitation of endogenous Ina22 after radiolabeling of mitochondrial-
encoded proteins revealed that it associates with newly translated Atp6, Atp8 and
with the Atp9 ring. As INAC is not a part of the mature F1Fo-ATP synthase,
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it was obvious that this interaction occurs within assembly intermediates. Our
further analysis confirmed that Ina22 is present in two different complexes. One of
them contains newly translated Atp6, Atp8 and Atp23. Another one contains the
assembled Atp9 ring. It is likely that the Atp6/Atp8-containing protein complex also
contains Atp10, however, due to the lack of antibodies raised against endogenous
Atp10, we could not show this experimentally. Moreover, we need to analyze whether
INAC associates with the Atp6/Atp8 module prior to the peripheral stalk and F1,
to facilitate their incorporation into complex V. Most likely this is the case, as it was
already shown that INAC facilitates peripheral stalk assembly (Lytovchenko et al.,
2014). However, due to the instability of the intermediate, this question will be very
difficult to address experimentally.
Our finding that Ina22 can be cross-linked to the Atp9 ring, and thus directly
interacts with it, but can also be cross linked to Atp4, ultimately proves that it
is present in the two final complex V assembly intermediates. Until now, no pro-
teins have been discovered that might link the Atp9 ring to the Atp6/Atp8 module
and, therefore, complete the F1Fo-ATP synthase. It is worth emphasizing again
how important the last step of complex V assembly is. Until this point, the proton
channel-forming subunits, Atp6 and Atp9, are kept spatially separated in the inner
mitochondrial membrane in order to avoid their premature association and proton
channel formation. In was shown in bacteria that the Fo module can dissipate mem-
brane potential (Franklin et al., 2004), therefore, a specialized mechanism should
exist to prevent this. We can speculate that the INA complex mediates the final
complex V assembly step. INAC is physically present on the Atp6/Atp8 module
and therefore directly monitors its assembly state. Furthermore, it is in direct con-
tact with the Atp9 ring to prevent the proton channel from being formed before the
peripheral stalk and F1 are assembled.
Two different models of INAC function can be proposed. According to the first
model, INAC remains associated with Atp6/Atp8 until the peripheral stalk and
F1 are correctly positioned. The correct attachment of nuclear-encoded subunits
might induce conformational changes in the Atp6/Atp8 module that releases Ina22
and enables Atp9 ring attachment. On the other hand, Ina22 associated with the
Atp9 ring is also released once the ring is incorporated into complex V. Whether
Ina22 is recycled between Atp6/Atp8 and Atp9 intermediates during assembly is an
interesting question that should be addressed. Our second hypothesis is that the
connection of the two assembly intermediates might be driven by INAC dimerization,
meaning that the dimer is formed by Ina proteins associated with the Atp9 ring and
the Atp6/Atp8 module. Once the peripheral stalk and F1 are positioned, slight
conformational changes in the Atp6/Atp8 intermediate are induced which could
drive INAC dimerization and complex V assembly. Afterwards, the dimer is released
from complex V. Additionally, this hypothesis requires some factors to disassemble
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the INAC dimer. This process would be energy-dependent and therefore, it is highly
unlikely that it can happen spontaneously.
Whereas Ina22 is highly unstable upon INA17 deletion, it is evident that Ina17
does not require Ina22 for its stability. Therefore, we can not exclude that Ina17
might be present in the cell in some Ina22-independent pool. However, our results
indicate that Ina17 can not associate with complex V in the absence of Ina22.
Therefore, we exclude that complex V assembly might be driven by Ina17-Ina22
association/dissociation. However, we can not exclude that some additional, not
yet identified, proteins might play a role in the assembly and an interplay between
them and INAC is possible.
It is tempting to speculate that Ina22 functions as a chaperone that interacts
with proton-channel forming residues on both Atp6 and Atp9 to protect them from
the membrane lipid environment. If this is true, Ina22 should be present in 1:1
stochiometry on the Atp9 ring, whereas only one Ina22 molecule would be required
to shield Atp6. This is hard to address experimentally and, most probably, structural
studies of purified intermediates would be required to prove whether this is the case.
3.6 A novel model of F1Fo-ATP synthase assembly
Based on the results obtained in this study, we propose a novel model of F1Fo-
ATP synthase assembly in S. cerevisiae. Accordingly, Atp6 is synthesized with an
N-terminal extension, which is cleaved by Atp23. We do not know at which assem-
bly step exactly the cleavage occurs. It is hard to address experimentally if Atp6
association with Atp8 is required for Atp23 recruitment and, therefore, N-terminal
processing. Moreover, we can only speculate that Atp6 is stabilized by Atp10 prior
to processing. Most likely, Atp10 engages first with preAtp6 and Atp23 is recruited
later, followed by Atp8 association. Nonetheless, experimental evidence for this is
still missing. Afterwards, Atp6 associates with Atp8 within an Atp10- and Atp23-
containing protein complex. This complex represents an assembly-competent pool
of Atp6 and Atp8 in the cell. Most importantly, the Atp6/Atp8 module functions as
a platform for the assembly of the peripheral stalk and F1. Whether some additional
factors associate with this complex to facilitate assembly of the nuclear-encoded pro-
teins is a matter of debate, but we have now shown that the INA complex interacts
with this assembly intermediate. Simultaneously, the INA complex associates with
a preformed Atp9 ring. In the last assembly step, INAC links the two assembly
intermediates together and the mature complex V is produced. After the Atp9 ring
is connected, INAC, Atp10 and Atp23 are released from the assembly intermediates
and no longer remain associated with complex V (see Fig.3.1).
The model of F1Fo-ATP synthase assembly proposed in this study differs by
one important aspect from the previously published one (Rak et al., 2011). Though
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Figure 3.1 A novel model for F1Fo-ATP synthase assembly. 1. After its synthesis, Atp6
engages with Atp10 and Atp23 and it N-terminus is processed by Atp23. 2. Atp6
interacts with Atp8 and remains associated with Atp10 and Atp23 within an assembly-
competent intermediate, called the Atp6/Atp8 module. 3. The peripheral stalk and
F1 assemble on the Atp6/Atp8 module to generate a first major assembly intermediate.
The INA complex is recruited to this intermediate to prevent an untimely Atp6/Atp9
interaction. 4. the Atp9 ring, associated with INAC, is connected to the first assembly
intermediate. 5. The final assembly step triggers release of the assembly factors.
the authors identified the Atp6/Atp8 module as an autonomous assembly inter-
mediate that is formed independently from the Atp9 ring, they claim that F1
does not associate with the Atp6/Atp8 module during complex V assembly. In-
stead, an Atp9 ring/F1 intermediate is formed, which associates later with the
Atp6/Atp8/peripheral stalk. According to our results, an Atp6/Atp8/F1/peripheral
stalk intermediate can be detected after IgG affinity chromatography or immuno-
precipitation from mitochondria, solubilized in 1% digitonin and 160 mM NaCl to a
final protein concentration of 1-2 mg/mL. Moreover, this complex is highly unstable
and therefore falls apart to a single F1 unit and Atp6/Atp8/peripheral stalk module
under BN-PAGE conditions. In contrast to our experimental conditions, Rak et al.
used mitochondria, solubilized in 3% digitonin and 400 mM NaCl to a final con-
centration of 10 mg/mL to isolate complex V assembly intermediates and analyzed
them by sucrose gradient centrifugation. We conclude that the conditions used by
Rak et al. were not optimal for keeping the above mentioned intermediate stable.
In agreement with this, in our hands Atp5 was co-isolated with the above mentioned
intermediate, whereas Rak et al. could not co-isolate Atp5 with the Atp6/Atp8 mod-
ule. When the authors tried to deplete the newly formed Atp6/Atp8 intermediate
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with anti-Atp2 antibodies, lysed mitochondria were incubated with the serum for 2
hours at room temperature, conditions that would definitely lead to F1 dissociation.
Nevertheless, despite the differences between the two models regarding this
one step of complex V assembly, the models agree on one very important aspect -
association of the Atp9 ring with Atp6 and, therefore, the formation of the membrane
proton channel is the final step of F1Fo-ATP synthase biogenesis.
3.7 Evolutionary conservation of the INA complex and the
F1Fo-ATP synthase assembly pathway
Close homologs of Ina proteins are present only in the fungal kingdom and can
not be identified in higher eukaryotes. Interestingly, our preliminary analysis showed
that there is a likely correlation between the existence of an Ina22 homolog in a fun-
gal species and the Atp9 protein being encoded in the mitochondrial genome. For
example, in Neurospora crassa, the Atp9 subunit is encoded in the nuclear genome
and an Ina22 sequence homolog is not found. On the other hand, in all species
that possess an Ina22 homolog and whose mitochondrial genome is sequenced, Atp9
was found to be mitochondrial-encoded. However, not enough fungal mitochon-
drial genomes have been sequenced to perform a more comprehensive analysis and
to obtain a clear conclusion. Therefore, it will be exciting to check in the future
whether this correlation between Atp9 being mitochondrial-encoded and the ex-
istence of INAC homologs can be substantiated. If true, this would additionally
support our hypothesis that the INA complex might be required to prevent a pre-
mature Atp6/Atp9 ring association.
Our search did not reveal obvious Ina17 or Ina22 homologs in higher eukaryotes,
including humans. It is worth mentioning that the assembly of human F1Fo-ATP
synthase is less studied compared to yeast complex V assembly. Some preliminary
data indicate that the assembly pathway involves formation of the F1/Atp9 ring and
the Atp6/Atp8/peripheral stalk intermediates, however, clear experimental evidence
for this is missing and the conclusion was made based on the model of yeast complex
V assembly according to Rak et al., 2011 (Fujikawa et al., 2015).
Clearly, it can not be excluded that assembly of the human F1Fo-ATP synthase
indeed differs to some extent from yeast. The major differences between the two
might be caused by the c-ring (Atp9 ring), which in humans consists of three nuclear-
encoded proteins (ATP5G1/2/3) and therefore might involve a different biogenesis
mechanism (Anderson et al., 1981). Of all assembly factors, only the homologs
for Atp23, Atp11 and Atp12 were identified in human (Wang et al., 2001; Fischer
et al., 2013). Whereas the Atp11 and Atp12 (ATPAF1 and ATPAF2) function in
F1Fo-ATP synthase assembly was shown, ATP23 involvement in the biogenesis of
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complex V was not investigated. Interestingly, although human ATP23 contains a
highly-conserved catalytic site required for the proteolytic activity, it is not known
whether human ATP6 is expressed with a leader peptide and requires processing by
ATP23.
No proteins involved in the regulation of ATP6 and ATP8 translation in hu-
man have yet been identified and therefore it is not known if translation of these
mitochondrial-encoded proteins is coordinated with complex V assembly. Never-
theless, we anticipate that formation of the Atp6/Atp9 proton channel in human
F1Fo-ATP synthase should be regulated in order to avoid membrane potential dissi-
pation and, most likely, a functional homolog of the INA complex might be present
in human mitochondria.
Recently, the TMEM70 protein was characterized as an essential protein in-
volved in human F1Fo-ATP synthase assembly. Patients, harboring heterozygous
mutations in TMEM70 suffer from severe complex V deficiency, leading to ultra-
structural mitochondrial degeneration, encephalocardiomyopathy and neonatal pul-
monary hypertension (Braczynski et al., 2015; Diodato et al., 2015; Finsterer and
Kothari, 2014). A homozygous knockout of Tmem70 in mice is embryonically lethal,
pointing to the importance of the protein in complex V biogenesis. Interestingly,
when respiratory chain complexes from Tmem70 -/- mice embryos were analyzed, a
severe reduction in the amount of mature complex V and an increase in unassembled
F1 were detected, similar to the ina mutants phenotype in yeast (Vrbacky et al.,
2016). The similarity of the complex V defects upon Tmem70 and INA complex
deletions might point to a similar role of TMEM70 in human Fo biogenesis and must
be investigated in more detail.
So far our knowledge on human F1Fo-ATP synthase assembly is far from com-
plete. We do not know anything about how translation of mitochondrial-encoded
ATP6 and ATP8 is regulated or how individual Fo is assembled and linked to F1.
Current knowledge is scarce and came mainly from studies of patients in which struc-
tural subunits or assembly factors of complex V are mutated. However, mutations in
proteins essential for complex V assembly might be lethal and therefore patients are
rare. Since oxidative phosphorylation is not an essential process in yeast, genome-
wide knockout screens can be performed to identify proteins involved in OXPHOS
machinery biogenesis. In some cases, the identified proteins have human homologs
and so knowledge on yeast OXPHOS system assembly can be transferred to the
human system. Unfortunately, this is not the case with the assembly of the human
F1Fo-ATP synthase. Therefore, another strategy must be employed and genetic
screens in human cells should be performed. Screening available knockout genomic
libraries, or libraries in which genes are systematically down- or upregulated, might
be very useful (Gilbert et al., 2014; Arroyo et al., 2016).
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3.8 C-terminal processing of Ina22
The mitochondrial proteome is very dynamic and 5-10% of mitochondrial pro-
teins are degraded within the organelle per generation under normal conditions
(Augustin et al., 2005). This is achieved by mitochondrial proteases of the IMS, the
matrix and the inner mitochondrial membrane. Due to such turnover, the misfolded
and damaged proteome is constantly eliminated and the organelle is maintained in
a healthy condition. Therefore, mitochondrial protease activity can be considered
to be necessary for normal mitochondrial physiology (Baker et al., 2011).
In our study, we discovered that Ina22 undergoes C-terminal processing. Due
to the lack of antibodies against the endogenous protein, C-terminally tagged Ina22
was used in the previous investigation and the processing was therefore overlooked
(Lytovchenko et al., 2014). Interestingly, the protein is processed twice, resulting in
the generation of two fragments of approximately 186 and 166 amino acids in length,
which can be detected along with full-length Ina22. The processed C-terminal pep-
tides are rather short in length (50 and 30 amino acids), soluble and can not be
easily detected with antibodies due to their small size. Screening several known
yeast IMS and IMM protease knockout mutants yielded no apparent candidate.
The amino acid motifs where the processing occurs, EKVYLS and GIVTDL for the
186 and 168 fragments, respectively, do not represent a conserved cleavage site for
any mitochondrial protease known so far.
We have noticed that Ina22 fragments are hard to detect by immunoblotting in
intact mitochondria. Moreover, their amount, as well as the ratio between the full-
length Ina22 and the processed forms, varies greatly among different mitochondrial
preparations and depends on the energy sources used (performed in collaboration
with N. Vögtle from C. Meisinger group, data was not shown), implying that the
processing might depend on the growth phase of the cell and physiological state of
mitochondria. As the antibodies were generated against the soluble C-terminus of
Ina22, we can not exclude that the recognized epitopes localize at the extreme C-
terminus and, therefore, get processed. However, after immunoprecipitation of Ina22
from solubilized mitochondria, two fragments always appear significantly enriched
compared to the full-length Ina22. Hence, we assume that stability of the Ina22
C-terminus decreases greatly upon solubilization. Overall, it seems like Ina22 is
highly intrinsically unstable and requires additional proteins, like Ina17, for its sta-
bility. Most likely, the multiple interactions, which Ina22 maintains within protein
complexes, decrease it turnover. Therefore, after solubilization, the potential stabi-
lizing proteins dissociate from Ina22, leaving its C-terminus accessible for processing.
We showed that the processing of Ina22 does not alter its function and, therefore,
yeast respiration. We speculate that it most likely represents normal physiological
turnover and is unlikely to have a regulatory role for complex V assembly.
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Nevertheless, identifying the protease involved, as well as its substrate spec-
trum, might contribute to our knowledge on mitochondrial protein homeostasis and
its regulation.
3.9 The elusive role of INAC*CBP association
In the previous study (Lytovchenko et al., 2014), Ina22 and Ina17 interaction
with Cbp proteins was identified. Here, we confirmed that endogenous, non-tagged
Ina22 and Ina17 indeed associate with Cbp3, Cbp6 and Cbp4 and that this interac-
tion is not a post-lysis artifact. Moreover, we showed that the interaction between
INAC and Cbps takes place within a multiprotein complex, containing newly trans-
lated cytochrome b. The integrity of this complex depends on the presence of cy-
tochrome b and can not be maintained without it. Moreover, our intensive analyses
confirmed that the above mentioned complex represents neither intermediate I or II
of complex III assembly. This conclusion was made based on the observation that,
first of all, the complex does not contain early complex III structural subunits and
it can not be accumulated upon stalling of complex III assembly. Importantly, in
ina mutants, neither the Cbp3-Cbp4 interaction and the integrity of intermediate I,
nor the amount of intermediate I are altered, implying that the INAC-CBP complex
does not represent a complex III assembly intermediate (data was not shown).
Despite our intensive analyses of ina and cbp deletion mutants, we could not
identify a phenotype associated with complex III and complex V respectively. There-
fore, we conclude that this newly identified complex is not important for biogenesis
of either complex III or F1Fo-ATP synthase and its possible function remains un-
known.
Cox1, Cox2 and Cox3 translational activators were previously shown to co-
localize on the inner mitochondrial membrane for localized translation of their re-
spective proteins and hence for a more efficient assembly of complex IV (Naithani
et al., 2003). Moreover, yeast proteins involved in the translation of seven mitochon-
drial mRNAs have been shown to associate in a 900-kDa protein complex for more
efficient interaction with the transcription machinery through Nam1 (Krause et al.,
2004). This was recently additionally confirmed by the identification of the mi-
tochondrial organization of gene expression (MIOREX) complexes (Kehrein et al.,
2015). Therefore, this evidence indicates that the mitochondrial gene expression
system is organized into large protein complexes, which presumably facilitate gene
expression in the organelle. However, neither the estimated size of the INAC/CBP
complex, nor the presence of cytochrome b in it allows us to assume its possible
association with ribosomes and consequently a transcription/translation regulatory
function. Moreover, no evidence exists so far to support a possible Ina22 function
in transcription/translation control for either complex V subunits or cytochrome b.
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In summary, the possible role of the INAC/CBP association remains unidenti-
fied. The size of this complex (around 300 kDa) makes it likely that more proteins
are present in it and, therefore, mass spectrometry analysis might reveal more can-
didates and shed a light on its function.
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4. Conclusions and Perspectives
Eukaryotic cells rely on efficient energy production by mitochondria. The F1Fo-
ATP synthase complex, the main energy-producing protein complex in most cells
and tissues, has an intricate architecture and originates from two different genomes.
Its proper biogenesis requires coordinated cytoplasmic and mitochondrial transla-
tion, as well as a highly-regulated assembly process. Failure in F1Fo-ATP synthase
biogenesis leads to decreased energy production and is deleterious for the cell. In
this thesis, open questions about the biogenesis of the F1Fo-ATP synthase were ad-
dressed. In particular, this study was devoted to the functional investigation of the
INA complex, which was previously shown to participate in complex V assembly.
We focused our attention on the functions of the INA complex in biogenesis of the
F1Fo-ATP synthase complex and tried to reveal its role in biogenesis of complex III.
Moreover, we checked if the interplay between assemblies of both complexes exists.
The main conclusions of this project can be summarized as follows:
• The INA complex consists of two mitochondrial inner membrane proteins,
Ina22 and Ina17. The proteins associate with each other in a stable complex,
required for maintaining Ina22 stability. Upon Ina17 deletion, Ina22 undergoes
degradation and therefore its levels decrease in the cell. However, remaining
Ina22 is able to associate with complex V assembly intermediates.
• The INA complex is not associated with the mitochondrial translation ma-
chinery and, therefore, does not directly regulate translation of Atp6, Atp8
and Atp9. However, in ina mutants, Atp6 and Atp8 translation and abun-
dance increase almost two-fold, resulting in an accumulation of stable proteins
within an assembly intermediate, the Atp6/Atp8 module. This module repre-
sents an assembly-competent pool of Atp6 and Atp8 in the mitochondria. We
speculate that the observed translational upregulation is an indirect effect of
elevated levels of free F1 module in ina mutants. Moreover, we assume that
the Atp9 ring is destabilized in ina22Δ and ina17Δ due to its delayed assembly
into F1Fo-ATP synthase.
• The INA complex interacts with the Atp6/Atp8 module and its assembly fac-
tors, namely Atp23 and Atp10. In ina mutants, the Atp6/Atp8 module accu-
mulates, implying that it associates with INAC downstream in the assembly
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pathway. Overexpression of Atp23 rescues the phenotype of the ina mutants,
namely F1 dissociation, and partially restores complex V levels.
• In this study, we show for the first time that the peripheral stalk and F1
assemble on the Atp6/Atp8 module, implying that an alternative assembly
mechanism might exist. This includes the formation of previously unknown
assembly intermediates.
• Ina22 could be cross-linked to components of the two final F1Fo-ATP synthase
assembly intermediates, the Atp6/Atp8 module and the Atp9 ring. Therefore,
the INA complex is the most likely candidate to mediate the final assembly
step, formation of the Fo proton channel, to complete complex V. In agreement
with this, connection of the Atp6/Atp8 module to the Atp9 ring is severely
delayed in ina mutants compared to wild type, resulting in less mature complex
V being formed.
• INAC association with the cytochrome b assembly machinery was investigated,
but the physiological significance of this interaction was not revealed.
In this study we have shown that the INA complex is involved in the formation
of the Fo proton channel. However, the molecular mechanisms behind it were not
investigated in detail. Therefore, it should be addressed in the future as to how
exactly INAC mediates Atp9 ring attachment to Atp6 and whether it functions as
a molecular chaperone for these two proteins.
Accumulation of the Atp6/Atp8 module in ina mutants might be used as a tool
to isolate and further study the protein composition of this assembly intermediate.
Thereby, novel F1Fo-ATP synthase assembly factors might be identified and the
exact mechanism of the peripheral stalk and F1 assembly can be determined.
In conclusion, the gained knowledge on the assembly of the yeast F1Fo-ATP syn-
thase has refined the current model of yeast F1Fo-ATP synthase assembly pathway
and can likely be used in the future to extend our understanding of the biogenesis
of the human enzyme.
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5.1 Materials
5.1.1 Chemicals
Standard reagents used in this study were purchased from AppliChem (Darm-
stadt, Germany), BD (Heidelberg, Germany), Bio-Rad (Richmond, USA), Bio-
Chemica (Sauerlach, Germany), Roche (Mannheim, Germany), Merck, Novagen and
Calbiochem (Darmstadt, Germany), Roth (Karlsruhe, Germany), Serva (Heidelberg,
Germany), Sigma-Aldrich (Taufkirchen, Germany), Thermo Scientific (Schwerte,
Germany). Enzymes and corresponding buffers were from Seikagaku Biobusiness
(Tokyo, Japan), Roche (Mannheim, Germany) and Invitrogen (Darmstadt, Ger-
many). The complete list of reagents can be found in Table 5.1.








Acrylamide/bisacrylamide (37.4:1) solution Roth
Acrylamide, 4x crystallized Roth












Bacto Yeast Extract BD
Bio-Rad Protein Assay Bio-Rad
Continued on the next page
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Chemical Supplier
Bis-Acrylamide Roth
Bis-Tris Buffer grade AppliChem
Bovine serum albumin Sigma-Aldrich
Chloramphenicol Sigma-Aldrich
CNBr activated sepharose 4B GE Healthcare
Complete EDTA-free protease inhibitor mix Roche
Coomassie Brilliant Blue G-250 Serva
Coomassie Brilliant Blue R-250 Serva





Cytochrome c from bovine heart Sigma-Aldrich
DAB (diaminobenzidine) Sigma-Aldrich
DDM (n-Dodecyl-β-D-maltoside) Sigma-Aldrich
DFDNB (1,5-difluoro-2,4-dinitrobenzene) Thermo Scientific
Digitonin Calbiochem
DMP (dimethyl pimelimidate dihydrochloride) Sigma Aldrich
DMSO (dimethylsulfoxide) AppliChem
DNA ladder mix “Gene Ruler” Fermentas
DSP (dithiobis(succinimidyl propionate)) Thermo Scientific
DSS (disuccinimidyl suberate) Thermo Scientific
DTT (1,4-dithiothreitol) Roth
EDTA (ethylenediaminetetraacetic acid) Roth
Ethanol Roth
Ethidium bromide 0.07% w/v AppliChem






HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid ) Roth
Herring sperm DNA Promega
Hydrochloric acid 37% w/v Roth
IgG from human serum Sigma Aldrich
IgG protein standard BioRad
Imidazole Sigma Aldrich
Lead (II) nitrate Merck
Lithium acetate AppliChem
Magnesium chloride heptahydrate Merck
Magnesium sulfate heptahydrate Roth
Methanol Roth
Methionine Roth
MOPS (morpholinopropanesulfonic acid) Sigma-Aldrich
NADH (nicotinamide adenine dinucleotide) Roche
Ni2+-NTA agarose Quiagen
Nourseothricin Werner BioAgents








Potassium dihydrogen phosphate Merck
Continued on the next page
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Chemical Supplier
Potassium hydroxid Roth
Proteinase inhibitor coctail Roche Applied Science
Proteinase K Roche
SDS (sodium dodecyl sulfate) Serva
SDS-PAGE protein standard Serva
Sepharose 4B GE Healthcare
SnakeSkin dialysis membrane (7000Da-MW cut-off) Thermo Scientific
Sodium azide Roth


















Yeast nitrogen base without amino acids BD
Zymolyase 20 T Seikagaku Biobusiness
5.1.2 Buffers and solutions
Recipes for the buffers used are given in Table 5.2. All buffers were prepared
using Milli-Q deionized water and analytical grade chemicals. Compositions of all
buffers are given in (1x) dilution. Media for yeast growth and transformation were
autoclaved/filtered after preparation.
Table 5.2 Buffers and solutions
Buffer Components
AVO mix 1 mM antimycin, 0.1 mM valinomycin, 2 mM oligomycin in ethanol
Blotting buffer 25 mM Tris, 192 mM glycine, 10% methanol
BN anode buffer 50 mM Bis-Tris pH 7.0
BN cathode buffer 50 mM tricine, 15 mM Bis-Tris, with or without 0.2% Coomassie
Brilliant Blue G-250
BN gel buffer 67 mM 6-aminocaproic acid, 50 mM Bis-Tris pH 7.0
BN sample loading buffer 0.5% (w/v) Coomassie Brilliant Blue G-250, 50 mM 6-aminocaproic
acid, 10 mM Bis-Tris pH 7.0
Continued on the next page
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BSA (bovine serum albumin)-
import buffer
3% (w/v) fatty acid free bovine serum albumin, 250 mM sucrose, 80
mM KCl, 5 mM MgCl2, 10 mM MOPS-KOH pH 7.2, 5 mM methio-
nine
Carrier DNA Herring sperm DNA (10 mg/ml) in TE buffer
Colloidal Coomassie staining so-
lution
0.1% (w/v) Coomassie Brilliant Blue G-250, 2% (w/v) phosphoric
acid, 10% (w/v) ammonium sulfate, 20% methanol
Coomassie staining solution 2.5 g/l Coomassie Brilliant Blue R-250, 40% ethanol, 10% acetic acid
Crosslinking buffer 20 mM HEPES pH 7.4, 100 mM NaCl
DDM solubilization buffer 20 mM Tris/HCl, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 0.6%
DDM
Destaining solution 30% ethanol, 10% acetic acid
Digitonin solubilization buffer
(low-stringent)




10 mM Tris/HCl pH 9.0, 400 mM NaCl, 10% glycerol, 10 mM imi-
dazole, 1 mM EDTA, 3% digitonin
DNA loading dye 10% sucrose, 0.25% OrangeG
DTT buffer 10 mM DTT, 100 mM Tris/H2SO4 pH 9.4
EM 10 mM MOPS-KOH pH 7.2, 1 mM EDTA
Fixation solution 50% methanol, 2% phosphoric acid
His-free media 6.7 % (w/v) yeast nitrogen base w/o amino acids, 20% (w/v) sucrose,
25% (w/v) agar (for plates), 0.77g/l CSM-HIS
Homogenization buffer 0.6 M sorbitol, 10 mM Tris/HCl pH 7.4, 1 mM EDTA, 0.2% (w/v)
fatty acid free BSA, 1 mM PMSF
LB medium (Lysogeny broth) 1% (w/v) tryptone, 0.5% (w/v) NaCl, 1% (w/v) yeast extract
Lithium acetate/PEG 0.1 M lithium acetate, 40% polyethylene glycol 4000 in water, filter-
sterilized
Na-deoxycholate 1.25% (w/v) sodium deoxycholate in water
PMSF stock 0.2 M phenylmethylsulfonyl fluoride in ethanol
Potassium phosphate buffer pH
7.2
71.7% (w/v) K2HPO4, 28.3% (w/v) KH2PO4
Potassium phosphate buffer pH
7.4
80.2% (w/v) K2HPO4, 19.8% (w/v) KH2PO4
Resolving gel (for SDS-PAGE) 10-16% acrylamide, 80 mM Tris-HCl pH 6.8, 0.1% SDS, 0.1% ammo-
niumperoxodisulfate, 0.05% TEMED
SDS loading buffer 10% glycerol, 2% (w/v) SDS, 0.01% bromophenole blue, 60 mM
Tris/HCl pH 6.8
SDS running buffer 25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS
SEM 250 mM sucrose, 10 mM MOPS-KOH pH 7.2, 1 mM EDTA
Stacking gel (for SDS-PAGE) 4% (w/v) arylamide, 0.1% (w/v) SDS, 380 mM Tris-HCl pH 8.8,
0.1% (w/v) ammonium peroxodisulfate, 0.05% TEMED
TAE buffer 40 mM Tris/acetate pH 8.0, 2 mM EDTA
TBST (Tris-Buffered Saline and
Tween-20)
50 mM Tris, 150 mM NaCl, 0.05% Tween-20
TBS (Tris-Buffered Saline) 50 mM Tris, 150 mM NaCl
TCA solution 72% trichloracetic acid in water
TE buffer 10 mM Tris pH 8.0, 1 mM EDTA
Ura-free media 6.7 % (w/v) yeast nitrogen base w/o amino acids, 20% (w/v) sucrose,
25% (w/v) agar (for plates), 0.77g/l CSM-URA
Urea acrylamide solution 60% (w/v) Acrylamide, 0.8 % (w/v) Bis-Acrylamide
Washing buffer 0.3% digitonin, 20 mM Tris/HCl pH 7.4, 100 mM NaCl, 10% glycerol,
1 mM PMSF, 1 mM EDTA
YPAD (2x) 2% (w/v) yeast extract, 4% (w/v) peptone, 4% (w/v) glucose, 0.008%
(w/v) adenine hemisulfate, autoclaved
YPD 1% yeast extract, 2% peptone, 2% glucose, autoclaved
YPG 1% (w/v) yeast extract, 2% (w/v) peptone, 3% (w/v) glycerol, auto-
claved
YPGal 1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) galactose, au-
toclaved
Continued on the next page
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Buffer Components
Zymolyase buffer 1.2 M sorbitol, 20 mM potassium phosphate pH 7.4
1.5xTranslation buffer 900 mM sorbitol, 225 mM KCl, 22.5 mM potassium phosphate buffer
pH 7.2, 30 mM Tris/HCl pH 7.4, 4.5 mg/ml BSA, 6 mM ATP, 0.75
mM GTP, 9 mM α–ketoglutarate, 10 mM Creatine phosphate, 10
μg/mL creatine kinase, 0.15 mM amino acid mix (Met-free), 7.5
μg/ml cycloheximide, 19 mM MgSO4
5.1.3 Kits and disposables
Disposables and commercial kits used in this study together with their suppliers
are listed in Table 5.3. Kits were used and stored according to the manufacturer’s
instructions.
Table 5.3 Kits and disposables
Product Supplier
anti-FLAG-M2 Affinity gel Sigma-Aldrich
Alkaline phosphatase, shrimp Roche Applied Science
CELLSTARR© Centrifuge Tubes 15 ml, 50 ml Geiner Bio-One
ECL Plus Western Blotting Detection Reagent GE Healthcare
FastDigest Restriction enzymes Fermentas/Thermo Scientific
FLAG-peptide Sigma-Aldrich
FlexiR© Rabbit Reticulocyte Lysate System Promega
GeneRuler DNA Ladder Mix Fermentas/Thermo Scientific
High Molecular Weight Calibration Kit GE Healthcare
HyperfilmTM ECL films GE Healthcare
Immobilon-P Transfer membrane Millipore
KOD Hot Start DNA Polymerase Novagen
Microtube 1.5 ml and 2.0 ml Sarstedt
Minisart syringe filters Sartorius AG
Pipette tips 10 μl, 200 μl and 1 ml Sarstedt
Protein A sepharose CL 4B GE Healthcare
Rapid ligation kit Thermo Scientific
Roti-QuantR© Roth
SP6 mMESSAGE mMACHINER© Kit AmbionR©, Life TechnologiesTM
Spin Columns Mobicol “Classic” MoBiTech
TNTR© Quick coupled Transcription/Translation System Promega
Tobacco Etch Virus (TEV) protease Sigma-Aldrich
Unstained SDS-PAGE protein Marker, 6.5 - 200 kDa Serva (Heidelberg, Germany)
WizardR© Plus SV Gel and PCR DNA Purification System Promega
WizardR© SV Minipreps Promega
5.1.4 Equipment






EPS 601 power supply GE Healthcare
Hoefer SE600 Ruby Blue native system GE Healthcare
Mini-PROTEANR© 3 Cell Bio-Rad
Mini-SubR© Cell GT Cell Bio-Rad
PowerPacTM HC Power Supply Bio-Rad
Semi Dry Blotting Chamber PEQLAB Biotechnologie
Centrifuges
SorvallR© RC 12BP Thermo Scientific








SorvallR© F14S- 6x250Y Thermo Scientific
SorvallR© F10S- 6x500Y Thermo Sientific
SorvallR© SS-34 Thermo Scientific







Agfa Curix 60 Developing machine Agfa
Autoradiography Storage Phosphor Screen GE Healthcare
BioPhotometer Eppendorf
iMarkTM 1300 Spectrophotometer GE Healthcare
LAS 1000 FujiFilm
Starion FLA-9000 FujiFilm
Storm 820 Phosphorimager GE Healthcare
UVsolo TS transilluminator Biometra
Other
Autoclave Systec DX-200 Systec
Balance BP 3100P Sartorius
Branson Sonifier 450 G. Heinemann, Schwäbisch Gmünd
Electronic Digital Balance Kern ABJ 220-4M KERN Son
EmulsiFlex C5 Avestin
ExcellaR© E10 platform shaker New Brunswick Scientific
G25 Shaker Incubator New Brunswick Scientific
InnovaR© 44 Incubator shaker New Brunswick Scientific
GeneQuantTM 1300 Spectrophotometer GE Healthcare
Magnetic Stirrer MR 3001 Heidolph
Milli-Q-Water purification system Millipore
NanoVueTM Spectrophotometer GE Healthcare
pH-meter InoLab
Pipettes Gilson
Potter S glass-Teflon Homogenizer Sartorius AG
Termomixer Comfort Eppendorf
TPersonal 48 thermocycler Biometra
UVsolo TS transilluminator Biometra
Vacuum gel drier Scie-Plas




List of software used for data analyses, image processing and documentation of
data is given in Table 5.5.
Table 5.5 Software used in this study
Software Company
Adobe Illustrator CS6 Adobe Systems, San Jose, CA, USA
Adobe Photoshop CS6 Adobe Systems, San Jose, CA, USA
DataGraph 3.1.1 Visual Data Tools, Inc.
Geneious Pro 5.3.6 Biomatters, Auckland, New Zealand
ImageQuant TL GE Healthcare BioSciences AB, Uppsala, Sweden
Microsoft Office Microsoft Corporation, Redmond, WA, USA
Genious Pro 4.8.3 Biomatters Ltd.
TeXShop 3.26 Richard Koch, Mathematics Department, University of Oregon
5.1.6 Antibodies
Rabbit polyclonal antisera were used for detection of Saccharomyces cerevisiae
proteins. For the detection of HA-tagged and FLAG-taged yeast proteins corre-
sponding mouse monoclonal antibodies were used (Sigma-Aldrich). Horseradish per-
oxidase (HRP)-conjugated goat anti-rabbit and goat anti-mouse antibodies (Jackson
ImmunoResearch) were used as secondary antibodies. The complete list of antibod-
ies is given in Table 5.6.
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Goat anti-rabbit, HRP conjugated Goat polyclonal
Goat anti-mouse, HRP conjugated Goat polyclonal
FLAG tag Mouse monoclonal
Protein A tag, HRP-conjugated Rabbit polyclonal
5.1.7 Yeast strains used in this study
All yeast strains used in this study are derivatives of BY4741 strain (Brachmann
et al., 1998), except for cbp1Δ strain, generated from intronless XMP171. Wild type
and newly generated yeast strains used in this study are listed in Table 5.7.
Table 5.7 Yeast strains
Strain Genotype Reference
BY4741 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 Euroscarf





ina17Δ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 ; INA17::kanMX4; Euroscarf
ina22Δ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 ; INA22::kanMX4 Euroscarf
Ina221-188 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 ;
INA22189-216::HIS3MX6
This study
Ina221-168 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 ;
INA22169-216::HIS3MX6
This study
Atp23↑ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; GPD:Atp23 This study
ina22ΔAtp23↑ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; INA22::kanMX4;
GPD:Atp23;
This study
ina22ΔAtp23H128A↑ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 ; INA22::kanMX4;
GPD:Atp23; atp23::ATP23 H128A-URA3
This study
Ina22↑ina17Δ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; GPD:Ina22;
INA17::kanMX4
This study




Continued on the next page
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Strain Genotype
Atp23HA MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; atp23::ATP23HA-
HIS3MX6
This study
Ina22FLAG MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; ina22::INA22FLAG-
URA3
This study
Atp10ProtA MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0;
atp10::ATP10TEV-ProtA-7HIS-HIS3MX6
This study
Atp10ProtAina22Δ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; INA22::kanMX4;
atp10::ATP10TEV-ProtA-7HIS-HIS3MX6
This study
atp22Δ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 ; ATP22::HISMX6 This study
Cbp3ProtA MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0;
cbp3::CBP3TEV-ProtA-7HIS-HIS3MX6
This study
Cbp4ProtA MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0;
cbp4::CBP4TEV-ProtA-7HIS-HIS3MX6
This study
Cbp6ProtA MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0;
cbp6::CBP6TEV-ProtA-7HIS-HIS3MX6
This study
cbp6Δ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 ; CBP6::HIS3MX6 This study
qcr8Δ MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 ; QCR8::HIS3MX6 This study
cbp1Δ MATα leu2-3, 112 ura3-52 lys2 arg8:hisG [cox1::ARG8m
cox2::COX1 COX2] cbp1::kanMX4
This study
Cbs1ProtA MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0;
cbs1::CBS1TEV-ProtA-7HIS-HIS3MX6
This study
Cbs2ProtA MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0;
cbs2::CBS2TEV-ProtA-7HIS-HIS3MX6
This study
For yeast strain generation, the corresponding chromosomal integration cas-
settes were used (Table 5.8) according to published procedures (Janke et al., 2004;
Gueldener et al., 2002). For protein tagging, we used cassettes encoding the required
C-terminal tag, allowing expression of the protein of interest from its endogenous
promoter. For gene deletion, the corresponding genes were replaced by a selectiv-
ity marker. For gene overexpression, the endogenous promoter was replaced by the
glyceraldehyde 3-phosphate dehydrogenase promoter, allowing an increase in protein
amount.
For generation of Atp23H128A catalytic mutant, a wild type ATP23 gene was
first cloned into p426TEF vector and a point mutation was introduced via a site-
directed mutagenesis with oligonucleotides 5’-AATTGCTTATTTCGATGATCTAA-
AATGG-3’ and 5’-AATTCATGCGAAAGCGTATCCTC-3’. Then, a fragment con-
taining ATP23H128A and URA3 genes was amplified from this plasmid and used for
homologous recombination to exchange the wild-type ATP23 with ATP23H128A in
Atp23↑ strain.
For Ina22 C-terminal tagging with a FLAG-tag, the integration cassette was
amplified from pUG72 plasmid with primers 5’-GCTTGCGTTATATTTACATGTG-
GTATATCCGGATGCATAGAGCCTAATCGATGAATTCGAGCTCG-3’ and 5’-G-
ATAAAATCCCAAAATTTCTAGACTACAAAGACGATGACGACAAGTAGCGT-
ACGCTGCAGGTCGAC-3’, encoding a FLAG peptide, and the obtained PCR-
product was used for yeast transformation.
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5.1.8 Oligonucleotides used in this study
All nucleotides used in this study were ordered at Metabion (Martinsried, Ger-
many) or SeqLab (Göttingen, Germany). The complete list is given in Table 5.10.
5.1.9 Plasmids used in this study
Plasmids, used in this study, are listed in Table 5.8. All plasmids were propa-
gated in E. coli XL1 blue strain and prepared according to 5.5.2.
Table 5.8 Plasmids
Plasmid Purpose Reference
pFA6a-kanMX4 yeast gene deletion Janke et al., 2004
pFA6a-HIS3MX6 yeast gene deletion Janke et al., 2004
pYM2 C-terminal tagging with 3HA Janke et al., 2004
pYM10 C-terminal tagging with TEV-ProA-7His Janke et al., 2004
pYM-N14 yeast protein overexpression Janke et al., 2004
pYM-N15 yeast protein overexpression Janke et al., 2004
pUG72 yeast gene deletion Gueldener et al., 2002
p426TEF yeast protein overexpression in yeast Promega
pTNT in vitro transcription/translation Promega
pPROEXHTc E. coli expression plasmid Life Technologies (Invitrogen)
5.1.10 E. coli strains used in this study
E. coli strains used in this study are listed in table 5.9
Table 5.9 Bacterial strains
Strain Genotype Reference































INA22 deletion in BY4741 5’-CAACAAGGAAAGACAAGTCATACGTAAAAGGTGTAAGGAAAAATGCGTACGCTGCAGGTCGAC-3’;
5’-GCGTTATATTTACATGTGGTATATCCGGATGCATAGAGCCTACTAATCGATGAATTCGAGCTCG-3’
INA17 deletion in BY4741 5’-GTAAACTTTGAGAAAGGAAATGGGAACCAAAGCATATAATAGACAATATGCGTACGCTGCAGGTCGAC-3’;
5’-CAATGGTACATTCTAGAAACACGAAAAGCCAACAAGATAACTAATTCTCAATCGATGAATTCGAGCTCG-3’
Ina22 C-terminal HA-tagging 5’-TTGAATGAAATCGCCAAAGAACATGATAAAATCCCAAAATTTCTACGTACGCTGCAGGTCGAC-3’;
5’-GCGTTATATTTACATGTGGTATATCCGGATGCATAGAGCCTACTAATCGATGAATTCGAGCTCG-3’










Ina2227-216 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-GAGCCTACTACATCATCATTAGAAATTTTGGG-3’
Ina2227-206 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-CTACTACATCATCATGGCGATTTCATTCAAATCACC-3’
Ina2227-196 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-CTACTACATCATCATCATCATCATATGGACAT-3’
Ina2227-186 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-CTACTACATCATCATAACCTTTTCATCTTCTTTTTTC-3’
Ina2227-176 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-CTACTACATCATCATTAAATCTTTTAGAACATTC-3’
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Ina2227-166 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-CTACTACATCATCATAATCCCTTCTTTGTTCTTAACGC-3’
Ina2227-156 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-CTACTACATCATCATTGGAGTTTTTTCGATTACTTC-3’
Ina2227-146 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-CTACTACATCATCATCTCGTCTATTATACTTTGCC-3’
Ina2227-136 mRNA synthesis 5’-GGATTTAGGTGACACTATAGAATACATGGTTGCATCAGCAAATGCGGG-3’;
5’-CTACTACATCATCATCAATGACTCTTCCTTAGGAACC-3’
ATP4 coning into pTNT 5’-ATATGAATTCCCATGAGCATGAGTATGGGTGTCC-3’;
5’-ATATGCGGCCGCTTA TTACATCATCATCTTCAATTTAGAAAGCAATTG-3’
ATP4 in vitro transcrip-
tion/translation
5’-GGATTTAGGTGACACTATAGAATAC ATGAGCATGAGTATGGGTGTCCGTG-3’;
Atp10 C-terminal tagging 5’-GCCAAATAGCCGCCCATCCCTTGTTGGCCGCCGCACAAAGCGTCAACTTCA ATCGATGAATTCGAGCTCG-
3’;
5’-GGCTACTCCATCTGAAAAGGAAGCATTGTGGAAGTTTGCCAAACGTCTGCGTACGCTGCAGGTCGAC-3’




Atp23 genomic overexpression 5’-GGAAAGCTGATAGTACCGAATTTTTTTTTTTTTTGGCACGATATGCGTACGCTGCAGGTCGAC-3’;
5’-GCATGGTCCGTCTCCACCACTCAAACCCAGCATTATCCCCACTGCTATTCATCGATGAATTCTCTGTCG-3’
ATP23 cloning into p426 TEF 5’-ATTATAGGATCCATGAATAGCAGTGGGGATAAT-3’;
5’-AATAATAAGCTTTCATCTGTAAATCTCATCAAACG-3’
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Atp23 C-terminal tagging 5’-GCGTCTATATATTTTCTATTATAGAATATTGTCATTTATTACATTGGTTCA ATCGATGAATTCGAGCTCG-3’;
5’-GGGACAGTTGCTTCGCCGATACGAGACCGTTTGATGAGATTTACAGA CGTACGCTGCAGGTCGAC-3’
QCR8 deletion in BY4741 5’-CAAATAATCAACAAAACACTACACAAAAACTTCTACGATAATGCGTACGCTGCAGGTCGAC-3’;
5’-GAAGATCAAAAGATCGATGTAATGTAGAGGCATGGAAACAATATTA ATCGATGAATTCGAGCTCG-3’
CBP6 deletion in BY4741 5’-GCTTACCAAGTTAAACTCCGTATTCCACAAGCAAGTGCCAAAATGCGTACGCTGCAGGTCGAC-3’;
5’-GAATAAATATGTATTTACAAGCTTAGAAAATAATGTGCTCTTTAATCGATGAATTCGAGCTCG-3’
Cbp3 C-terminal tagging 5’-CTAAACGAGCTAGTTTGTAACTTCAAAACTTATGAAAACACATCGATGAATTCGAGCTCG-3’ ;
5’-CCTAAAACCTTACCAAGCGAGAGAAGTAGGCTGTCATATACAAACCGTACGCTGCAGGTCGAC-3’
Cbp4 C-terminal tagging 5’-GCAAAAGTTCAAGCTGCCCTTCCTAATTGAGTGACCCGACCCATCTAATCGATGAATTCGAGCTCG-3’ ;
5’-GGAAATAGTCCAGGATAAGCAGGTTAAAAGCTGGTGGCGCTTCTGGCGTACGCTGCAGGTCGAC-3’
Cbp6 C-terminal tagging 5’-GAATAAATATGTATTTACAAGCTTAGAAAATAATGTGCTCTTTAATCGATGAATTCGAGCTCG-3’ ;
5’-GGAAAGCTTATTTACTGCAATGAGAACTGTATTATTTGGTAAACGTACGCTGCAGGTCGAC-3’
INA22 mRNA synthesis ; 5’-GGATTTAGGTGACACTATAGAATACATGTTTATGGCAAGACAAGTG-3’
5’-GAGCCTACTACATCATCATTAGAAATTTTGGG-3
CBP1 deletion in XMP171 5’-GCACTTTAGGATAGCAGTAGTTTGCATTTTGCACGTTTCCCTTTCCATGCAATGCGTACGCTGCAGGTCGAC-
3’;
5’-GTTATTATTTGCTTTGTTATTTATATCGTAAATGTGCGTTTGGCCGTTCATATCGATGAATTCGAGCTCG-3’
Cbs1 C-terminal tagging 5’-GTAAATAAAACAAAGGGATAACGGACAAAAAGGCATCGTTTCTTTTGTACTAATCGATGAATTCGAGCTCG-
3’;
5’-CAATTATAAAAACTATATGCATACCTCTAATTAATTACCATTTGCGTAAATCA CGTACGCTGCAGGTCGAC-3’




5.2 E. coli methods
5.2.1 E. coli growth
E. coli cultures were grown according to standard procedures using lysogeny
broth (LB, 1% NaCl, 0.5% yeast extract, 1% tryptone) (Sambrook and Russell,
2001). Plates were supplemented with 15 g/L agar. Antibiotic selection markers
were used in the following concentrations: 0.1 g/L ampicillin, 0.03 g/L kanamycin.
Cryo-stocks of E. coli were generated by mixing 800 μL of a culture in selective LB
medium with 200 μL sterile 80% glycerol in a cryo vial and freezing it at -80◦C.
5.2.2 E. coli transformation
Chemically-competent E. coli cells were prepared according to Hanahan, 1983.
In brief, a 100 mL culture with OD600 of 0.6 was cooled down on ice and cells were
harvested by centrifugation for 5 min at 3000 g. The cell pellet was resuspended in
40 mL ice-cold buffer 1 (30 mM KAc, 100 mM RbCl, 10 mM CaCl2, 50 mM MnCl2,
15% glycerol, pH 5.8), followed by a 5 min incubation on ice. After one more
centrifugation step, cells were resuspended in buffer 2 containing 10 mM MOPS, 75
mM CaCl2, 10 mM RbCl, 15% glycerol, pH 6.5, aliquoted and stored at -80
◦C.
For transformation, cell aliquots were defrosted on ice, mixed with 100 ng plas-
mid DNA or 10 μL ligation mix, incubated for 30 min on ice and subjected to a
heat-shock (60 sec at 42◦C). Afterwards, cells were cooled down on ice and incubated
for 1 hour at 37◦C in 1 mL LB medium. Then, the cells were pelleted for 2 min,
3000 g, resuspended in 100 μl LB and plated to LB plates containing an appropriate
selectivity marker.
5.3 S. cerevisiae cultivation and preparation of mitochon-
dria
5.3.1 Cultivation of S. cerevisiae
For cultivation of S. cerevisiae, YPD, YPG and YPGal media were used (see
Table 5.2). Liquid cultures were grown at 30◦C with shaking (190 rpm). For the
preparation of solid media, 2% (w/v) agar was added to the respective media be-
fore autoclaving. For the cultivation of nourseothricin and geneticin 418 sulfate –
resistant strains on solid media, the antibiotic was added to the media after auto-
claving, to the final concentration of 1 mg/mL. Synthetic medium lacking histidine
or uridine was used to cultivate strains bearing HIS3 and URA3 genes in BY4741
background.
Yeast strains were preserved as cryo-stocks by transferring material from an
appropriate plate into cryo vials containing 1 mL of 2xYPAD with 15% glycerol and
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storing them at -80◦C.
5.3.2 Growth test
To examine the viability of different yeast strains, growth tests on fermentable
(YPD) and non-fermentable (YPG, YPGal) carbon sources were performed. 5 ml
of YPD medium were inoculated with yeast cells and grown overnight at 30◦C with
shaking (200 rpm). On the next day, cells were spun down (100 g, 5 min), washed
once with sterile water and adjusted to the final OD600 = 1. Serial 10-fold dilutions
of cells were prepared (range from OD600=1 to OD600=0,00001), and the cells were
spotted on plates with corresponding media. The plates were grown at different
temperatures (24, 30 or 37 ◦C) for 2 days for YPD medium and up to five days for
YPG and YPGal media-containing plates.
5.3.3 Yeast transformation
For yeast transformation with exogenous DNA, the lithium acetate/PEG method
was used (Gietz and Schiestl, 2007). Yeast strains were precultured in 10 ml of (2x)
YPAD medium (see Table 5.2) overnight at 30 ◦C with shaking. On the next day,
the overnight culture was used to inoculate 50 ml of (2x) YPAD medium to OD600 of
approximately 0.6 and grown until OD600 reached 1.5-2.0. The cells were harvested
by centrifugation (1000 g, 10 min) and washed once with sterile water (1000 g, 10
min). The cell pellet was washed with 0.1 M lithium acetate solution and resus-
pended in 2 ml 0.1 M lithium acetate. For further transformation steps, 100 μl of
cells prepared in this way were used. 300 μg of purified exogenous DNA were added
to 100 μl of resuspended cells together with 120 μg of carrier DNA, followed by a
30 min incubation at 30◦C with shaking (450 rpm). After this, 600 μl of lithium
acetate/PEG solution were added (see Table 5.2), cells were carefully mixed by
pipetting and incubated for 1 more hour at 30◦C, 450 rpm. Then, 68 μl of DMSO
were added, the cells were exposed to 42◦C heat shock for 15 min, harvested by
centrifugation (100 g 2 min), resuspended in 60 μl of 1 M sorbitol and plated on
appropriate solid selective media. Cells transformed with an antiobiotic-resistance
cassette were grown additionally for 4 hours at 30◦C in 1 mL 2xYPAD, cells were
collected by centrifugation and plated on appropriate selective plates.
5.3.4 Preparation of mitochondria
Mitochondria from yeast cells were prepared by differential centrifugation as
described in Meisinger et al., 2006. For the mitochondrial preparation, yeast were
pre-cultured in 5 mL of YPD media and then sequentially in 100 and 200 mL of
either YPG or YPGal. The last pre-culture was used to inoculate the main cul-
ture. Flasks were incubated overnight at 30◦C with shaking (190 rpm), until OD600
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reached 1.5 - 2.5. Cells were pelleted at 4000 g for 15 min, washed with water and
resuspended in DTT buffer (2 ml of buffer per 1 g of initial cell pellet, see Table
5.2), followed by a 30 min incubation at 30 ◦C with shaking (200 rpm). Then the
cells were collected by centrifugation (3000 g 10 min), washed with 1.2 M sorbitol
and zymolyase buffer and resuspended in zymolyase buffer (7 ml of buffer per 1 g
of initial cell pellet). Yeast cells were treated with 1 mg/g of zymolyase for 1 hour
at 30◦C with shaking (190 rpm), to digest the cell wall and to obtain spheroplasts.
Treated cells were washed once with zymolyase buffer without the enzyme, resus-
pended in homogenization buffer (7 ml/g of starting yeast pellet) and homogenized
by 15 strokes at 800 rpm in Potter S glass-Teflon homogenizer. Then the homog-
enized cells were subjected to several centrifugations to remove unbroken cells and
cellular debris: 5 min at 3000 rpm, then 10 min at 4000 rpm and, finally, 15 min
at 12000 rpm to pellet the mitochondrial fraction (centrifugation was performed in
Sorvall R© RC6 Plus centrifuge, with Sorvall R© F10S rotor). The mitochondrial pellet
was washed once with SEM/PMSF buffer and resuspended in approximately 0.5 ml
of SEM/PMSF buffer. The protein concentration was determined by a Bradford
assay (see 5.4.1) and the mitochondrial suspension was diluted to obtain final pro-
tein concentration 10 mg/ml. Prepared mitochondria were aliquoted in single-use
aliquots, flash-frozen and stored at -80◦C.
5.3.5 S. cerevisiae whole-cell extract preparation
To prepare a whole cell extract, yeast were first precultured in YPD medium
for few hours. An amount of cells corresponding to 3 OD600 was taken. The cells
were spun down for 5 min at 3000 g and resuspended in 275 mM NaOH with 1%
β-mercaptoethanol, followed by 15 min incubation on ice. Afterwards, proteins were
precipitated with 12% TCA for 30 min on ice and samples were centrifuged for 10
min at 16000 g. The pellet was washed with ice-cold acetone, resuspended in SDS-
loading buffer and titrated with Tris base until the color of the sample turned blue.
After this, samples were incubated at 37◦C with shaking for at least 15 min and
used for further SDS-PAGE analysis.
5.4 Methods for analysis of proteins and protein complexes
5.4.1 Determination of protein concentration
To determine protein amounts in isolated mitochondria, Roti R©-Quant Bradford
protein determination assay was used. First, 0, 7.5, 15, 30 and 60 μg/μl bovine
immunoglobulin was used to establish a calibration curve. Then 5, 10 or 20 μl of
mitochondrial suspension were adjusted to a volume of 84 μl and 1 ml of Roti R©-
Quant reagent was added. After a 5 min incubation at room temperature, the
108
MATERIALS AND METHODS
optical density was measured at 595 nm. The protein concentration was determined
according to the calibration curve and adjusted to the concentration of 10 mg/ml
with SEM buffer.
5.4.2 SDS-PAGE
Electrophoretic separation of proteins under denaturing conditions (Laemmli,
1970) was performed using polyacrylamide gels of different percentages with 0.1%
SDS. For a stacking gel, a 4% polyacrylamide gel buffered with Tris/HCl pH 6.8
was used. For the separation of proteins, we used 10-17.5% resolving acrylamide
gels, buffered with Tris/HCl pH 8.8. Protein samples were loaded on a gel after
mixing with SDS-loading buffer and a 5 min incubation at 95◦C, or after a 15
min agitation at room temperature. Gels were run at 30 mA/gel in SDS-running
buffer containing 1 % SDS. For the estimation of protein electromobility, SDS-PAGE
Molecular Weight Standart, Broad Range (Bio-Rad) or unstained protein standard
from Serva was used.
5.4.3 Urea SDS-PAGE
For separation of small proteins and mitochondrial-encoded products, proteins
were analyzed by 17.5% Urea SDS-PAGE. In brief, proteins were stacked in a stack-
ing gel containing 5.45% Urea acrylamide solution, 0.1 M Tris/HCl pH 6.8, 3.64
M Urea and 0.1% SDS. For the separation of proteins, the resolving gel was used,
containing 17.5% of Urea acrylamide solution, 0.68 M Tris/HCl pH 8.8, 8 mM NaCl,
5.43 M Urea and 0.1% SDS. Samples were prepared as in 5.4.2, loaded on a gel and
the gel was run at 35 mA/gel for 5 hours in Urea running buffer (0.1% SDS, 50 mM
Tris, 192 mM glycine).
5.4.4 BN-PAGE
For separation of large mitochondrial protein complexes in native conditions,
BN-PAGE electrophoresis was used (Schägger and Jagow, 1991). Mitochondrial
samples were pelleted (16000g, 10 min, 4◦C) and solubilized to the final protein
concentration 1 μg/μL for 15 min at 4◦C. Unsolubilized material was removed by a
clarifying spin (10 min, 16000g, 4◦C), supernatant was mixed with 10X Blue Native
loading buffer and loaded onto a gradient gel of desired percentage with 4% stacking
gel. Electrophoresis was performed using the SE600 Ruby System (GE-Healthcare),
at 4◦C, starting with the voltage of 200 V, 15 mA for 1h, and then shifted to 600
V. High molecular weight calibration kit (GE Healthcare) was used to estimate
the molecular weight of protein complexes. For the first 2 hours, cathode buffer
with Coomassie Brilliant Blue G-250 was used. Afterwards, the cathode buffer was
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exchanged toa Coomassie-free buffer and the gel was run until the running front
reached the gel bottom.
For analysis of protein complexes by second-dimension electrophoresis, a gel
strip was cut out of a Blue Native gel and assembled on top of an SDS-PAGE
stacking gel. The gel was run according to 5.4.2.
Solubilization buffer: 20 mM Tris/HCl (pH 7.4), 0.1 mM EDTA (pH 8.0), 50
mM NaCl, 10% glycerol, 1mM PMSF, supplemented with 1% (w/v) digitonin or
0.6% (v/v) dodecylmaltoside (DDM).
5.4.5 Western blotting and immunodecoration
Proteins separated on SDS-PAGE or BN-PAGE gels were transferred to PVDF
membranes by semi-dry blotting using PEQLAB chambers. A membrane of appro-
priate size was activated in methanol and assembled underneath the gel, between
layers of Whatman paper soaked in blotting buffer. Transfer to the membrane was
performed at 250 mA for 2.5 hours. After the transfer, the membrane was stained in
Coomassie staining solution to visualize protein bands and protein molecular weight
marker. The membrane was cut in appropriate parts, the Coomassie dye was re-
moved by washing with methanol and the membrane was incubated for 1 hour in 5%
milk in TBST (for SDS-PAGE gels) or 2 hours in 10% milk in TBST (for BN-PAGE
gels) for blocking. After this, membranes were incubated with primary antibodies
for 1 hour at room temperature or at 4◦C overnight. Membranes were washed with
TBST buffer 3 times for 5 minutes, followed by 1 hour incubation with secondary
antibodies, coupled to HRP. After 3 more washing steps, signals were detected with
the help of enhanced chemiluminescence detection kit (GE Healthcare) using X-ray
films.
5.4.6 Coomassie Brilliant Blue staining
Proteins in acrylamide gels and on PVDF-membranes were stained with Coomas-
sie staining solution (see Table 5.2) for 1 hour for gels and for a few minutes for
membranes. After this, gels and membranes were destained in destaining solution
until protein bands appeared. To remove the Coomassie dye, the membranes were
washed with methanol.
5.4.7 Colloidal Coomassie staining
To avoid background staining of acrylamide gels, Colloidal Coomassie stain-
ing was used. In brief, a polyacrylamide gel was first fixed in a fixing solution
(40% ethanol, 10% acetic acid) for at least 60 min. Afterwards, the gel was briefly
washed twice with distilled water. Following washing, the gel was stained in dye
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solution (20% methanol, 0.08% (w/v) Coomassie Brilliant Blue G-250, 1.6% ortho-
phosphoric acid, 8% (w/v) ammonium sulfate) for at least 24 hours. Then, Coomassie
particles were removed by washing the gel in 1% acetic acid until the background
disappeared.
5.4.8 IgG affinity chromatography
IgG affinity chromatography was used for isolation of protein complexes. For
this, yeast strains were generated, in which the C-terminus of the protein of in-
terest was fused to Protein A from S. aureus. IgG-sepharose beads were prepared
by cross-linking purified human IgG to cyanobromide-activated Sepharose 4B (GE
Healthcare) according to manufacturer’s instructions. Before use, the beads were ac-
tivated by washing twice with 5 bed volumes of acetate buffer pH 3.4 (1.43 ml acetic
acid was diluted with 50 ml of water, pH was set to 3.4 with 3.8% (w/v) NH4Ac).
Then the beads were washed twice with 2x and 1x solubilization buffer. Mitochon-
drial membranes were solubilized as described in 5.6.1. Unsolubilized particles were
removed by 10 minutes centrifugation at 16000 g and the supernatant was mixed
with activated IgG sepharose. The mixture was incubated for 2 hours at 4◦C with
moderate shaking. After this, the unbound fraction was removed by centrifugation
at 200 g for 30 seconds. Beads with bound proteins were washed 10 times with 5
bed volumes of washing buffer (30 seconds, 200 g). For SDS-PAGE analysis, elution
from the beads was performed with SDS-loading buffer. Approximately 40 μl of
SDS-loading buffer were added to the beads and the mixture was incubated at 37◦C
for 15 min with shaking. Eluted proteins were analyzed by SDS-PAGE, followed
by immunoblotting. For isolation of native protein complexes, the protein A tag
was cleaved by His-tagged tobacco etch virus (TEV) protease (10 μg protease/1 mg
mitochondrial proteins) overnight at 4◦C. After cleavage, the protease was removed
by adding Ni-NTA beads (1 hour incubation at 4◦C) and purified protein complexes
were eluted by centrifugation (200 g, 2 minutes). For purification of Atp10ProtA con-
taining protein complexes in low and high-stringent conditions, mitochondria were
solubilized either in a low stringency (20 mM Tris/HCl pH 7.4, 10% glycerol, 160 mM
NaCl, 2 mM PMSF, 1 % digitonin) or in a high stringency buffer (10 mM Tris/HCl
pH 9.0, 400 mM NaCl, 2 mM PMSF, 3% digitonin, 10 mM Imidazol, according to
Rak et al., 2011), respectively, as in 5.6.1. Supernatant was incubated with beads
for 1.5 hours at 4◦C and beads were washed with 0.3% digitonin-containing low and
high-stringency buffers. All other steps were performed as in 5.4.8.
5.4.9 Protein immunoprecipitation
To immunoprecipitate endogenous yeast proteins, a corresponding specific an-
tiserum was covalently coupled to Protein A CL 4B sepharose (GE Healthcare).
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For this, the sepharose was transferred to a Mobicol spin column and washed twice
with 50 mM phosphate buffer pH 7.4 for 30 sec, 100g. After this, the specific serum
was diluted 1:1 with a 50 mM phosphate buffer pH 7.4, added to the column and
incubated with the protein A-coupled sepharose for 1 hour at room temperature,
with shaking. Afterwards, columns were washed with 0.1 M sodium borate (30 sec,
100g). To chemically crosslink Protein A to IgG, dimethyl pimelimidate (DMP)
was diluted in sodium borate buffer to a final concentration of 5 mg/mL and added
to the spin columns. The crosslinking reaction was performed for 30 min at room
temperature. The columns were afterwards washed twice with 1 M Tris/HCl pH
7.4 and further incubated in it for 2 hours at room temperature or overnight at
4◦C, with shaking. During the last step, non-crosslinked IgG was removed from the
beads by washing them 3 times with 5 bed volumes of 0.1 M glycine pH 2.6. The
columns were further washed 5 times with TBS buffer and stored in TBS with 1%
sodium azide at 4◦C.
Mitochondria were solubilized as in 5.6.1 and isolation of proteins was performed
as in 5.4.8. Bound proteins were eluted with 0.1 M glycine pH 2.6 and further
analyzed.
5.4.10 FLAG-affinity purification
To perform a native isolation of protein complexes, Ina22 was C-terminally
tagged with a FLAG peptide. To purify Ina22-containing complexes of interest,
Anti-FLAG M2 Affinity Gel (Sigma-Aldrich) was used. In brief, mitochondria were
solubilized according to 5.6.1, unsolubilized material was removed by centrifugation
for 10 min at 16000 g, 4◦C. The obtained supernatant was mixed with anti-FLAG
beads in ratio 10 μL of beads/1 mg of mitochondrial proteins and incubated on
the rotation wheel for 2 hours at 4◦C. The unbound material was removed by 30
sec centrifugation at 200g and beads were washed 10 times with 5 bed volumes
of washing buffer. Bound proteins were eluted with either 0.1 M glycine pH 2.6
(for further SDS-PAGE analysis) or with the FLAG-peptide (for further BN-PAGE
analysis of isolated protein complexes).
5.4.11 In vivo labeling of mitochondrial-encoded proteins
For in vivo labeling of mitochondrial-encoded proteins with [35S]Met, yeast
cells were grown overnight in YPG medium at 30◦C with agitation (200 rpm). The
next morning, yeast cultures were diluted to OD600 of 0.4 and grown in YPG until
OD600 reached approximately 1. After this, the amount of cells corresponding to
0.3 OD600 was taken, cells were pelleted by centrifugation (2 min 3000 g, room
temperature) and washed once with labeling buffer (50 mM phosphate buffer pH
7.2, 2% galactose). Afterwards, cells were resuspended in 0.5 mL of labeling buffer
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and incubated at 30◦C for 10 min, 600 rpm. Next, cycloheximide was added to
the final concentration of 150 μg/mL and cells were incubated for 5 more minutes.
To start labeling of mitochondrial-encoded proteins, 20 μCi of [
35S]Met were added
and labeling was performed for the required time period. Labeling was stopped
by addition of 10 mM unlabeled methionine and 100 μg/mL chloramphenicol. To
address protein stability, samples were incubated at 30◦ for additional 30, 60 or
90 minutes. Cells were spun down and washed once with water. Cell pellet was
resuspended in 500 μL of water and yeast whole-cell lysate was prepared (see 5.3.5).
Proteins were precipitated with TCA and analyzed by SDS-PAGE or Urea SDS-
PAGE, Western blotting and digital autoradiography.
5.4.12 TCA protein precipitation
For protein precipitation, TCA and sodium desoxycholate were added to the
protein sample to reach final concentrations of 14% and 0.0125%, respectively. The
samples were incubated at 4◦C for 30 minutes. After this, the samples were cen-
trifuged at 4◦C for 30 minutes to pellet the proteins. The pellet was washed with
500 μl of ice-cold acetone, dried at 37◦C for 10-15 minutes, diluted in SDS-PAGE
loading buffer and incubated for 15 minutes at 37◦C, 900 rpm. The samples were
loaded on SDS-PAGE or Urea SDS-PAGE and analyzed further.
5.4.13 Digital autoradiography
Radioactively labeled proteins in dried SDS-PAGE, BN-PAGE gels or on PVDF
membranes were visualized by exposure to Storage Phosphor Screen and detecting
signals with a Storm 820 Phosphorimager (GE Healthcare).
5.5 Molecular biology techniques
5.5.1 Preparation of genomic DNA from S. cerevisiae
To prepare genomic DNA from S. cerevisiae, yeast were precultured overnight
in 5 ml of YPD medium at 30◦C. On the next day, the cells were pelleted for 10 min
at 3000 g and resuspended in 150 μl of 50 mM Tris/HCl pH 7.5, 10 mM EDTA, 0.3%
β-mercaptoethanol, 0.5-0.25 mg/ml Zymolyase. The mixture was incubated at 37◦C
for 1 hour. After this, 20 μl of 10% SDS and 100 μl of 8 M ammonium acetate were
added, the solution was mixed and incubated at -20◦C for 15 minutes. Proteins were
pelleted by a 15 min centrifugation at 14000 rpm, and 180 μl of clear supernatant
were taken. This supernatant was mixed with 180 μl of isopropanol and spun down
for 15 min, 14000 rpm at 4◦C. The pellet was washed with 70% ethanol, dried and
resuspended in 100 μl of nuclease-free water. DNA concentration was determined
using NanoVueTMSpectrophotometer (GE Healthcare).
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5.5.2 Plasmid isolation from E. coli
Plasmid DNA was isolated using Wizard R© Plus SV Minipreps DNA Purification
System (Promega) according to manufacturer’s instructions. In brief, 4 mL of E. coli
culture were grown overnight at 37◦C in LB medium supplemented with appropriate
antibiotic. Next morning, the cells were harvested (5000g, 1 min). The pellet
was resuspended in 250 μL resuspension buffer and 250 μL lysis buffer were added
together with 10 μL alkaline protease. The samples were inverted 5 times and
incubated at room temperature for 5 min. Afterwards, 350 μL of neutralization
buffer were added and the samples were centrifuged for 10 min at 16000g. The
supernatant was collected, loaded on a filter column and centrifuged for 1 min,
16000g. The filter columns were sequentially washed with 750 and 500 μL of washing
buffer and dried afterwards. DNA was eluted from the column with 100 μL of dH2O
by centrifugation for 1 min, 16000g. Plasmid concentration was determined using
NanoVueTM Spectrophotometer (GE Healthcare) and DNA was stored at -20◦C.
5.5.3 Polymerase chain reaction (PCR)
DNA fragments for molecular cloning and yeast transformation were amplified
using KOD Hot Start DNA polymerase (Novagen) according to the manufacturer’s
protocol. Each 50 μl reaction mix contained 100 ng of genomic or plasmid DNA,
0.2 mM dNTP, 1 mM MgSO4, 0.3 μM forward and reverse primers and 1 U KOD
polymerase in 1x KOD reaction buffer. First, template DNA was denatured at 95◦C
for 2 minutes. After this, 35 cycles of polymerase chain reaction were performed,
each consisting of 10 sec primer annealing (temperature of annealing depended on
primers) and 20 sec elongation at 70◦C. PCR products were analyzed by agarose gel
electrophoresis with ethidium bromide staining followed by exposure to UV-light.
5.5.4 Agarose gel electrophoresis
For the visualization and purification of PCR products of different length,
agarose gel electrophoresis was used. 1% (w/v) agarose solution was freshly pre-
pared by dissolving an appropriate amount of dry agarose in TAE buffer. The
mixture was heated until agarose dissolved completely and then cooled to approx-
imately 50◦C. Ethidium bromide was added to the final concentration of 1 μg/ml
and a solid gel was prepared. Samples were mixed with DNA loading dye, loaded
on the solid gel and run at 8 V/cm. Separated DNA fragments were visualized by
illuminating the gel with UV-light.
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5.5.5 Purification of PCR products
PCR products were purified using Wizard R© Plus SV Gel and PCR purification
system (Promega) according to the manufacturer’s protocol. For this, a PCR prod-
uct was mixed with an equal amount of Membrane Binding solution, the mixture
was transferred to a Minicolumn and incubated for 1 minute at room temperature.
The minicolumn was centrifuged for 1 min at 16000 g and washed with 700 and 500
μl of Membrane Wash solution. DNA bound to the column was eluted with 50 μl of
DNase-free water. The final DNA concentration was estimated using NanoVueTM
Spectrophotometer (GE Healthcare).
5.5.6 Molecular cloning
Molecular cloning was performed according to standard procedures (Sambrook
and Russell, 2001). In brief, the plasmid of interest and purified PCR products were
digested with the appropriate restriction enzymes (FastDigest, Fermentas). For
this, 30 μL reactions were prepared containing 1x FastDigest buffer, 1 μL of each
restriction enzyme and 500 ng DNA. The reaction was incubated at 37◦C for 30 min
with slight agitation (600 rpm). The cut plasmid was dephosphorylated with 1 μL
alkaline phosphatase in 1x phosphatase buffer. DNA was purified according to 5.5.5
and ligated. For the ligation reaction, 100 ng of plasmid was mixed with insert in
1:3 molar ratio, and the reaction was carried out in a 1x ligation buffer with 1 μL T4
DNA ligase (Rapid DNA ligation Kit, Thermo Scientific) at 21◦C for 1 hour. The
ligation reaction was used to transform XL1 blue E. coli cells. All plasmids were
sequenced by GATC Biotech AG, Konstanz, or SeqLab, Göttingen.
5.5.7 In vitro mutagenesis
For introducing a point mutation in the catalytic site of Atp23, the ATP23 gene
was first cloned into the p426TEF plasmid. Afterwards, the plasmid was amplified
with ATP23 -specific forward and reverse primers. The forward primer contained
a nucleotide exchange allowing the mutation of a Histidine residue to Alanine. In
brief, the PCR reaction (50 μL) contained 100 ng plasmid DNA, 0.2 μM forward and
reverse primers, 1 μL dNTP mix and 2 U of polymerase in 1x buffer. The reaction
was performed according to 5.5.3. After the reaction, the template plasmid was
digested for 1 hour at 37◦C with DpnI, then the DNA was purified and ligated (see
5.5.6).
5.5.8 In vitro mRNA synthesis
For in vitro mRNA synthesis, SP6 mMESSAGE mMACHINE R© Kit was used
according to the manufacturer’s protocol. 0.1-0.2 μg of purified PCR products was
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incubated at 37◦C for 2 hours in a 20 μl reaction mixture containing 1x Reaction
buffer, 1xNTP/Cap and 2 μl enzyme mix. To recover the mRNA, 30 μl of lithium
chloride precipitation solution was added, mixed and incubated for 30 min at -20◦C.
Then the mRNA was pelleted for 30 min at 14000 rpm. The pellet was washed once
with 70% ethanol and dried at room temperature for 15 min. mRNA was diluted
with approximately 25 μl of RNAse-free water and the mRNA concentration was
determined using NanoVueTMSpectrophotometer (GE Healthcare).
5.5.9 Synthesis of radiolabeled protein precursors
Mitochondrial protein precursors were translated in vitro in the presence of
[35S] methionine using TNT SP6 quick Coupled Transcription/Translation system
(Promega) or Flexi R© Rabbit Reticulocyte Lysate system (Promega). Reactions
were assembled according to manufacturer’s protocols and incubated for 1 hour 30
minutes at 30◦C. 2 μl of plasmids containing the open reading frame of interest
under the control of SP6 promoter or 1.5 μg of mRNA were used per 50 μl reaction
volume for both systems, respectively.
5.5.10 Determination of nucleic acid concentration
mRNA or DNA concentrations were determined using NanoVueTMSpectropho-
tometer (GE Healthcare) according to the manufacturer’s instruction.
5.6 Assays with purified mitochondria
5.6.1 Solubilization of mitochondrial membranes
Mitochondrial membranes were solubilized in solubilization buffer containing
1% digitonin or 0.6% DDM (see Table 5.2). For this, mitochondria were thawed on
ice, pelleted by centrifugation (10 min, 16000 g) and then resuspended at 1 mg/ml
in solubilization buffer. The suspension was incubated for 15 min on a rotation
wheel at 4◦C. Unsolubilized particles were pelleted by centrifugation (10 min, 16000
g), clear supernatant was collected and used for different purposes.
5.6.2 Import of radiolabeled protein precursors into mitochondria
For protein import into mitochondria, radiolabeled protein precursors were syn-
thesized as described in 5.5.9. Mitochondria were thawed on ice and 65 μg of mito-
chondria diluted in 100 μl BSA import buffer were used per reaction. 12 mM NADH
and ATP were added to mitochondrial samples. 1 μl of AVO mix was added to the
control reaction to disrupt the membrane potential. The import reaction was started
by addition of 10 μl of radiolabeled protein precursor and stopped by addition of 1
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μl AVO mix. Import was performed at 25◦C for 4 different time points. After this,
mitochondria were spun down for 10 minutes at 16000 g, washed once with SEM
buffer and treated with 1 mg/ml proteinase K if needed (4 μl of 1 mg/ml PK was
added per reaction followed by 15 minutes incubation on ice). The mitochondrial
pellet was resuspended in 25 μl of SDS-loading buffer and proteins were separated
by SDS-PAGE electrophoresis. The gel was stained in Coomassie R-250 staining
solution, dried and exposed on storage phosphor screens (GE Healthcare).
5.6.3 In organello protein labeling with [35S]Met
For the analysis of mitochondrial translation products, proteins encoded in
the mitochondrial genome were labeled with [35S] methionine during mitochondrial
translation. 40 μg of thawed mitochondria were used per reaction. The reaction
buffer contained 40 μl 1.5x translation buffer (see 5.2), 1.5 μl creatine kinase (1
mg/ml) and 12.5 μl of water. Samples were prewarmed to 30◦C and the reaction
was started by adding 20 μM of [35S] methionine. Samples were incubated at 30◦C
during different pulse periods. The reaction was stopped by adding 5 μM methionine
and put on ice. In order to estimate the degradation of newly synthesized translation
products, samples were left at 30◦C for different time points. Then, the samples were
spun down (10 minutes, 16000 g) and mitochondrial pellets were washed once with
SEM buffer. The final pellet was resuspended in 30 μl of SDS-loading buffer and
incubated at 37◦C with shaking for 20 min. Samples were loaded on a 16% gel and
proteins were separated by SDS-PAGE followed by transfer to a PVDF membrane.
Membranes were stained in Coomassie staining solution to visualize protein marker,
dried and exposed on a storage phosphor screen (GE Healthcare).
5.6.4 Proteinase K protection assay
To determine mitochondrial protein localization, a proteinase K protection as-
say was performed. For this, mitochondria were incubated for 20 min in 1 mg/ml
either SEM, EM buffer or EM buffer with addition of 0.16% Triton-X100. Then each
sample was treated for 10 minutes with either 10 or 20 μg proteinase K. Proteinase
K was inhibited by addition 1 mM PMSF and samples were clarified by 10 minutes
centrifugation at 14000 rpm. The pellet was resuspended in SDS-Loading buffer and
analyzed using SDS-PAGE and western blotting.
5.6.5 Carbonate extraction of proteins
To determine the mode of protein association with the mitochondrial mem-
brane, carbonate extraction was performed. Mitochondria were resuspended in 0.1
M Na2CO3 pH 11.5 or sonicated in a buffer containing 500 mM NaCl, 0.125% Triton-
X100 and 20 mM Tris/HCl pH 7.4 (40% duty cycle, 1 minute, 5 cycles) followed by a
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20 minutes incubation on ice. After the incubation, samples were spun down for 30
minutes at 16000 g. The supernatants were transferred to new eppendorf tubes and
the pellets were resuspended in 100 μl of SEM buffer. Proteins were precipitated
with TCA as described in 5.4.12. The protein pellet was diluted in SDS-loading
buffer, loaded on SDS-PAGE and the protein content of each fraction was analyzed
by western blotting and immunodecoration.
5.6.6 Determination of in-gel activity of F1Fo-ATP synthase
To perform in-gel activity assays for mitochondrial complex V, mitochondria
were first solubilized as described in 5.6.1 and protein complexes were separated
using BN-PAGE (see 5.4.4). For the F1Fo-ATP synthase activity determination, a
gel strip was cut from the BN-PAGE gel and incubated for 30 min in complex V
calibration buffer (35 mM Tris, 220 mM glycine pH 8.3). After this, the gel was
transferred to complex V staining buffer (35 mM Tris, 220 mM glycine pH 8.3, 14
mM MgSO4, 0.2% (w/v) Pb(NO3)2, 8 mM ATP) and incubated at 30
◦ until bands
appeared. This method was modified from Wittig and Schägger, 2005.
5.6.7 ATPase activity measurement with and without oligomycin
ATPase activity of complex V was measured as the rate of ATP hydrolysis
(Chen et al., 1956; Ackerman and Tzagoloff, 2007). In brief, mitochondria (0.2
mg/ml) were resuspended in assay buffer (50 mM Tris-sulfate, pH 8.5, 4 mM MgSO4)
with or without 50 μM oligomycin. The reaction was started by addition of 20 mM
ATP and stopped after 20 min at 37◦C by adding 10% TCA. Reference samples
were treated in the same manner, except that the TCA was added prior to ATP.
After a clarifying spin (5 min, 16000 g), the amount of inorganic phosphate in the
supernatant was determined by an ammonium molybdate colorimetric assay. For
this, an equal volume of ammonium molybdate reagent (2% (w/v) ascorbic acid,
0.5% (w/v) ammonium molybdate, 1.2 N sulfuric acid) was added, the samples
were incubated at 37◦C for 2 h, and the absorbance at 820 nm was monitored. The
amount of released phosphate was determined based on a calibration curve with
known phosphate concentrations.
5.6.8 Fractionation of mitochondrial lysate through a sucrose cushion
To pellet mitochondrial ribosomes and their associated proteins, 300 μg of iso-
lated mitochondria were lysed for 30 min on ice in lysis buffer containing 1% Triton
X-100, 50 or 150 mM NaCl, 1 mM PMSF, 20 mM MgCl2 and 20 mM HEPES/KOH
pH 7.4. Unsolubilized material was removed by a clarifying spin at 16000 g, 4◦C
for 10 minutes. Afterwards, one half of the lysate was directly precipitated with
TCA, and the other half was underlayed with 50 μL of a sucrose solution (1.2 M
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sucrose in 20 mM Hepes/KOH pH 7.4) and centrifuged for 120 min at 145000 g at
4◦C. The supernatant was then collected and the pellet was resuspended in a lysis
buffer. Proteins from all fractions were precipitated with 12% TCA and analyzed
by SDS-PAGE and Western blotting.
5.6.9 Chemical protein cross-linking in mitochondria
For chemical cross-linking, mitochondria were thawed on ice and resuspended
in 1 ml/mg of mitochondria cross-linking buffer (20 mM HEPES pH 7.2, 100 mM
KCl). DSS or DSP, diluted in DMSO, were added to a final concentration of 250
μM. Samples were incubated on ice for 30 minutes, then the reactions were quenched
with 100 mM Tris/HCl pH 7.4 on ice for 10 minutes. Finally, mitochondria were
pelleted by centrifugation at 16000 g 4◦C for 10 min, the pellet was resuspended in
SDS-loading buffer, run on SDS-PAGE and analyzed by Western blotting.
5.6.10 Protein assembly into mitochondrial protein complexes
To perform assembly of radioactively labeled protein precursors into mitochon-
drial protein complexes, proteins were first imported into mitochondria and analyzed
by BN-PAGE. In brief, 75 μg of mitochondria per reaction were incubated in BSA-
import buffer containing 0.4 M KCl, 40 mM potassium phosphate buffer pH 7.4, 3
mM ATP, 3 mM NADH, 9 mM creatine phosphate and 10 μl of 10 μg/ml creatine
kinase. AVO-mix was added to the control samples to disrupt the membrane poten-
tial. 10 μl of lysate were added per reaction and import/assembly was performed for
15 and 45 min time points. After this, 4 μl of 1 mg/ml proteinase K was added to
all samples followed by 15 min incubation on ice. Proteinase K was inhibited by ad-
dition of 2 mM PMSF (5 minutes incubation on ice). Mitochondria were pelleted by
centrifugation (10 min, 16000 g), washed once with ice-cold SEM buffer, solubilized
as described in 5.6.1 and analyzed by BN-PAGE and digital autoradiography.
5.7 Miscellaneous
Mitochondrial targeting signals were predicted using the MitoProt Server (Claros
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